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Abstract 
Mesenchymal stem cells (MSCs) are multipotent stem cells residing within the 
bone marrow, with the ability to differentiate into cells of mesodermic origin 
(e.g. bone, cartilage and fat). These cells also possess extensive 
immunomodulatory and wound healing properties. Therefore, MSCs have 
multiple applications in the field of regenerative medicine. However, present 
day culturing techniques, encourage a loss of multipotency and limit the 
availability of true MSCs, for research and clinical use. A culturing technique, 
which is able to sustain multipotent and quiescent MSCs, is therefore required 
for future use. 
MSCs reside within a unique microenvironment in the bone marrow, termed the 
niche, which protects and regulates stem cell homeostasis. The niche 
environment controls maintenance, proliferation and differentiation of the stem 
cells. Current research is focused on the creation of an in vitro niche model, to 
study the regulatory mechanisms, which govern stem cell fate. The majority of 
existing models use traditional two-dimensional (2D) techniques. However, stem 
cells cultured by this method are known to lose potency and spontaneously 
differentiate into undesired cell types. These issues are caused by 2D in vitro 
niche models lacking the complexity and the three-dimensional (3D) nature, of 
the native in vivo niche. Therefore, in the last few years, research has moved 
away from 2D models, towards creating 3D in vitro niche models. 
This project aimed to develop a novel, bio-responsive in vitro 3D MSC niche 
model. The methodology adopted the use of magnetic nanoparticle loaded MSCs, 
which were levitated using an external magnetic field, to form multicellular 
spheroids which were subsequently located within a Type I collagen gel. The 
MSCs within the spheroid niche model exhibited native niche behaviour 
(retention of multipotency and quiescence). Furthermore, in the presence of a 
wound, the model accelerated the wound healing process. The MSCs 
directionally migrated out of the niche towards the wound site and start 
differentiating into the local resident cell type. Further investigation, identified 
IL-6 as a potential MSC migratory signal in this bio-response.   
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Chapter 1 – Introduction 
 
1 General Introduction: 
1.1 Stem Cells 
At the turn of the 20th Century, scientists recognised that during foetus 
development, certain cell types became the building blocks of life, which were 
able to differentiate into various tissue cell types. In 1908, at the annual 
Congress of the Haematologic Society in Berlin, Alexander A. Maximov first 
proposed the term stem cell (Loya, 2014). Maximov hypothesised blood cells 
originated from only one cell type and he suggested the local environment 
impacted on the differentiation capability of these cells (Friedenstein, 1989). 
The term ‘stem cell’ helped to describe these experimental observations, by 
comparing the process to the stem of a tree, giving rise to numerous branches. 
However, it was only in the 1960s, when McCulloch and Till studied mouse 
haematopoiesis, the researchers were able to unravel the potential properties of 
these stem cells (Till and McCulloch, 1961). The researchers discovered that 
transplanting spleens into irradiated mice formed cell colonies which were able 
to self-renew and differentiate into other cell types (Becker et al., 1963). 
Since the 1960’s, stem cell research has intensified, in order to better 
understand, as well as harness, two highly desirable and unique properties; self-
renewal and differentiation (Slack, 2012). Self-renewal allows the proliferation 
and generation of daughter stem cells, which possess the same properties as the 
parent stem cell. Conversely, stem cells are also able to differentiate and 
generate daughter cells with different characteristics, which become more 
specialised and form distinct tissue types. However, whilst these differentiated 
daughter cells (termed progenitor cells) have multi-lineage differentiation 
potential, they have limited self-renewal capabilities. 
Stem cells are categorised by their ability to differentiate, termed ‘potency’. 
When an egg is fertilised (zygote), totipotent stem cells are created in the first 
few divisions. These totipotent stem cells have the potential to recreate all 
extra-embryonic and embryonic cell types, making them the most versatile type 
of stem cell (McClure and Schubiger, 2007). Following further cell division and 
proliferation, these cells form a blastocyst, a structure comprising an inner mass 
20 
Chapter 1 – Introduction 
 
of pluripotent stem cells, which will form the embryo, and a rich source of 
embryonic stem cells (ESCs). These pluripotent cells are restricted to forming 
the three germ layers: ectoderm, endoderm and mesoderm. The endoderm layer 
forms the gastrointestinal tract and lungs of the foetus, whilst the mesoderm 
layer forms the muscle, bone and blood system, and the ectoderm layer 
develops into the epidermal and nervous system. ESCs become even more 
specialised as the foetus develops, creating a hierarchy of stem cell potency; 
multipotent, oligopotent and unipotent stem cells (Table 1-1 and Figure 1-1) (Lin 
et al., 2013). Adult stem cells are also known as somatic stem cells and 
encompass all multipotent, oligopotent and unipotent stem cells (Slack, 2012). 
Adult stem cells have a more restricted differentiation ability and are only able 
to differentiate into a limited number of different cell types. 
Table 1-1: Characterisation of stem cells with regard to their potency (differentiation 
potential). 
Stem cell type Characteristic Example 
Totipotent Differentiate into all 
embryonic and extra-
embryonic cell types. 
Cells of the zygote. 
Pluripotent Differentiate into all three 
germ layers. 
Embryonic stem cells and 
adult stem cells. 
Multipotent Differentiate into limited 
number of cell types. 
Adult stem cells e.g. 
mesenchymal stem cells. 
Oligopotent Differentiate into one or 
two cell types. 
Adult stem cells e.g. lymphoid 
stem cells. 
Unipotent Differentiate into one cell 
type. 
Adult stem cells e.g. 
spermatogonial stem cells. 
21 
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Figure 1-1: Stem cell classification indicating direction of stem cell differentiation potential. 
Embryonic stem cell (ESC), induced pluripotent stem cell (iPSC), mesenchymal stem cell 
(MSC), neural stem cell (NSC), epithelial stem cell (EpSC), common myeloid progenitor 
(CMP), lymphoid stem cell (LSC), spermatogonial stem cells (SSC) and mammary stem cells 
(MaSC) (Adapted from (Lin et al., 2013). 
Multipotent stem cells are only capable of differentiating into a limited number 
of cells, which are closely related to the stem cell. For example, haematopoietic 
stem cells (HSCs) are able to differentiate into all of the blood’s cellular 
components including platelets, red blood cells and white blood cells. Whereas, 
oligopotent stem cells are only able to differentiate into one or two mature cells 
types. An example of oligopotent stem cells are lymphoid stem cells, which are 
able to create some blood cells including B and T cells, but are not able to 
differentiate into red blood cells. 
Unipotent stem cells have the ability to self-renewal, but have the lowest 
differentiation capability, because they are only able to differentiate into a 
single cell type. For example, spermatogonial stem cells, which reside within the 
testes are only able to differentiate into spermatozoa. 
To potent	
Pluripotent	
Mul potent	
Oligopotent	
Bi-,	Uni-potent	
Zygote	
ESC	 iPSC	
MSC	 NSC	 EpSC	
CMP	 LSC	
SSC	 MaSC	
Li
n
ea
ge
	P
o
te
n
al
	
Ex
p
re
ss
io
n
	o
f	
P
LU
R
IP
O
TE
N
C
Y
	g
e
n
e
s	
22 
Chapter 1 – Introduction 
 
Pluripotent stem cells, such as ESCs, have a wide differentiation capacity 
compared to other stem cell types. Another advantage of ESCs is their ability to 
indefinitely self-renew in vivo, as well as retain an undifferentiated state, which 
are easily maintained ex vivo (Barker and de Beaufort, 2013). However, there is 
ethical and political controversy regarding the use of human ESCs in regenerative 
medicine, as it involves the destruction of embryos (Lo and Parham, 2009). 
Furthermore, evidence has shown ESCs induce an immune response by the host 
which may lead to rejection and failure of the transplant (English and Wood, 
2011). 
In 2006, Yamanaka et al., overcame these ethical issues by creating the first 
induced pluripotent stem cells (iPSCs) from adult mouse fibroblasts. These cells 
possessed similar properties to ESCs, without the associated ethical issues. The 
somatic cells were reprogrammed by the introduction of 4 transcription factors 
(Oct4, Sox2, c-Myc and Klf4) increasing their capability of expansive 
differentiation and self-renewal in vitro (Takahashi and Yamanaka, 2006). As the 
genome of somatic cells had been altered to create iPSCs, they are known to be 
less immunogenic upon transplantation into the original host, compared to the 
use of ESCs (Zhao et al., 2011). Therefore, iPSCs may provide patient specific 
somatic cells, which may model their disease to assess the effects of drug 
interactions ex vivo (Yu and Thomson, 2014). Although the use of iPSCs alleviates 
the ethical issues of using ESCs, there are still challenges when implanting iPSCs, 
which have been identified by Wan et al., (Wan et al., 2012). These concerns 
include the introduction of viral vectors, which alter the genome leading to the 
possible creation of tumourigenic cells. At present, the use of iPSCs are 
considered unsafe for clinical trials, until such time as the oncogenic and 
immunogenic problems have been resolved (Damdimopoulou et al., 2015). 
Unfortunately, both ESCs and iPSCs produce teratomas (tumours) upon in vivo 
implantation, within the host organism. The teratomas are benign tumours 
consisting of various tissues from all three germ layers and exhibit rapid growth 
formation (Zhang et al., 2008). These tumours have been known to consist of 
organs, teeth, hair, muscle, cartilage, and bone tissue (Turgut and Lu, 2007). 
Therefore, stem cell research has shifted focus towards the use of adult derived 
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stem cells, which alleviate the issues associated with ESCs and iPSCs (Barker and 
de Beaufort, 2013). 
1.2 Mesenchymal Stem Cells 
In 1974, Friedenstein et al., isolated and identified stem cells, which he called 
colony forming unit fibroblasts (Friedenstein et al., 1974). In 1991, Caplan 
renamed the cells MSCs, due to their ability to differentiate into cells of 
mesoderm origin (mesenchymal tissue) including; adipocytes (fat), chondrocytes 
(cartilage) and osteocytes (bone) (Figure 1-2) (Caplan, 1991). 
 
Figure 1-2: Mesenchymal Stem Cell differentiation. 
MSCs are capable of self-renewal and differentiation into cells of the mesoderm lineage. 
(Adapted from (Caplan and Bruder, 2001)). 
MSCs have been discovered within bone, skeletal muscle, cartilage, fibroblasts 
and haematopoiesis-supporting stroma (Bianco et al., 2013). MSCs have also 
been found and isolated from other tissue sources, including adipose tissue, 
umbilical cord and Wharton’s jelly (Ragni et al., 2013). Most MSCs are commonly 
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isolated from the bone marrow, even though these cells only make up 0.01% of 
the total bone marrow population. However, they are easily cultured ex vivo, 
due to their excellent adherent properties to tissue culture plastic (Maltman et 
al., 2011). MSCs, obtained from bone marrow and adipose tissues, are known as 
“adult” MSCs. These adult MSCs have a limited differentiation capacity 
compared to “young” MSCs from an umbilical cord, and studies have also shown 
the differentiation potential of “adult” MSCs decreases with age (Ragni et al., 
2013). 
Within the bone marrow, MSCs are known to reside in a microenvironment, 
termed the niche. Two distinct niche areas have been identified, the sinusoidal 
niche and the endosteal niche; both are critical to MSC survival and growth. 
Recent evidence has found MSCs residing on the outer surface of sinusoids (blood 
vessels in bone marrow) and have been described as a subset of perivascular 
cells (see Figure 1-3). The sinusoids are formed during the organogenesis of bone 
and are part of the perivascular stromal compartment in the bone (Bianco et al., 
2013). All MSCs are pericytes and are known to interact with endothelial cells, 
which allow the stem cells to react to injury/inflammation, within a localised 
area (Sorrell et al., 2009). 
25 
Chapter 1 – Introduction 
 
 
Figure 1-3: Schematic diagram of the location of the MSC niche within bone marrow. 
(A) Indicates the location of MSCs within trabecular bone marrow, by the sinusoidal 
capillaries (sinusoidal niche) and the inner bone lining (endosteal niche). Adapted from 
(Ehninger and Trumpp, 2011) (B) Immunofluorescence image of a MSC (personal image). 
Red = actin, blue = nucleus, 40x objective, scale bar = 20 μm. 
1.2.1 MSC Characteristic Properties 
Characterising MSCs has proved challenging. In 2005, the International Society 
for Cellular Therapy (ISCT) suggested the acronym MSC might encompass 
multipotent mesenchymal stromal cells, because they possess similar biological 
activities to the stem cells, but do not meet all stem cell activity criteria 
(Horwitz et al., 2005). The ISCT meeting identified some data lacked evidence of 
MSCs retaining their multipotency properties in unfractionated plastic-adherent 
cells (Horwitz et al., 2005). Currently, there is no consistent nomenclature or 
definition of MSCs however, the ISCT proposed a set of minimal criteria to 
characterise MSCs, as MSCs may express different cell surface markers depending 
on their location within the body. For example, adipose derived MSCs may 
express Cluster of Differentiation-90 (CD90) and only change to CD105, 
(commonly referred as endoglin-an angiogenic marker) when they adhere to 
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tissue culture plastic (Keating, 2012). In 2006, the ISCT committee identified 
three main criteria to characterise MSCs, which are as follows: (a) MSCs must be 
able to adhere to plastic when cultured in standard conditions, (b) MSCs must 
express CD105, CD73 and CD90, and lack CD45, CD34, CD14 or CD11b, CD79alpha 
or CD19 and HLA-DR surface molecules expression and (c) MSCs must be able to 
differentiate in vitro into the following cell types, osteoblasts, adipocytes and 
chondrocytes (Dominici et al., 2006). 
MSCs reside within a heterogeneous cell population and demonstrate a diverse 
range of morphologies, physiologies and surface antigen expression. Therefore, 
MSCs are identified using a combination of these characteristics. In vivo, MSC 
function and cell phenotype have been identified by their expression of growth 
factor receptors, protein cytokines, extracellular matrix proteins and adhesion 
molecules. The scientific community have decided MSCs used in research should 
not express haematopoietic or endothelial cell lineage markers such as CD11b, 
CD14, CD31, CD33, CD34, CD133 and CD45 or co-stimulatory molecules CD80, 
CD86 and CD40. However, it has been widely accepted that all MSCs express 
STRO-1 and CD271 (Casado-Díaz et al., 2011). A detailed list of generically 
accepted MSC markers, providing an immunophenotypic profile, is depicted in 
Table 1-2. 
Table 1-2: The MSC Immunophenotype Profile. 
A comprehensive list, description and role for each MSC cluster of differentiation (CD). 
Positive (+) and negative (-) indicate the protein expression for MSC classification. (Adapted 
from (Casado-Díaz et al., 2011)). 
Immunophenotype Description Role 
CD11- A component of various 
integrin’s 
Mediates leukocyte 
adhesion 
CD14- Human gene Expressed by 
macrophages 
CD18- Integrin Cell adhesion and cell-
surface signalling 
CD31- 
(PECAM-1) 
Type I integral 
membrane glycoprotein 
Platelet endothelial cell 
adhesion molecule-1 
CD34-  Cell surface glycoprotein Cell-cell adhesion 
molecule 
CD40- Co-stimulatory protein Expressed by endothelial 
cells 
CD45- Type I trans-membrane 
protein 
Expressed by 
differentiated 
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haematopoietic cells 
CD56- 
(NCAM) 
Single trans-membrane 
glycoprotein 
Neural cell adhesion 
molecule 
CD80- Co-stimulatory molecule Signals T cell activation 
and survival 
CD86- Co-stimulatory molecule Signals T cell activation 
and survival 
MHC-II- Cell surface molecule Mediates interactions of 
leukocytes 
CD29+ Integrin Cell adhesion 
CD44+ Cell-surface glycoprotein Cell–cell interactions, 
cell adhesion and 
migration 
CD54+ 
(ICAM-1) 
Intercellular adhesion 
molecule 
Plays role in 
inflammation, immune 
responses and in 
intracellular signalling 
events 
CD71+ 
(TfR1) 
Transferrin receptor Mediates uptake of 
transferrin-iron 
complexes 
CD73+ 
(5'-NT) 
Enzyme Converts AMP to 
adenosine 
CD90+ 
(Thy-1) 
Glycosylated membrane 
protein 
Thought to play role in 
cell-cell and cell-matrix 
interactions 
CD105+ 
(Endoglin) 
Type I membrane 
glycoprotein 
Plays role in angiogenesis 
CD106+ 
(VCAM-1) 
Vascular cell adhesion 
molecule 
Cell adhesion molecule 
CD120a+ 
(TNFR) 
Tumour necrosis factor 
receptor 
Cooperates with an 
adaptor protein 
determining cell response 
e.g. inflammation 
CD124+ Type I cytokine receptor Regulates IgE antibody 
production in B cells 
CD166+ 
(ALCAM) 
Type I trans-membrane 
glycoprotein 
Mediates adhesion 
interactions 
CD271+ Low affinity nerve growth 
factor receptor 
Stimulates neuronal cells 
to survive and 
differentiate 
MHC-I+ Cell surface molecule Mediates cellular 
immunity 
STRO-1+ Cell surface antigen  
Nestin+ Type VI intermediate 
filament protein 
Used in assessing cell 
proliferation and 
migration 
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1.2.2 Immunomodulatory Properties 
MSCs are classed as non-immunogenic, and therefore do not cause an immune 
response upon implantation. As described above, MSCs are characterised as 
CD40-, major histocompatibility complex-II (MHC-II-), CD80- and CD86-, but are 
MHC-I+. The lack of immune response may occur because the MSCs do not possess 
these co-stimulatory molecules, even though the cells are MHC-I+, which may 
activate T cells (Ozawa et al., 2008, Uccelli et al., 2008, Sohni and Verfaillie, 
2013). The MSCs respond to both the adaptive and innate immune systems by 
supressing T cells and dendritic cell (DC) maturation, decreasing B cell activation 
and proliferation (Figure 1-4). 
 
Figure 1-4: Diagram highlighting the immunosuppressive properties of MSCs. 
MSCs inhibit proliferation of T cells, natural killer (NK) cells and B cells. Additionally, MSC’s 
prevent the differentiation of monocytes into dendritic cells (DCs). (Adapted from (Gebler et 
al.)). 
MSCs play an active role in disrupting the innate immune system. DCs express 
MHC-I and MHC-II, as well as co-stimulatory factors. MSCs have been shown to 
reduce the expression of MHC-I, CD11c, CD63 and co-stimulatory molecules on 
DCs, thus impeding their antigen expression on the cell surface. MSCs are known 
to inhibit the production of DCs, by affecting the maturation process of 
monocytes, which turn into DCs, as well as inhibiting the production of tumour-
necrosis factor (TNF) in DCs (Jiang et al., 2005, Ramasamy et al., 2007, Aggarwal 
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and Pittenger, 2005). The combination of all these factors causes a reduction in 
the pro-inflammatory effects of the DCs. 
NK cells are cytotoxic lymphocytes and MSCs have been shown to down regulate 
expression of certain activating receptors (NKp30 and NKG2D) in resting NK cells 
(Spaggiari et al., 2006). Therefore, this process reduces the cytotoxic activity 
and target-cell killing by NK cells. Interferon gamma (INF-γ) is a cytokine 
produced from NK cells. In the presence of high concentration of INF-γ, MSCs are 
protected from NK cell mediated lysis, which may inhibit NK cell function. 
Furthermore, MSCs have displayed the ability to disrupt the neutrophil process, 
by slowing down the respiratory burst, after the neutrophils have bound to 
bacteria (Raffaghello et al., 2008). 
During the adaptive immunity process, MSCs inhibit T cell proliferation by 
supporting their survival, thus over stimulating T cells through the T cell 
receptor, which then undergo activation-induced cell death (Benvenuto et al., 
2007). Reduced T cell proliferation instigates a decrease in INF-γ production, 
which in turn alters the state of the cells from a pro-inflammatory to an anti-
inflammatory state. Additionally, MSCs aid the generation and proliferation of 
regulatory T cells, which suppress the immune system by releasing HLA-G5 
(Selmani et al., 2008). 
Research conducted in vitro indicates MSCs inhibit B cell proliferation and 
differentiation, which is involved in antibody production, by turning B cells into 
antibody-secreting cells (Corcione et al., 2006). It has been suggested B cells 
respond to T cells activity and therefore, B cells may be affected by the 
inhibition of T cell function by MSCs. 
Therefore, the immunomodulatory properties of MSCs indicate their potential 
use as a universal donor by reducing the hosts’ immune response and therefore, 
the MSCs have great potential in treating a large number of immune and non-
immune diseases. 
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1.3 MSCs in Regenerative Medicine 
Over the past 15 years there has been a gradual emergence of interest in the 
field of regenerative medicine. Regenerative medicine heralds a promising 
future, focusing on the regeneration and replacement of cells, tissues and 
organs to restore functionality, using the body’s own repair mechanisms. 
Previously, cell and tissue regeneration has been achieved by using either cell 
therapy based treatments and/or tissue engineering, combining engineered 
scaffolds, cells and biomolecules, to stimulate regeneration of the defective 
area with a view to producing functional tissues (Liu et al., 2007). The advent of 
stem cell research has led researchers to develop exciting new approaches to 
improve these advancements, and increase their applications in biomedical 
science (Liao et al., 2008). The potential use of MSCs in cell therapies and tissue 
engineering has been steadily gaining momentum, due to their diverse range of 
properties, as highlighted in Figure 1-5. 
 
Figure 1-5: MSCs examples used in cell therapy and tissue engineering. 
Diagram of potential MSC uses in cell therapy and tissue engineering. (Adapted from 
(Kagami et al., 2011)). 
When MSCs are used in cellular therapy, the cells are either intravenously (IV) 
delivered through the patient’s drip system or directly injected into the 
defective site. The self-renewal and differentiation capacity of MSCs have also 
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shown potential clinical use in regenerating damaged tissue in the 
musculoskeletal system. Recent in vivo studies have demonstrated the self-
renewal properties of transplanted MSCs. These transplanted MSCs were able to 
create a miniature bone organ, which allowed the establishment of 
haematopoiesis from the host animal (Sacchetti et al., 2007). Using MSCs in this 
way may help patients suffering from large bone defects (trauma as well as 
skeletal abnormalities), maxillofacial injuries, osteoarthritis, bone loss 
(osteoporosis) or atrophic non-union fractures (where the bone will not heal 
without intervention). Bone autografts are currently the gold standard for 
augmenting bone in non-healing bone fractures. However, when this method 
fails (due to problems of altered osteogenic properties at the donor site or when 
the risk out ways the benefits of the bone graft), cell based therapies using MSCs 
are a viable alternative (Gómez-Barrena et al., 2015). This method involves 
transplanting MSCs incorporated in scaffolds to accelerate bone formation during 
the repair and regeneration process. A further potential use for MSCs is in the 
repair of damaged oral bone and subsequent tooth loss, which costs the US $5-6 
billion/year in surgical treatments (Fischer et al., 2011). Current dental 
treatments have not always been successful and have resulted in long recovery 
times and increased resource costs. 
Therefore, instead of creating and implanting replacement materials, research 
has invested in the development of new functional tissue, leading to the 
generation of a natural system of in situ tissue repair, with the implantation of 
MSCs within the patient (Kon et al., 2012). For example, a patient suffering from 
osteoarthritis also has cartilage degeneration, which may lead to knee and hip 
replacements. Alternative regenerative medicine treatments, such as using 
tissue engineering and stem cells, may eliminate the need for knee or hip 
replacements and improve the patient’s quality of life. A clinical trial intra-
articularly injected MSCs into patients suffering from osteoarthritis in the knee. 
The researchers found improved knee joint function, reduced pain sensation, as 
well as regenerating hyaline-like articular cartilage (Jo et al., 2014). Jo et al., 
suggested the improved knee function and regeneration of hyaline-like articular 
cartilage may be due to MSCs differentiating into chondrocytes and secreting 
paracrine signals, as they induce chondrocyte proliferation and ECM synthesis. 
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MSCs excellent immunosuppressive and immunomodulatory properties have led 
to the suggestion that the harnessing of these effects may treat autoimmune 
diseases such as multiple sclerosis (MS). The use of cell therapies in the 
treatment of autoimmune diseases has developed from the idea of rebuilding 
damaged immune-regulatory networks, by the creation of a group of memory 
cells, which would be able to react to environmental pathogens (Dazzi and 
Krampera, 2011). A mouse study conducted by Karussis et al., used a chronic 
autoimmune encephalomyelitis (EAE) model, to investigate MS (Karussis et al., 
2008). The researchers intravenously administrated MSCs into the mice and 
found the cells induced neuroprotection, maintaining the axons in the central 
nervous system (CNS). Furthermore, the MSCs were shown to differentiate into 
cells of neural-glial lineage. In other studies, MSCs immunomodulating properties 
were shown to successfully down regulate the clinical manifestations of MS in 
the EAE model (Zappia et al., 2005). MSCs inhibit the autoimmune attack of the 
CNS, thus reducing damage to the axons and limiting the effects of MS (Gerdoni 
et al., 2007). 
Other potential uses for MSC-based regenerative medicine therapies, include 
Parkinson’s disease, spinal cord injury and cardiovascular repair. Parkinson’s 
disease is a neurodegenerative disease, which attacks the dopaminergic neurons. 
Currently, there are no treatments for Parkinson’s disease to stop or reverse this 
process. Animal models studying Parkinson’s disease have shown MSCs protect 
and regenerate damaged DA neurons (Glavaski-Joksimovic and Bohn, 2013).  
MSCs have shown promise in aiding recovery following spinal cord injury, by 
secreting neurotrophic molecules to reduce the glial cyst, thus leading to 
neuroprotection in the damaged area (Boido et al., 2014). A study using dogs 
with spinal cord injuries, found MSCs directly remyelinated numerous axons in 
the damaged area after transplantation (Lee et al., 2011b). Moreover, MSCs used 
in cell therapy have been shown to aid cardiovascular repair by secreting pro-
angiogenic and cardioprotective paracrine molecules (Williams et al., 2013). 
Williams et al., intra-myocardially injected MSCs into pigs suffering from 
myocardial infarction and found progressive reduction in infarct size post 
injection. 
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MSCs have potential within regenerative medicine by exploiting MSC self-renewal 
and differentiation capabilities, in repairing and restoring functionality to a wide 
range of tissues (bone, cartilage and cardiovascular). However, there have been 
failures with MSCs engrafting into the target area. In pre-clinical and clinical 
studies, MSCs are most commonly delivered systemically by intravenous injection 
(IV). Following the introduction into the host, MSCs have been found to 
congregate in pulmonary vasculature due to the pulmonary first-pass effect, 
rather than the MSCs reaching the target area (Lee et al., 2009, Lin et al., 2014, 
Fischer et al., 2009). Therefore, studies have shown treatment using MSCs have 
been inefficient or of limited effect in the treatment, because the MSCs tend to 
accumulate in the lungs (Kean et al., 2009). Additionally, there have reports on 
the efficacy of the administration in the timing of MSCs injections. A study 
conducted by Cho et al., compared single and multiple injections of MSCs into 
pigs to induce the adaptive immune system (Cho et al., 2008). The single 
injections did not induce the immune system however, multiple injections into 
the same site led to detectable antibody production levels. Therefore, these 
problems need to be addressed, before MSC therapy may be utilised as a 
favourable treatment. 
1.4 Stem cell niche 
At present, there has been limited in vivo research into the MSC niche, which is 
known to provide cues that control MSC self-renewal and differentiation. As 
discussed earlier, recent evidence suggests part of the MSC bone marrow niche is 
located in the perivascular areas and pericytes (contractile cells associated with 
endothelial cells) aid the niche in situ (Zhao et al., 2014a, Mitsiadis et al., 
2007). The niche nurtures the stem cells, as well as controlling homeostasis, 
through a process of complex molecular events (Mitsiadis et al., 2007, Laine et 
al., 2012). For example, the niche sustains the stem cell population, by assessing 
whether the cells are active or quiescent (Joddar and Ito, 2013), and protects 
stem cells from over stimulation, preventing differentiation and apoptosis (cell 
death) (Weber and Calvi, 2010). Researchers have suggested the niche also 
protects stem cells from multiple gene mutations (creating cancer cells) by 
maintaining the stem cells in a quiescent state as well as possessing a low 
metabolic rate (Gattazzo et al., 2014). Recently, studies have shown the major 
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purpose of the niche is to anchor stem cells via membrane proteins to either the 
surrounding environment, such as extracellular matrix (ECM), or allow cells to 
adhere to each other (Joddar and Ito, 2013). The interactions between stem 
cells, the ECM and the resident niche cells are regulated by these adhesion 
molecules (Lane et al., 2014). For example, these membrane proteins attaching 
the niche to the ECM are exposed to the surrounding environment and are 
influenced by the physical properties (bulk stiffness) of the ECM. Examples have 
shown these physicals properties activate intracellular pathways within the stem 
cells in the niche thus, influencing stem cell fate (Watt and Huck, 2013, Swift et 
al., 2013). 
The fate of the stem cells within the niche is influenced by several factors 
including cell-cell interactions, cell-surrounding environment interactions and 
soluble factors (e.g. growth factors and cytokines), as illustrated in Figure 1-6 
(Higuchi et al., 2012). The stem cell niche microenvironment consists of stem 
cells, differentiating progenitors, non-stem support cells and ECM, all of which 
regulate stem cell fate and differentiation. Signals from soluble and surface-
bound factors, along with mechanical properties of the surrounding environment 
and cell-cell connections, are integrated within the niche (Rasi Ghaemi et al., 
2013). 
 
Figure 1-6: Conceptual model of a stem cell niche. 
(Adapted from (Joddar and Ito, 2013)) 
The niche has an organised structure, which permits cell-fate decisions and 
allows key signalling between stem cells and the surrounding environment. 
Moore and Lemischka identified three main categories of a mammalian stem cell 
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niche: 1) anatomical organisation of cells within the niche, 2) integrated positive 
and negative feedback signalling, and 3) shared intercellular signalling pathways 
between stem cells and supporting cells (Moore and Lemischka, 2006). 
Stem cell proliferation may be controlled by these positive and negative 
feedback systems. Research has suggested maintaining stem cell supply is 
controlled by feedback mechanisms from progenitor cells, as well as from the 
autocrine and paracrine systems (Ema and Suda, 2012). A recent study showed 
the location of the stem cell in the niche influenced cell behaviour (Rompolas et 
al., 2013). Rompolas et al., were able to predict fates of stem cells (i.e. 
whether stem cells remain uncommitted, generate precursors or committed to 
differentiating) by the position of the stem cell within the hair follicle niche. 
The researchers identified stem cells in the upper half of the bulge remained 
quiescent whereas, cells in the compartment, which becomes the new hair germ 
became committed to differentiation. This vital niche homeostasis and control 
of stem cell fate creates a dynamic system, dictated by cell-cell communication 
(signals), both within the niche and the external environment. 
The ECM is known to directly and indirectly play a role in the maintenance of the 
stem cell niche. Biochemical, physical, structural, and mechanical properties of 
the ECM composition are able to regulate stem cell fate by permitting signals to 
travel through the ECM and interact directly with the stem cells (Gattazzo et al., 
2014). Additionally, the ECM creates biochemical gradients by directly binding to 
growth factors, which in turn creates a pool of biofactors ready for release.  
The stem cells in the niche respond to metabolic, inflammatory and hormonal 
cues released from the surrounding area (Kiel et al., 2005, Chen et al., 2014). 
Additionally, the niche cells fate and decisions are affected by temperature 
fluctuations, shear forces and chemical signals from the external environment 
(Chen et al., 2009b, Dong et al., 2009). The MSCs niche has been shown to 
respond to growth spurts, skeletal tissue damage and infection to repair bone, 
cartilage and tendons (e.g. a broken bone or a slipped disc). 
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1.4.1 Cellular Communication 
Due to the limited research conducted on the MSC niche in vivo, whilst some 
evidence exists for the structure and cellular components, the exact location is 
still ambiguous. However, there have been extensive investigations into the HSC 
niche, which also resides within the bone marrow environment and MSCs are 
known to support the HSC niche. Studies have shown parts of the HSC niche and 
the MSC niche occupy the same perivascular regions within bone marrow. 
Therefore, information concerning signalling, ECM interaction and molecular 
pathways found within the HSC niche, may possess similarities compared to the 
MSC niche. 
Although there are dissimilarities between the different types of the stem cell 
niche, there are key similarities between the individual stem cell niches. For 
example, there are common key signalling pathways (e.g. Wnt/β-catenin, Notch 
and Hedgehog), which have been identified. Additionally, there are common 
“support” cells, which lend critical support to stem cells, (e.g. osteoblasts for 
HSCs and pericytes for MSCs) and communicate with each other through cell 
surface receptors, gap junctions and soluble factors. As well as possessing these 
properties, the niche must allow for intercellular adhesion to permit signals to 
communicate between the stem cells (Roeder et al., 2011). 
Integrins are important in the interaction between the ECM and stem cells, and 
are key in the adhesion, anchorage and homing of stem cells. Integrins are 
transmembrane receptors, which attach the cytoskeleton of the cell to specific 
proteins in the ECM. Also, integrins are known to directly activate stem cell self-
renewal and proliferation, via their interaction with focal adhesion kinase (FAK) 
and phosphoinositide 3-kinase (PI3K) (Legate et al., 2009, Buitenhuis, 2011). 
The biophysical properties of the extracellular environment have been shown to 
affect stem cell behaviour. Compression of the ECM by neighbouring cells, alter 
the stiffness; stem cells can accommodate this change by regulating their 
internal cytoskeletal tension through a mechanism termed 
mechanotransduction. This mechanism generates isometric tension within the 
cytoskeleton thus maintaining cell shape. Cell geometry and cytoskeletal 
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organisation are regulated by specific mechanotransduction pathways 
(Ras/MAPK, PI3K/Akt, RhoA/ROCK, Wnt/β-catenin and TGF-β) and YAP/TAZ 
transcription factors (Halder et al., 2012, Dupont et al., 2011, Sun et al., 2012). 
1.4.2 Cell cycle 
In the absence of regeneration cues, MSCs maintain a quiescent (resting) state 
within the niche, which reduces the generation of genetic defects (Rasi Ghaemi 
et al., 2013). MSCs remain in this quiescent state, indicating the cells have not 
been activated in the cell cycle process. There are four phases/segments of the 
cell cycle, with G0 reflecting the quiescent state (Figure 1-7). 
 
Figure 1-7: Diagram depicting cell cycle. 
The phases of cell cycle regulation; G0 indicates MSC quiescent state. A dividing MSC 
passes through a series of stages described as the cell cycle. There are two gap phases (G1 
and G2); an S (for synthesis) phase, when the genetic material is duplicated; and an M 
phase, in which mitosis separates the genetic material and the cell divides. (Taken from 
(Matsumoto and Nakayama, 2013)) 
These cell cycle phases are highly regulated, particularly with the progression 
from Gap 1 (G1) to synthesis (S) phase and from Gap 2 (G2) to Mitosis (M) phase. 
Each stage of the cell cycle is governed by pairs of cyclins and cyclin-dependent 
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kinases (CDKs) (Orford and Scadden, 2008). Progression through G1 phase 
depends upon the cyclin D-CDK4 or CDK6 complex. The cycle subsequently 
requires the presence of the cyclin E-CDK2 complex to pass from the G1 to S 
phase. Moreover, the progression from G2 to M phase depends upon the presence 
of cyclins A and B with CDK1 complexes (Matsumoto and Nakayama, 2013). 
Intrinsic and extrinsic signals must stimulate the cell to allow progression 
through the G1 phase to enter the cell cycle. Once progression has travelled 
beyond the restriction (R) point, the cell no longer requires external stimulation 
to enter the cell cycle. In the absence of intrinsic and extrinsic signals, the MSCs 
in the niche are known to exit the cell cycle during the G1 phase and enter a 
quiescent (G0) stage (Orford and Scadden, 2008). 
Mitosis is governed and regulated by the transcription factor E2F, which is key to 
the activation of cell cycle progression. Retinoblastoma proteins (Rb) may be 
phosphorylated by cyclin-CDK complexes, which in turn activate E2F, via the 
inhibition of the Rb (Matsumoto and Nakayama, 2013). Additionally, CDK 
inhibitors (CDKIs) are members of either Ink4 or Cip/Kip families, which 
negatively regulate cell cycle progression. Inhibitors of CDK4/CDK6 belong to the 
Ink4 group whereas, members of the Cip/Kip family directly inhibit CDK2 in the 
late G1 phase (Orford and Scadden, 2008). 
Stem cells divide to produce daughter cells, either through symmetric or 
asymmetric cell division, to replace cells undergoing differentiation. Symmetric 
cell division produces either two differentiating cells or two stem cells. 
Whereas, asymmetric cell division produces one stem cell and one 
differentiating cell (Rasi Ghaemi et al., 2013). The positioning of a daughter 
stem cell in the niche is dependent upon exposure to external environmental 
cues. 
1.4.3 MSC migration from the niche 
MSCs have an active role in tissue repair. Studies have shown MSCs migrate 
towards sites of injury, inflammation and tumours (Shi et al., 2012). The 
processes involved in normal wound healing require a series of complex events, 
progressing from initial bleeding to inflammation, cell migration, proliferation, 
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re-epithelisation and finally remodelling of the ECM. The three main stages of 
the wound healing process have been identified as inflammation, proliferation 
and remodelling (Maxson et al., 2012). The inflammatory phase occurs within 
the first three days, after which the proliferation stage is initiated and may 
continue for 2 weeks. This stage is followed by the remodelling phase, which 
may continue for a few years to allow the wound to fully heal. MSCs are involved 
within all three stages of wound healing and tissue repair, as shown in Figure 
1-8. 
 
Figure 1-8: Mesenchymal stem cell roles in each stage of the wound healing process over 
time. 
(Taken from (Maxson et al., 2012)) 
Inflammation or injury causes cellular release of cytokines, which stimulate the 
recruitment of MSCs. These cytokines include TNF-α, IFN-γ, interleukin-6 (IL-6) 
or hypoxia-induced mitogenic factor (HIMF) (Yagi et al., 2012). Inflammation and 
injury sites contain high levels of cytokines, following the activation of Natural 
Killer (NK) cells and T cells secreting TNF-α and IFN-γ. MSCs are stimulated by 
the detection of IFN-γ to produce indoleamine 2 3-dioxygenase (IDO), which 
inhibits proliferation of activated T or NK cells. Additionally, injury leads to the 
maturation of DCs, which initiate T cell responses, although MSCs have also been 
shown to disrupt the DC maturation process. The release of prostaglandin E2 
(PGE2) and IL-6 cytokines from MSCs controls DC maturation, leading to T cell 
suppression. Furthermore, MSCs are able to suppress T cells via the NFκB 
pathway (Yagi et al., 2012). The initial stage of injury causes MSCs to secrete 
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anti-inflammatory cytokines IL-10 and IL-4 (Maxson et al., 2012). MSCs possess 
the chemokine receptor (CXCR4) and stromal-derived factor-1 (CXCL12), which 
are activated by inflammation or injury and are key to the migration of the cells 
to the injury site. Furthermore, it has been reported MSCs migrate following the 
activation of other chemokine receptors including CCR1, CCR4, CCR7, CCR9, and 
CCR10, CXCR5 and CXCR6 (Sohni and Verfaillie, 2013). 
Local cellular responses to injury/inflammation are regulated via the paracrine 
signalling from the MSCs, whilst differentiation of the MSCs aids tissue repair. 
Research has shown an improvement in tissue repair by the differentiation and 
paracrine signalling from MSCs (Sasaki et al., 2008, Chen et al., 2008). Cytokines 
released during injury cause immune modulators to be secreted from MSCs (e.g. 
platelet-derived growth factor (PDGF-AB), insulin-like growth factor 1 (IGF-1), 
hepatocyte growth factor (HGF), epidermal growth factor (EGF), chemokine 
ligand 5 (CCL5)) (Maxson et al., 2012). Paracrine signalling from MSCs has been 
shown to affect the regulation of cell survival, proliferation, migration and gene 
expression of various cell types. These cell types include endothelial cells, 
keratinocytes and fibroblasts (Hocking and Gibran, 2010). The soluble factors 
released from MSCs stimulate proliferation and migration of other cell types to 
enhance and accelerate wound healing. Additionally, MSCs secrete growth 
factors, including vascular endothelial growth factor (VEGF) and HGF through 
paracrine signalling, which reduces scar tissue and maintains the balance of 
transforming growth factor-β1 (TGF-β1) and TGF-β3 (Ennis et al., 2013). 
Therefore, MSCs have been found to accelerate damaged tissue repair by their 
active involvement in all three stages of the wound healing process. 
1.5 Exploitation of the stem cell niche 
Over the past decade, the scientific community has recognised the huge 
potential of the exploitation of the niche in the development of novel 
therapeutics, in particular the field of regenerative medicine (Mason and 
Dunnill, 2008). The use of stem cells has revolutionised cell therapies however, 
there are still issues related to their clinical use. Particular problems occur with 
low viability upon in vivo transplantation and the possibility of the manifestation 
of unfavoured behaviours, by differentiating into undesired cell types. Further 
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research is necessary to understand the underlying mechanisms controlling stem 
cell homeostasis in the niche and utilise this knowledge to advance novel 
therapeutics and aid damaged tissue repair. 
Further understanding of cell-cell communication in the niche, may allow 
researchers to mimic the regulation observed within the niche, allowing control 
over MSC fate (i.e. either promoting self-renewal or driving MSCs towards a 
specific cell lineage) (Wagers, 2012). Understanding the behaviour of MSCs in the 
niche environment, under normal and pathological conditions, will allow 
important exploration of their therapeutic potential in various clinical 
applications (Samadikuchaksaraei et al., 2014). If MSCs were able to be 
manipulated in vitro, it would potentially provide two important sources of 
cells. Firstly, it would allow the promotion of MSCs self-renewal, thus promoting 
the expansion of MSC numbers for experiments or transplantation use in clinic. 
Secondly, it would allow the direction of MSCs to become certain cell types, for 
example, bone forming osteoblasts, which may be used in clinical treatments of 
various bone conditions. 
Therefore, an important research area has emerged over the past few years to 
focus on the design of ex vivo stem cell niche models to study and mimic this 
special microenvironment. Lane et al., have suggested in the future, niche stem 
cells will be directly targeted by a combination of various factors (e.g. small 
biomolecules), which may be applied at different stages of treatment (Lane et 
al., 2014). This treatment would allow the patient’s own stem cells to 
regenerate damaged tissue, without ex vivo cell expansion and differentiation as 
shown in Figure 1-9 (Lane et al., 2014). 
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Figure 1-9: Issues to be assessed for successful application of stem cells within 
regenerative medicine. 
(Adapted from (Samadikuchaksaraei et al., 2014)). 
1.6 In vitro studies of the stem cell niche 
The development of in vitro models of the MSC niche will enhance our 
understanding of the communication mechanisms between MSCs and the 
surrounding environment. To date, researchers have mainly developed two-
dimensional (2D) monolayer models. However, these 2D models provide poor 
representations of the true MSC niche due to the lack of ECM and three-
dimensional (3D) environment, therefore limit extrapolation to the in vivo 
situation. Furthermore, MSCs spontaneously differentiate in monolayer culture 
over a short incubation period (Baer et al., 2010). Therefore, research is shifting 
towards the development of three-dimensional (3D) in vitro niche models, which 
are more complex and better mimic the in vivo niche environment (Cheng et al., 
2012). 
1.6.1 Two-dimensional stem cell niche models 
In vitro MSC niche studies have been performed using 2D substrates to maintain 
stem cell self-renewal or drive down a specific differentiation pathway. Studies 
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have tried to replicate the niche by using ECM components, soluble factors and 
manipulating the physiochemical environment. For example, mimicking the 
niche by culturing on 2D substrates or scaffolds may be achieved by coating the 
surface with ligands or ECM proteins, immobilising growth factors or applying 
oxygen gradients. Furthermore, altering the stiffness of the substrate/scaffold 
itself or imprinting relevant topographies on the surface prior to cell attachment 
can also more closely mimic the in vivo niche (Dalby et al., 2007, McMurray et 
al., 2011, Dellatore et al., 2008). 
As previously discussed, cell-cell communication is important in modulating stem 
cell behaviour within the niche. To this end, researchers have designed in vitro 
environments to improve the understanding of cell-cell and cell-substrate 
interactions. Recently, for example, Kim and Kino-oka used polyamidoamine 
dendrimer (highly branched cascade polymer) immobilised surfaces on 
polystrene substrates in the presence of feeder cells, to examine the 
mechanisms of iPSCs in cell-cell and cell-substrate interactions (Kim and Kino-
oka, 2014). The researchers altered the cell-cell and cell-substrate interactions, 
by increasing the dendrimer density on the substrate and they were able to 
identify key signalling pathways and transcription factors in self-renewal and cell 
differentiation (Kim and Kino-oka, 2014). 
Research has been conducted to study the physicochemical properties of the 
MSC stem cell niche by exploring the mechanical properties of the ECM. Altering 
the stiffness of the material is known to guide MSCs down various differentiation 
lineages, such as neurogenesis, chondrogenesis and osteogenesis. The pioneering 
study by Engler & Discher showed the importance of substrate stiffness on MSC 
differentiation (Engler et al., 2006). Their study showed MSCs seeded on 
polyacrylamide gels of varying stiffness’s (0.1, 1, 11, and 34 kPa) caused 
neurogenic, myogenic and osteogenic differentiation. Furthermore, Wen et al., 
found matrix porosity did not induce adipose stromal cell differentiation, but 
was directly dependent on substrate stiffness (Wen et al., 2014). Additionally, 
Zhao et al., cultured MSCs directly onto hydrogels of varying stiffness and found 
the physicochemical properties of the surrounding area were important factors 
in stem cell differentiation (Zhao et al., 2014b). 
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Zhang and Kilian demonstrated MSC cell shape was also extremely important in 
maintaining stem cell quiescence, an important facet of MSC behaviour in the 
niche (Zhang and Kilian, 2013). They were able to control MSC proliferation and 
maintenance through imprinting nanotopographies on the surface of substrates. 
The resultant topography directed MSC spreading, focal adhesion formation and 
cell morphology, thus creating low cytoskeleton tension, which in turn promoted 
low actomyosin contractility leading to MSC quiescence. Alternatively, 
nanotopographies may be used to increase stem cell spreading and thus induce 
osteogenic differentiation (Dalby et al., 2007). 
In summary, whilst a great deal of useful information regarding MSC behaviour 
has been identified through using 2D cell culture models, this technique is too 
simplistic to aid the description of the full complexity of the special 
microenvironment. Culturing stem cells in 2D has led to unnatural niche cell 
morphologies and different functionality compared to the in vivo cells. Studies 
have shown vast differences between cells cultured within a 3D and 2D 
environment, concerning cell-cell and cell-matrix interactions (Griffith and 
Swartz, 2006). Furthermore, differences have been shown between cell 
morphology and receptor expression between the two culturing methods. A 
study, which investigated non-malignant and malignant epithelial cells, found 
enormous phenotypic differences between the cells being cultured in 2D and 3D 
models (Weaver et al., 1997). There were no phenotypic differences between 
the two cell types, when they were cultured two dimensionally however, the 3D 
culture assay showed phenotypic discrimination. The researchers found the non-
malignant cells formed polarised, growth arrested alveolar structures and the 
malignant cells produced disordered proliferative amorphous structures (Weaver 
et al., 1997). Therefore, currently there is a drive to create 3D in vitro niche 
models, which may allow for greater similarity to cellular behaviour and 
characteristic expression of the in vivo MSC niche. 
1.6.2 Three-dimensional stem cell multicellular spheroid niche 
models 
Research of in vitro 3D cell culture modelling is in its exploratory phase. Table 
1-3 summarises current cell research utilising 3D spheroid models. 
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Table 1-3: Table summarises current studies into 3D spheroid modelling. 
Cell Type Year Method Results Conclusion Reference 
Ovarian cancer 
cells 
2015 Aggregation by 
hanging drop 
- Tightly packed spheroids 
- Observed cell–cell interaction 
- High viability 
- Higher resistance to cis-platin 
compared to 2D models 
System may be used to: 
- Improve knowledge of ovarian 
cancer spheroid biology 
- Perform preclinical drug 
sensitivity assays 
(Raghavan 
et al., 
2015) 
Colon 
carcinoma cells 
and breast 
cancer cells 
2015 Aggregation on PVA 
coated PDMS 
microfluidic device 
- Model used to screen anticancer 
drugs 
- Varied drug dosages and spheroid size 
-  Found drug susceptibility was lower 
with increasing tumour size 
- Spheroids exhibited higher resistance 
to the drugs compared to 2D cultures 
System may be used to: 
- Screen the anticancer candidates 
with increased reliability and 
physiologic accuracy 
- model drug cytotoxicity 
- Analyse signalling pathways in 
drug screening 
(Chen et 
al., 2015) 
MSCs 2015 Self-aggregation 
with media 
containing methyl 
cellulose 
- Dedifferentiated MSCs in spheroids 
- Identified Oct4, Nanog and Sox2 
levels in 3D MSCs were lower than 
ESCs 
-  Found 3D MSCs did not reach 
pluripotency but underwent lineage-
restricted dedifferentiation 
- Identified balanced autophagy as a 
main mechanism for dedifferentiation 
- Mimicked features of blastema 
formation with MSC spheroids 
- Model important in improving 
the understanding of tissue 
dedifferentiation and 
regeneration 
(Pennock et 
al., 2015) 
MSCs 2013 Aggragation by 
membranes made 
of chitosan or 
chitosan and 
hyaluronan (HA) 
- Up-regulation of N-Cadherin 
- Increased expression of Wnt genes/ 
proteins and substrate-dependent cell 
fate 
- Identified activated signalling 
pathways (ERK1/2 or Smad2/3) 
3D platform may be used to: 
- Examine the role of Wnt 
signalling in controlling MSC fate 
- Study stem cell behaviour in 
various environments 
(Hsu and 
Huang, 
2013) 
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- Controlled Wnt signalling by varying 
the density of HA on chitosan 
Osteosarcoma 
cells and breast 
adenocarcinoma 
cells 
2014 Cells aggregated on 
agarose-coated 
plates and then 
embedded into 
collagen gels 
- Largest osteosarcoma spheroids in 
stiffest gel 
- Largest adenocarcinoma spheroids in 
softer gels 
-  Found metabolically active ring of 
cells on the periphery and non-viable 
cells in the core 
- Identified expansile nanoparticles as 
better delivery of anti-cancer drug 
compared to bolus delivery 
Created a 3D biomimetic culture 
platform to: 
- Study basic cancer cell behaviour 
- Evaluate new anticancer drugs, 
plus delivery of new anticancer 
drugs 
(Charoen et 
al., 2014) 
HepG2 cells 2015 Chemically 
aggregated with 
NaIO4 and acrylic 
acid-modified 
chitosan (chitosan-
AA). Then 
embedded in 
hydrogels 
- Pre-aggregation group produced 
spheroids in 1 day compared to 
several days in control group 
- Spheroids formed in the pre-
aggregation group were bigger than 
control group 
- Cells in the pre-aggregation group 
grew and proliferated faster 
compared to control group 
- Developed a new inter-cellular 
linker- chitosan-AA 
- Improved cell-cell interaction in 
pre-aggregated group 
(Liu et al., 
2015) 
Colorectal 
cancer cells and 
fibroblasts 
2015 Cells aggregated on 
agarose-coated 
plates 
- Increased fibroblast proliferation and 
migration in co-cultured spheroids 
compared to single cancer cell type 
spheroids 
- Increased fibronectin and EGFR but 
decreased laminin, β-catenin, E-
cadherin and type I collagen 
expression in co-cultured spheroids 
- Co-culture model mimicked the 
epithelial–mesenchymal 
transition state of in vivo 
tumours in early metastasis 
(Kim et al., 
2015) 
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compared to single cancer cell type 
spheroids  
Mouse dental 
papilla cells 
2014 Aggregated on low-
attachment culture 
plates 
- Significantly increased osteoblastic 
marker gene expression and 
mineralized nodule formation in 
spheroids compared to 2D cultures 
- Identified a proliferating cell-dense 
peripheral zone and a hypoxic/ 
apoptotic cell-sparse core zone 
- Created an effective formation 
of homogeneous spheroid 
colonies and high throughput 
method 
- However, the spheroids were 
small 
(Yamamoto 
et al., 
2014) 
MSCs 2012 Forced aggregation 
and either 
embedded with 
gelatin 
microparticles or 
left alone 
- No differences in spheroid size or cell 
morphology 
- No differences in cellular spatial 
organisation 
- Increased spheroid stiffness with 
embedded microparticles 
- Model may allow the delivery of 
growth factors in a controlled 
manner 
- Microparticles may modulate 
MSCs physiology to direct cell 
fate 
(Baraniak et 
al., 2012) 
Fibroblasts, 
myoblasts and 
ESCs 
2007 Cell aggregation by 
biotinylation and 
avidin cross-linking 
- Aggregate formation was dependent 
on concentration 
- Increased aggregation rate of 
modified ESCs compared to 
unmodified ESCs 
- Greater differentiation capacity of 
engineered ESCs compared to natural 
ESCs 
- Aggregation methodology may 
be transferred to improve the 
complexity of other in vitro 3-D 
spheroid models 
(De Bank et 
al., 2007) 
 
48 
Chapter 1 – Introduction 
 
There are various techniques available to create 3D cell culture models and each 
one has their own advantages and disadvantages. These techniques include 
forced floating, hanging drop multicellular spheroids, agitation/spheroids, 
matrices/scaffolds and microfluidic devices (Breslin and O’Driscoll, 2013). There 
are difficulties creating a realistic in vitro niche, because cells need to be 
encouraged to congregate together, in isolation from the surrounding 
environment. Most recently, researchers have focused on generating simple 3D 
models by creating multicellular spheroid structures of stem cells. 
The forced floating method allows the cells to congregate together using a non-
adhesive substrate material with high nutrient culture media. However, this 
technique does have limitations, as it takes several days for the aggregates to 
form and there are issues with the mass production of the spheroids. For 
example, Cheng et al., used chitosan-coated substrates and formed aggregates 
with adipose-derived stem cells over 7 days (Cheng et al., 2012). Even though 
the stem cells expressed high multipotent markers, this method is inefficient 
because it is labour intensive, as the substrates require non-adhesive coatings. 
An alternative method of creating multicellular spheroids is via the hanging drop 
technique. Cells are held in suspension in growth media and then inverted, 
which suspends the cells in media droplets, forcing the cells to accumulate at 
the tip of the liquid-air interface. This method has high reproducibility however, 
it is labour intensive and spheroids are very fragile and fall apart very easily. 
Therefore, this technique to produce spheroids is impractical for longer-term 
studies. Bartosh et al., used the hanging drop technique to create 3D MSC 
spheroids, but the technique was laborious and it took 4 days for the cell 
aggregates to form (Bartosh et al., 2010). 
Another way to create 3D cell cultures is to use mechanical agitation, such as 
bioreactors or rotational spinning flasks. There are some issues associated with 
using this technique, as it requires specialised equipment and the cells are 
exposed to unnatural shear forces within the spinning flasks. Gerlach et al., used 
a bioreactor system with adipose-derived stem cells and created adipose-like 
tissue (Gerlach et al., 2012). Also, Alimperti et al., cultured MSCs within 
spinning flasks to form cell aggregates (Alimperti et al., 2014). However, this 
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method of culturing MSC spheroids requires the use of expensive specialised 
bioreactors. 
One-way to improve the complexity of 3D in vitro models involves using a 
scaffold-based system thus, creating a more realistic in vitro environment. A 
recent study conducted by Souza et al., successfully suspended spheroids in 
hydrogels using a quick and cost effective method (Souza et al., 2010). They 
preloaded glioblastoma cells with magnetic iron oxide nanoparticles and placed 
them in a hydrogel in the presence of an external magnetic field. Even though 
the cells contain mNPs, studies have shown their incorporation does not affect 
natural cellular responses (Qin et al., 2013). 
MSCs cultured in vitro within any of the above 3D spheroids exhibit more 
realistic and natural cellular characteristics. Therefore, using 3D culture 
methods provides an excellent environment to probe cell-cell and cell-matrix 
interactions. For example, MSC spheroids have allowed the intricate study of 
intercellular adhesion proteins N-cadherin and cadherin-7 (Oberlender and Tuan, 
1994, Kim and Rajagopalan, 2010). Close observations of cadherins in a realistic 
3D niche model may allow the study of important differentiation pathways 
associated with cell-cell and cell-matrix interactions (Bratt-Leal et al., 2011). In 
addition, signalling pathways in MSCs linked to chondrogenesis and osteogenesis 
have been studied, using 3D MSC spheroids which showed activation of SMAD2/3, 
ERK1/2, Wnt genes and β-catenin upon differentiation (Hsu and Huang, 2013). 
Furthermore, studies of MSCs 3D spheroids have demonstrated high 
multipotency, with cells retaining their stem cell properties far better compared 
to 2D monolayer culture (Shen et al., 2013). For example, MSC spheroids have 
shown greater differentiation capabilities by the expression of similar osteogenic 
and adipogenic markers, compared to conventional 2D culture methods 
(Baraniak and McDevitt, 2012). Additional studies have found MSC spheroids 
exhibit significantly greater differentiation capacity, compared to MSCs cultured 
in the 2D monolayer technique (Huang et al., 2011, Wang et al., 2009). The shift 
from 2D cultures to 3D spheroids increases the complexity of the environment 
thus, improving the cellular characteristics observed within an organism Figure 
1-10. 
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Figure 1-10: Diagram depicting various 3D culturing techniques. 
(Adapted from (Page et al., 2013)). 
ECM proteins are commonly used to build scaffolds in 3D culture models. 
Collagen is an ECM protein and the most prevalent protein in the body, making 
up approximately 25-35% of the total body protein content (Higuchi et al., 
2012). Additionally, collagen has been found to be the main component of 
connective tissue. There are various different types of collagen however, 
collagen Type I has been found to be the most abundant type, as well as the 
main constituent of bone, bone marrow, skin and tendons (Campbell and Wicha, 
1988, Higuchi et al., 2012). The physical properties of collagen change 
depending on temperature, due to its thermo-sensitive properties. Collagen has 
low critical solution temperature properties, allowing it to dissolve in aqueous 
solutions at low temperatures and stiffen to a gel at ~37°C. The adhesion of 
MSCs with collagen Type I has shown to involve integrin α1β1 and α2β1 receptors 
on the cell surface (Higuchi et al., 2013). 
Research has shown various deficiencies using in vitro 3D models. These include 
fluctuations in the matrix derived from biological specimens, which may lead to 
unrepeatible and inconsistent experimental data (Tibbitt and Anseth, 2009). 
Another weakness using 3D models is the increased cost of reproducing large 
scale and high throughput assays, compared to existing 2D monolayer models, 
particularly in the drug development industry (Gurski L. et al., 2010). 
Furthermore, some research has shown a wide variation in size of the spheroids 
within the same well, which leads to non-uniform results (Wilson and McDevitt, 
2013). Also, 3D spheroids show a lack of vascularisation in the model, which is 
pivotal for assessing drug delivery, in comparison to the in vivo environment 
51 
Chapter 1 – Introduction 
 
(Edmondson et al., 2014). Nevertheless, using collagen Type I within an in vitro 
MSC 3D niche model would provide a realistic ex vivo model which mimics the in 
vivo environment. 
1.7 In vivo studies of the stem cell niche 
Studying the stem cell niche in vivo would provide the most relevant information 
about the native niche environment within the organism. Unfortunately, 
research conducted on the MSC niche has been extremely limited due to their 
low abundance in the bone marrow and diverse range of cell surface marker 
expression (Shiozawa et al., 2008). However, other stem cell niches have been 
investigated in vivo and has allowed the identification of certain stem cell 
behaviours, which would not have been determined using in vitro models. For 
example, Rodgers et al., identified two distinct phases (GAlert and G0) within the 
quiescent state in the cell cycle of muscle stem cell niche in mice (Rodgers et 
al., 2014). Using this particular model, the authors were able to confirm the 
regulatory mechanisms, which were previously suggested with in vitro models. 
Furthermore, the model showed the transition between the two phases was 
important in stem cell positioning is crucial in determining cell location and 
allows a rapid response to injury and also plays an active role in niche 
homeostasis. 
Using in vivo models has allowed the extensive study of stem cell niche cycling 
states, identifying active and quiescent phases (Morrison and Scadden, 2014). 
For example, Kurth et al., detected slow cycling MSCs within the synovium knee 
joint in injured mice (Kurth et al., 2011). Furthermore, in vivo analysis of stem 
cells in their natural environment has allowed the identification of Wnt 
signalling functionality in hair follicle stem cells within mice (Lien et al., 2014). 
This in vivo model established T cell factor 3/4 proteins were able to supress 
Wnt target genes, as well as perform an active role in stem cell fate. 
1.8 Magnetic Nanoparticles 
During the last decade extensive research has been conducted using magnetic 
nanoparticles (mNPs) within biomedicine (Berry, 2009). These nanoparticles may 
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be synthesised from magnetic elements such as iron oxide, nickel and cobalt. 
However, all clinical studies currently use iron oxide as the core metal, as it has 
high biocompatibility (inertness in the human body) and may be easily 
manufactured using standard chemical methods. Due to their high reactivity, the 
core of the nanoparticle is usually coated with either a natural or synthetic 
biocompatible material, which improves the nanoparticle stability and also 
confers stealth properties for in vivo use (i.e. to evade the reticuloendothelial 
system). The majority of these mNP coatings are created from polymers such as 
dextran and polyethylene glycol (PEG), as well as fatty acids. The mNPs may be 
further functionalised by combining them with target specific cell-targeting 
ligands or antibodies, as well as tags such as fluorescent dyes, providing both 
particle monitoring, plus high biological affinity, as shown in Figure 1-11. 
 
Figure 1-11: Schematic diagram of a partially functionalised mNP. 
(Adapted from (Chemicell, 2015)). 
There have been issues associated with using mNPs in vivo, particularly with 
their bio-distribution and low tissue specificity within the body. Therefore, there 
are particular parameters which need to be considered before mNPs may be 
applied in vivo, (e.g. pharmacokinetics, passive targeting and direct targeting) 
(Prijic and Sersa, 2011). External magnetic fields may be used to increase target 
specificity and direct the mNPs to a desired location. Furthermore, direct 
targeting has shown to be improved by the addition of specific antibodies on the 
mNPs, which causes them to accumulate in the desired tissue (Leuschner et al., 
2006). 
Iron oxide mNPs consist of a magnetite (Fe3O4) or maghemite (γ-Fe2O3) core, and 
their sub-micron size confers unique thermal, chemical and magnetic properties, 
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which are distinct from the bulk material and therefore makes them excellent 
diagnostic and therapeutic tools. Furthermore, the particles benefit from their 
use as contrast agents in magnetic resonance imaging (MRI), because they are 
inherently trackable (Chang et al., 2013). MNPs have been applied to both in 
vitro and in vivo settings, as they respond rapidly to a magnetic field. For 
example, mNPs have been used in numerous biological applications, ranging 
from detecting biomolecules in magnetic cell selection, to inducing 
hyperthermia in malignant cancer tumours (Sun et al., 2008, Chen et al., 2009a, 
Dejardin et al., 2011). Additionally, cells have been tracked and cell migration 
has been observed via the cellular uptake of mNPs using microscopy and MRI. 
Fluorescence microscopy has been used to easily observe the mNPs, which have 
been tagged with a fluorescence probe (Berry, 2009). 
1.8.1 Cellular uptake and intracellular processing of mNPs 
The majority of biomedical applications using mNPs, including MSC spheroid 
generation, require nanoparticle (NP) ingestion by the cell. Several factors are 
known to influence cellular uptake, including NP size shape and charge 
(Chithrani et al., 2006). For example, Chithrani and Chan, demonstrated rod-
shaped nanoparticles had a slower rate of cellular uptake compared to spherical 
nanoparticles (Chithrani and Chan, 2007). The mNPs are uptaken into cells via 
endocytosis, whereby the mNPs are transported into the cell body (Sahay et al., 
2010). 
Endocytosis may be further sub categorised into either (a) phagocytosis; large 
particles up to 20 µm are engulfed into the cell, (b) pinocytosis/fluid phase 
uptake; particles are enveloped by fluids and solutes, transported through the 
cell membrane and thus absorbed into the cell or (c) receptor mediated 
endocytosis by either clathrin or caveolin. The exact endocytosis pathway used 
to uptake mNPs into cells is dependent upon the surface chemistry, size, charge 
and shape of the NP. Researchers have suggested nanoparticles smaller than 200 
nm are endocytosed via clathrin vesicles whereas particles between 200 and 
1000 nm are engulfed through caveolin-mediated endocytosis (Kelf et al., 2010). 
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MNP cellular uptake may be increased by the application of an external 
magnetic field. In a method termed ‘magnetofection’, studies have shown mNP 
uptake may be increased by culturing cells above an external magnetic field. 
Zhang et al., applied an external magnetic field to cancer cells in the presence 
of magnetic, mesoporous silica nanoparticles and observed a 2-fold higher 
efficiency rate of mNP cellular uptake compared to cells only exposed to mNPs 
(Liu et al., 2012, Zhang et al., 2010). Essentially, the external magnetic field 
accelerated the sedimentation of the mNPs on the surface of the cells thus 
making the mNPs more readily available for endocytosis. Furthermore, Dejardin 
et al., observed cellular uptake of mNPs was significantly enhanced in the 
presence of an external magnetic field over an exposure period of 1, 5, 30 and 
60 minutes (Dejardin et al., 2011). 
1.8.2 Nanotoxicology 
Studying the niche in vitro requires the cells in this environment to behave and 
possess the same characteristics as the true native niche in vivo. Therefore, the 
internalisation of mNPs must not have a detrimental effect on the intracellular 
or intercellular mechanisms, as this may provide a misinterpretation of MSC 
behaviour. Excessive iron ions are known to form oxygen radicals within cells and 
tissue, causing peroxidative damage to the surrounding area via the Fenton 
reaction. Therefore, the long-term cytotoxic effects of these mNPs require 
further study. 
Shin et al., assessed HeLa cells exposed to a static external magnetic field whilst 
containing ferromagnetic mNPs (Shin et al., 2012). The researchers found the 
internalisation mNPs within the cells did not affect morphology or deform the 
cytoskeleton network, which plays an important role in adhesion and division. 
Furthermore, cell viability was not affected by the presence of the mNPs within 
the cells compared to control cells. 
Soenen et al., studied the cytotoxic effects of iron oxide mNPs on neural 
progenitor cells, rat pheochromocytoma cells and human endothelial cells 
(Soenen et al., 2011). The researchers assessed cell morphology, cell 
proliferation, induction of reactive oxygen species, cell homeostasis, viability 
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and functionality. Cell morphology was affected at high mNPs concentrations 
(600 μg/mL) however, at concentrations of 300 μg/mL there were no significant 
differences in cell surface area compared to the controls. Additionally, focal 
adhesions, cell cycle progression or cell proliferation were not affected at the 
300 μg/mL concentration of mNPs. All the mNPs concentrations used during 
these experiments did not induce acute cytotoxic effects however, there was a 
requirement of long-term monitoring of the effects of internalised mNPs in cells. 
MSCs incubated with iron oxide mNPs were assessed in both in vitro and in vivo 
for cell viability, proliferation, migration and cell homing (Xu et al., 2012). 
Migration and cell homing of MSCs were monitored in an in vivo mouse model 
and assessed on their ability to migrate and home towards a site of 
inflammation. The cells containing the mNPs exhibited the same responses as 
the control cells. The cells containing the mNPs were able to transmigrate to 
site of inflammation, suggesting that the mNPs did not affect MSC phenotype. 
Additionally, they found the viability and proliferation of the MSCs were not 
affected by the incorporation of the mNPs. 
Furthermore, Qin et al., showed that adipose-derived stem cells, containing iron 
oxide mNPs, demonstrated similar cell viability, cell cycle, apoptosis and 
differentiation capacity compared to non-labelled cells (Qin et al., 2013). The 
researchers assessed the cells in vivo by MRI for 4-8 weeks and found cells 
migrated to ischemic tissues, thus the cells exhibited native in vivo behaviour, 
without any cytotoxic effects. 
The creation of an in vitro niche in an ex vivo environment, requires the 
retention of the mNPs within the cells, to form the levitated spheroid, at least 
until the cells have formed their own cell-cell integrin binding and stabilised the 
spheroid.  
1.9 Aims and Objectives 
As previously stated in Chapter 1 section 1.6.1, there are numerous issues 
associated with developing a relevant in vitro MSC niche environment. However, 
the use of a 3D MSC multicellular spheroid may alleviate these problems. A 
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technique whereby cells containing mNPs can be levitated via an external 
magnetic field to form cell spheroids may be adapted to create a MSC niche ex 
vivo. Due to the magnetic properties exhibited by the mNPs, 3D MSC niches 
created in this way, have the potential to be monitored both in vitro (if 
fluorescently tagged) and in vivo via MRI following transplantation. Furthermore, 
MSC spheroids have shown they are may be easily manipulated using an external 
magnetic field suggesting, once implanted in vivo the spheroids may be moved 
to a desired location (Kyrtatos et al., 2009). Also, cellular responses within this 
implanted spheroid niche may be closely observed by tracking the stem cells 
using MRI. 
The MSC niche is known to control stem cell fate by either promoting self-
renewal or directing the stem cells to differentiate. Therefore, unravelling the 
processes and mechanisms within this specialised microenvironment, may enable 
direct manipulation of the stem cells, to either maintain self-renewal or drive 
specific differentiation. Enabling artificial control of MSC fate will aid current 
therapeutic treatments, particularly in the field of tissue regeneration, to create 
a bank of stem cells or required differentiated cells. Current in vitro niche 
models are too simplistic and do not represent the native niche environment and 
MSCs are known to differentiate into undesired and unspecific cells. 
The aim of this thesis is to create a physiologically relevant 3D biomimetic in 
vitro MSC niche model, using mNPs and collagen gels, which will assess MSC 
functionality and behaviour. The following objectives will need to be met to 
achieve the aim. 
 
1. Development of a 3D MSC niche model in vitro using mNPs. 
o Verify mNP uptake into MSCs, via an external static field. 
o Assess MSC spheroid formation via magnetic levitation.  
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o Compare MSC phenotype and quiescence in 3D spheroids with 
corresponding 2D culture. 
o Assess MSC spheroid model in collagen gels to create a more 
realistic niche model. 
2. Assess MSC functional behaviour within the 3D spheroid niche model. 
o Compare MSC niche model migration response in the presence 
and absence of an artificial wound. 
o Assess differentiation capabilities of MSC niche model in a 
scratch wound assay. 
3. Identify MSC migratory signals in the 3D niche model. 
o Determine cytokine release profile from an osteoblast and 
fibroblast scratch wound assay. 
o Assess MSC migratory response in the 3D niche model following 
exposure to specific cytokines. 
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2 Materials and methods 
Table 2-1: A List of materials reagents and suppliers used throughout all experiments. 
(*Preparation methods of solutions are described in detail in Section 2.1). 
Materials/Reagents Supplier(s) 
1. Cells 
Human bone marrow MSCs 
Promocell GmBH, Germany 
and 
Southern General Hospital, 
UK 
Infinity telomerase-immortalised primary human 
fibroblasts (h-TERT-BJ1) 
Clontech Laboratories Inc., 
USA 
Human primary osteoblast cells Promocell GmBH, Germany 
2. Nanoparticles 
200 nm sized mNPs coated in polydimethylamine 
(PEA) 
Chemicell GmBH, Germany 
200 nm sized mNPs coated in PEA-FITC tag Chemicell GmBH, Germany 
3. Cell Culture 
Dulbeccos modified eagle medium (DMEM) Sigma-Aldrich, UK 
Medium 199 Sigma-Aldrich, UK 
Foetal bovine serum (FBS) Sigma-Aldrich, UK 
Penicillin-streptomycin Sigma-Aldrich, UK 
MEM Non-essential amino acids Sigma-Aldrich, UK 
L-glutamine 200 mM Invitrogen, UK 
Sodium pyruvate Life Technologies, UK 
Ascorbate-2-phosphate Sigma-Aldrich, UK 
Dexamethasone Sigma-Aldrich, UK 
Insulin Sigma-Aldrich, UK 
Indomethacin Sigma-Aldrich, UK 
Isobutylmethylxanthine Sigma-Aldrich, UK 
Trypsin Sigma-Aldrich, UK 
Versene* In house 
Trypsin/versene solution* In house 
Sodium Chloride (NaCl) VWR Chemicals, UK 
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Potassium Chloride (KCl) VWR Chemicals, UK 
Glucose Fisher Scientific, UK 
HEPES Fisher Scientific, UK 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, UK 
Phenol Red solution 0.5% Sigma-Aldrich, UK 
HEPES solution In house 
EasySep™ Human CD271 Selection Kit 
StemCell Technologies, 
France 
Ficoll-Paque™ PREMIUM GE Healthcare, UK 
Rat Tail Collagen Type I, > 2 mg/mL First Link Ltd., UK 
10X MEM First Link Ltd., UK 
0.1 M sodium hydroxide (NaOH) Sigma-Aldrich, UK 
4. Electron Microscopy 
Gluteraldehyde (25% aq pure, EM Grade) Sigma-Aldrich, UK 
Sodium cacodylate Agar Scientific Ltd, UK 
Osmuim tetroxide Agar Scientific Ltd, UK 
Aqueous uranyl acetate Agar Scientific Ltd, UK 
Ethanol VWR Chemicals, UK 
Methanol VWR Chemicals, UK 
Propylene oxide VWR Chemicals, UK 
Epon resin araldite (812 Kit E202) TAAB Lab Equipment Ltd UK 
Uranyl acetate Sigma-Aldrich, UK 
Reynolds lead citrate Agar Scientific Ltd, UK 
5. Cell Staining 
PBS Sigma-Aldrich, UK 
Formaldehyde (38%) Fisher Scientific, UK 
Sucrose Fisher Scientific, UK 
Magnesium Chloride ((MgCl2) hexahydrate) VWR Chemicals, UK 
Triton X Sigma-Aldrich, UK 
BSA Sigma-Aldrich, UK 
LIVE/DEAD® Viability/Cytotoxicity kit Invitrogen, UK 
anti-BrdU antibody kit GE Healthcare, UK 
Rhodamine-phalloidin Invitrogen, UK 
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Vectashield-DAPI Vector laboratories, USA 
Primary antibodies Abcam, UK and Santa Cruz 
biotechnologies, USA 
Biotinylated secondary antibodies Vector laboratories, USA 
Unbiotinylated secondary antibodies-Texas Red Vector laboratories, USA 
Streptavidin-FITC/Texas Red Vector laboratories, USA 
0.5% Tween 20 in PBS* In house 
Tween 20 Sigma-Aldrich, UK 
Oil Red O Sigma-Aldrich, UK 
Triethyl phosphate Sigma-Aldrich, UK 
Mayer Haematoxylin solution Sigma-Aldrich, UK 
6. ICP-MS 
RIPA buffer* In house 
TRIZMA® base Sigma-Aldrich, UK 
Sodium deoxycholate Sigma-Aldrich, UK 
Sodium dodecyl sulfate (SDS (1%)) VWR Chemicals, UK 
aqua regia* In house 
Concentrated nitric acid VWR Chemicals, UK 
Concentrated hydrochloric acid Fisher Scientific, UK 
7. RNA Isolation 
TRIzol Life Technologies, UK 
Chloroform Sigma Aldrich, UK 
Glycoblue Ambion, UK 
Isopropanol Sigma Aldrich, UK 
RNase free water Qiagen, UK 
RNeasy micro kit Qiagen, UK 
Primers 
Eurofins Genomics, 
Luxembourg 
SuperScript III Reverse Transcriptase Invitrogen, UK 
2x TaqMan PreAmp Master Mix  Applied Biosystems, UK 
2x SsoFast EvaGreen Supermix  Bio-Rad 
RNaseOUT Recombinant RNase inhibitor Invitrogen, UK 
DNA suspension buffer Life Technologies, UK 
Exonuclease I Reaction Buffer New England Biolabs, UK 
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Exonuclease New England Biolabs, UK 
BioMark, 20x DNA Binding Dye sample loading 
reagent 
Fluidigm Corporation, USA 
8. Cytokine analysis 
Pro Human Cytokine Group I, 5-plex Assay Kit Bio-Rad, UK 
Human IL-6 full length protein Abcam, UK 
 
2.1 Cell Culture Solutions 
Modified alpha-MEM (stem cell growth media) 
DMEM 500 mL 
FBS 50 mL 
Penicillin-streptomycin 10 mL 
MEM non-essential amino acids 5 mL 
Sodium pyruvate 5 mL 
 
Modified DMEM (standard growth media) 
DMEM 400 mL 
Medium 199 100 mL 
FBS 50 mL 
Penicillin-streptomycin 10 mL 
L-glutamine 200 mM 5 mL 
Sodium pyruvate 5 mL 
 
Versene 
Water 1000 mL 
NaCl 8 g 
KCl 0.4 g 
Glucose 1 g 
HEPES 2.38 g 
EDTA 0.2 g 
0.5% phenol red 2 mL 
Adjusted to pH 7.5 
 
Trypsin/versene solution 
Versene (In house solution) 20 mL 
Trypsin 0.5 mL 
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PBS solution 
PBS 1 tablet 
Water 200 mL 
 
Cell Fixation buffer 
PBS solution 90 mL 
Formaldehyde (38%) 10 mL 
Sucrose 2 g 
 
Cell Permeability buffer 
PBS solution 100 mL 
Sucrose 10.3 g 
NaCl 0.292 g 
MgCl2 hexahydrate 0.06 g 
HEPES 0.476 g 
Adjusted to pH 7.2 
Triton X 0.5 mL 
 
0.5% Tween 20 in PBS 
PBS solution 100 mL 
Tween 20 0.5 mL 
 
RIPA lysis buffer 
Water 45 mL 
NaCl 0.44 g 
TRIZMA® base 0.3 g 
Triton X 0.5 mL 
Sodium deoxycholate (1%) 0.5 g 
SDS (1%) 0.05 g 
Make up to 50 mL with water 
 
Aqua Regia 
Concentrated nitric acid 10 mL 
Concentrated hydrochloric acid 30 mL 
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2.2 Cell Culture 
2.2.1 General Protocol 
The hMSCs were cultured in T75 flask with modified alpha-MEM media at 37°C 
with 5% CO2. Once the cells were confluent, the media was removed and the 
cells were washed with HEPES solution. Cells were detached from the surface 
using trypsin/versene (2 minutes at 37°C). Fresh media was added to the flask to 
neutralise the active trypsin, and the cell suspension was centrifuged for 4 
minutes at 1400 rpm. After centrifugation, the supernatant was removed leaving 
a pellet of cells. The cells were re-suspended in fresh media and seeded into 
appropriate wells for experiments. 
The same protocol was followed for other cells types including h-TERT 
fibroblasts and primary osteoblasts, except using different culture mediums for 
h-TERTs and primary osteoblasts. H-TERTs were cultured with modified-DMEM 
whereas, primary osteoblast were cultured with modified alpha-MEM. 
2.2.2 Bone Marrow extraction 
Each bone marrow sample was divided into two and centrifuged for 10 minutes 
at 1400 rpm. Any bone chips were placed into flasks containing modified alpha-
MEM media. The supernatant was removed and the pellet was re-suspended in 10 
mL fresh media; the cell suspension was centrifuged (10 minutes at 1400 rpm). 
The media was removed and the pellet was re-suspended in 10 mL fresh media; 
the cell suspension was slowly overlaid onto 7.5 mL Ficoll-Paque™ PREMIUM and 
then centrifuged for 45 minutes at 1513 rpm. The middle layer was extracted 
and placed in a new tube containing 10 mL fresh media, which was then 
centrifuged for 10 minutes at 1400 rpm. The supernatant was removed and the 
pellet was re-suspended in 10 mL fresh media, followed by centrifugation for 10 
minutes at 1400 rpm. The supernatant was removed and the pellet was re-
suspended in 10 mL fresh media and then placed in a vented flask at 37°C with 
5% CO2. 
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2.2.3 CD271 positive selection from bone marrow extracts 
The EasySep™ Human CD271 Selection Kit was used to isolate CD271+ MSCs. Once 
the cells were confluent, the media was removed and the cells were washed 
with HEPES solution. Cells were detached using trypsin/versene (2 minutes at 
37°C). Fresh media was added to the flask and the cell suspension was 
centrifuged for 4 minutes at 1400rpm. After centrifugation, the supernatant was 
removed leaving a pellet of cells. The cells were re-suspended in 500 μL 2% 
FBS/1xPBS and the mixture was added to a round bottom tube. Fc receptor 
blocker (12 μL) was added to the tube, followed by the addition of CD271+ (25 
μL) selection cocktail, for 15 minutes at room temperature. 2.5 mL of 2% 
FBS/1xPBS was thoroughly mixed with the cell solution. The tube was placed in 
the magnet block for 5 minutes at room temperature and subsequently inverted 
for 2 seconds. The tube was removed from the magnet block and 2.5 mL of 2% 
FBS/1xPBS was thoroughly mixed with the cell suspension. The tube was placed 
in the magnet block for a further 5 minutes at room temperature and inverted 
for 2 seconds to remove the solution. This process was repeated once more and 
then the cells were re-suspended in 500 μL of fresh media, before being smeared 
across the centre of a vented flask. The flask was left for 30 minutes (37°C/5% 
CO2), at which point 10 mL fresh media was added to the flask. 
The maximum number of passages used MSCs collected from Southern General 
Hospital, Glasgow was 3. 
2.3 Cell Culturing Methods 
2.3.1 Optimising Magnetic Nanoparticle Uptake into Cells 
hMSCs were seeded at a concentration of 1x104 cells/cm2 directly onto sterile 
glass coverslips (13 mm diameter) in a 24 well plate and left overnight to adhere 
(37°C/5% CO2). The media was removed and exchanged for 1 mL of magnetic 
nanoparticles (mNPs) diluted in fresh alpha-MEM media (0.01 mg/mL or 0.1 
mg/mL), and incubated for 15 minutes, 30 minutes or 1 hour in the presence or 
absence of a magnetic field of 350 mT (24 magnet array from Chemicell, placed 
beneath the 24 well plate). Cells cultured in media for 1 hour were used as 
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control samples. Optimised conditions were 0.1 mg/mL mNPs concentration 
for 30 minutes with a magnetic field. 
2.3.2 Type I collagen gel formation 
2.3.2.1 Collagen gel formation 
The following described preparation allows for three gels. 0.5 mL fresh alpha-
MEM media with 0.5 mL 10xDMEM and 0.5 mL FBS added stepwise to each cell 
suspension. 2.5 mL acetic acid solubilised collagen Type I, and 1 mL 0.1 M NaOH 
were mixed homogeneously, then added to the cell suspension mixture; 0.1 M 
NaOH was subsequently added drop wise to the to neutralise the solution, which 
turned pink (via phenol red indicator in the media). The suspension was then 
added to the appropriate wells and allowed to gel during incubation at 37°C 
with 5% CO2 for the required experimental period. Media was changed with fresh 
media twice weekly. 
2.3.2.2 Collagen gel formation with cells 
The same procedure described above was followed whereas, 0.5 mL cell 
suspension in fresh alpha-MEM media was used instead of 0.5 mL fresh alpha-
MEM media. Cells were pre-loaded with mNPs as described in Section 2.3.1. 
2.3.3 Monolayer Culture 
hMSCs were seeded at a concentration of 3x104 cells/cm2 and left overnight 
(37°C/5% CO2). The media was removed and exchanged for 1 mL of mNPs diluted 
in fresh alpha-MEM media (0.1 mg/mL), and incubated for 30 minutes in the 
presence of a magnetic field. Cells were washed with HEPES followed by 
trypsinisation with trypsin/versene and centrifuged at 1400 rpm for 4 minutes. 
The supernatant was removed and pellet re-suspended in media, re-seeded onto 
sterile glass coverslips (13 mm diameter) for the appropriate incubation period. 
Media was changed twice weekly. 
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2.3.4 Spheroid Culture 
2.3.4.1 MSC Spheroid Culture in Media 
The preparation described below generates two spheroids. Following incubation 
with the mNPs, the cells (1x104 cells/cm2) were trypsinised, pooled together and 
centrifuged at 1400 rpm for 4 minutes. All control cells (i.e. without mNPs) were 
also pooled together and centrifuged at 1400 rpm for 4 minutes. The cells were 
re-suspended in 1 mL fresh and 0.5 mL of cell suspension was added to 4 mL 
fresh media in a well (6 well plate). A single magnet (13 mm diameter, 350 mT) 
was either placed on the top or the bottom of the well and the plate was 
incubated at 37°C with 5% CO2 for the required experimental period. 
2.3.4.2 MSC Spheroids in Type I Collagen gels 
 Spheroids were prepared as previously discussed in Section 2.3.4.1. After 24 
hours, the spheroids were added to the gel mixture described above in section 
2.3.2, but without the addition of the cells in the initial stages. 
2.4 Statistical Analysis 
GenStat software version 15 (VSN International, UK) was used to determine the 
statistical significance of each statistical analysis. The analysis of variance 
(ANOVA) was performed using either one-way ANOVA or two-way ANOVA tests 
depending on the sample set. The statistical significance of the results was 
determined by calculating the probability of a null hypothesis being true, using a 
pre-specified threshold (p-value). If the level of confidence was lower than 5% 
(p-value ≤ 0.05), the null hypothesis was rejected and the result was classed as 
being statistically significant. The embedded statistical analysis in Microsoft 
Office Suite version 2013 (excel) was used to calculate the mean and standard 
deviation of each experiment. 
2.5 Research collegues 
David Stirling, University of West Scotland, operated the equipment to obtain 
ICP-MS results. TEM samples were sectioned by Margaret Mullin, Electron 
Microscopy Facility, University of Glasgow. Monolayer samples were stained Oil 
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Red O by Lynn Robertson from the Veterinary Diagnostic Services Laboratory, 
University of Glasgow. 
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3 The Development of an In vitro Mesenchymal 
Stem Cell Niche Model 
3.1 Introduction 
3.1.1 The Bone Marrow Niche Microenvironment 
The bone marrow niche environment has a fundamental role in controlling 
mesenchymal stem cell behaviour, by either regulating stem cell fate through 
the promotion of self-renewal or directing stem cell differentiation. The niche 
dynamically regulates these processes by balancing MSC quiescence, 
proliferation and differentiation. As described in section 1.4, the MSC niche 
environment is comprised of various components, including MSC niche cells, 
support cells (pericytes), growth factors (e.g. FGF, HGF, VEGF and TGF-β), ECM 
proteins (e.g. collagen, fibronectin, laminin and proteoglycans), signalling 
molecules (e.g. cytokines, CXCL-12, and SCF), as well as HSCs, endothelial cells, 
adipocytes and macrophages. The interactions between the cells and the 
surrounding ECM environment are important in preserving a MSC pool to maintain 
homeostasis and tissue regeneration, throughout the species lifetime. The ECM is 
important in maintaining the stem cell niche, because its composition and 
properties (structural, mechanical, biochemical and physical), allow for signal 
transmission and interaction with the stem cells. Additionally, the ECM anchors 
stem cells in the niche and binds growth factors, which diffuse to the stem cells 
and regulate stemness as well as differentiation. 
3.1.2 3D In Vitro Bone Marrow Niche Models 
Recently, there has been huge interest in exploiting the MSC niche to develop 
novel therapeutic regenerative medicines. Harnessing the specialised 
microenvironment properties and understanding the regulatory signals within the 
niche may lead to direct manipulation of stem cells, allowing external control 
over their fate. The knowledge gained from this research is very important 
because MSCs possess interesting immunomodulatory and differentiation 
properties. Controlling MSC fate within bone marrow niche models may allow, 
for example, the creation of a multipotent stem cell bank ready to use for 
transplants. Additionally, directing the MSCs to differentiate down a specific 
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lineage, for example towards osteoblasts, to correct bone defects such as 
osteoporosis or osteoarthritis. 
In the past there has been limited research conducted on the MSC niche and 
there is scant information regarding cellular communication between cells and 
the extracellular environment (see section 1.4.1). Therefore, creating in vitro 
models of the MSC niche would allow for detailed studies into these processes. 
Initially, 2D in vitro models have been employed using various substrates, with 
surfaces coated in ECM proteins including collagen and fibronectin, as well as 
different growth factors to simulate the in vivo niche. However, these models 
have been described as too simplistic as they lack the 3D niche structure, 
represented within the bone marrow. Most cell types, including MSCs are known 
to express different receptors and exhibit different cell morphologies when 
cultured in 2D models compared to 3D model techniques. Therefore, recently 
there has been a shift from using 2D to 3D culturing methods, to create a more 
realistic model. 
There are various methods involved in creating 3D MSC niche models however, 
the use of multicellular spheroids has been described as an effective and 
efficient technique. Typical protocols for generating spheroids, including 
hanging drop or mechanical agitation, were summarised in section 1.6.2. This 
chapter aims to adapt a recently described protocol, which coerces cells to 
clump together to create spheroids using magnetic nanoparticles (mNPs). The 
internalisation of mNPs within cells has allowed direct cell manipulation through 
the application of an external magnetic field. Previous studies have shown the 
incorporated iron oxide mNPs within the MSCs does not affect phenotypic and 
the characteristic behaviour of these cells (Arbab et al., 2005, Farrell et al., 
2008). Additionally, increasing the complexity of the model has been achieved 
by incorporating spheroids into collagen gel scaffolds. 
MSCs within the bone marrow niche, express certain phenotypic characteristics. 
In an unstimulated niche, the MSCs remain in a low metabolic and quiescent 
state, until they become stimulated by external factors. These MSCs express 
high multipotency (e.g. STRO-1 and nestin) markers, which are indicative of the 
cells retaining their stem cell properties. However, upon stimulation via 
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osteogenic and adipogenic induction, the MSCs are directed to differentiate and 
express osteogenic or adipogenic characteristics. Monitoring these phenotypic 
characteristics or markers will provide an insight into whether the MSCs within 
this 3D niche model are mimicking their innate environment. 
3.2 Objectives 
This chapter aims to develop a new 3D MSC niche model in vitro, which mimics 
the native in vivo bone marrow niche. The generation of a more physiologically 
relevant 3D model may allow native cellular responses and will facilitate a 
detailed study in isolation, to observe cellular events in this milieu. If successful, 
the model will enable the study of niche regulatory signals, as well as both cell-
cell and cell-extracellular matrix signalling. Understanding these processes will 
further develop the artificial manipulation of niche MSCs to produce the desired 
response or behaviour. 
These objectives will be achieved through the following stages via: 
 Pre-loading a MSC monolayer with mNPs, assessing mNP uptake and 
retention, as well as subsequent MSC movement to an external magnetic 
field. 
 The creation of 3D MSC spheroids utilising mNP-loaded cells. MSC viability, 
phenotypic characteristics, cell cycle state and differentiation capacity 
will be assessed and compared with monolayer cultures over time. 
 The incorporation of MSC spheroids into Type I collagen gel scaffolds to 
mimic the bone marrow environment, with assessment of the model’s 
mechanical properties. 
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3.3 Materials and Methods 
3.3.1 Cell culture and Magnetic Nanoparticle Incubation 
All results shown within this thesis used MSCs bought from Promocell, Germany. 
However, initial data collected but not displayed within the thesis used MSCs 
from patients at the Southern General Hospital, Glasgow. Cells were cultured as 
monolayers, spheroids and/or as spheroids encapsulated within Type I collagen 
gels in all experiments in this chapter. The cells cultured in this way were 
prepared as previously discussed in Chapter 2, section 2.3.3 and 2.3.4. The mNPs 
(200 nm) were purchased from Chemicell and they consisted of a magnetite core 
(Fe3O4) coated in poly (ester amide) (PEA) with a FITC green fluorescent tag (see 
Figure 3-1). 
 
Figure 3-1: Schematic diagram of the fluorescent mNPs employed in the project. 
(Adapted from Chemicell (Chemicell, 2015)). 
3.3.2 Magnetic Nanoparticle Uptake into MSCs  
3.3.2.1 Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) 
ICP-MS was used to quantitatively assess the uptake of mNPs into MSCs in 
monolayer culture. The mNPs consisted of an iron oxide core therefore, the ICP-
MS elemental analysis of the iron within each sample, served as a direct 
correlation to the amount of mNPs taken up within the MSCs. This mNP uptake 
allowed for quantification and optimisation of mNP loading into cells. 
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Following incubation with the mNPs, cells were washed with 1xPBS. The PBS was 
then removed and 400 μL of RIPA buffer was added for 10 minutes at room 
temperature. The buffer was removed from the wells, then added to allocated 
tubes. Each well was washed with 100 μL distilled water, then transferred to 
each relevant tube. Subsequently, 1 mL of aqua regia was added to each tube 
and the tube was incubated at 70°C overnight. The next day, each tube was 
made up to 50 mL with distilled water ready for analysis by ICP-MS (THERMO X 
Series III). 
3.3.2.2 Transmission Electron Microscopy (TEM) 
TEM was used to qualitatively verify mNP uptake of MSCs in the monolayer 
culture, as well as allowing the study the location of nanoparticles within the 
cells. 
Following incubation with the mNPs, the media was removed and cells were 
fixed in 1.5% glutaraldehyde/0.1M sodium cacodylate (1 hour at 4°C). The wells 
were subsequently washed with 0.1M sodium cacodylate, post fixed then stained 
with 1% osmium tetroxide/1xPBS (1 hour at room temperature). The cells were 
washed with distilled water, stained in 0.5% aqueous uranyl acetate (1 hour at 
room temperature) then washed with distilled water. The cells were dehydrated 
using increasing levels of alcohol concentrations (30%, 50%, 70%, 90%, 100% and 
100% (absolute)) for 10 minutes at each step. Samples were left in propylene 
oxide: Epon resin araldite/812 mix (1:1) overnight. The next day, samples were 
placed into pure resin and cured for 24 hours at 60°C. Ultrathin sections were 
stained with 2% methanolic uranyl acetate and Reynolds lead citrate, ready for 
analysis using Leo 912 AB TEM at 120kV. 
3.3.3 Observing Cells via Fluorescence Microscopy 
MSCs were seeded into a 24 well plate, at a concentration of 1x104 cells/cm2 and 
left overnight (37°C/5% CO2). The media was removed and 1 mL of 0.1 mg/mL 
mNPs were added to the wells and incubated for 30 minutes in the presence of a 
magnetic field (control cells did not contain mNPs). 
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3.3.3.1 Cell viability staining 
After the appropriate incubation period the cells, which were either in media or 
collagen gel, were assessed for cell viability, by preparing 1 mL of fresh alpha-
MEM media containing 1 μL calcein AM and 1 μL ethidium homodimer. This media 
was added to the cultures then incubated for 1 hour at 37°C. Subsequently, the 
cells or gels were washed three times with fresh media and analysed 
immediately using a Zeiss Axiovert 200M fluorescent microscope. 
3.3.3.2 Actin staining 
Monolayer Cell Cultures: Following the addition of mNPs and after the 
appropriate incubation period, the cells were washed with 1xPBS, fixed for 15 
minutes at 37°C, permeabilised for 5 minutes at 4°C, then 1% BSA/1xPBS was 
added to each well for 5 minutes at 37°C. F-actin was stained using rhodamine-
phalloidin (1:500 in 1% BSA/1xPBS) for 1 hour at 37°C. The cells were washed 
with 0.5% Tween 20/1xPBS and mounted onto slides with DAPI (to stain DNA). 
Images were taken using a Zeiss Axiovert 200M fluorescent microscope. 
Collagen Gel Cell Cultures: Cell samples, prepared in a gel environment, were 
treated similarly and images were taken using either a Zeiss Axiovert 200M 
fluorescent microscope or a Zeiss Axiovert 200M confocal microscope, collecting 
sequential images every 20 μm through the gel, to create a z-stack. 
3.3.3.3 STRO-1 and nestin staining 
Following mNP incubation, the cells were washed with 1xPBS, fixed for 15 
minutes at 37°C, permeabilised for 5 minutes at 4°C, then 1% BSA/1xPBS was 
added to each well for 5 minutes at 37°C. Subsequently, 1 mL of anti-STRO-1 or 
anti-nestin (1:50 in 1% BSA/1xPBS) was added for 1 hour at 37°C, washed with 
0.5% Tween 20/1xPBS, and 1 mL of biotinylated secondary (1:50 in 1% 
BSA/1xPBS) was added and incubated for 1 hour at 37°C. The cells were washed 
with 0.5% Tween 20/1xPBS, and finally 1 mL of streptavidin-Texas Red (1:50 in 
1% BSA/1xPBS) was added to each well for 30 minutes at 4°C. Following washing 
in 0.5% Tween 20/1xPBS, cells were mounted with DAPI. Cells were analysed by 
Zeiss Axiovert 200M fluorescent microscope. 
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3.3.3.4 BrdU staining 
Following mNP incubation, 6 hours prior to fixing the cells, 1 mM BrdU solution 
in alpha-MEM was added to each well. The cells were washed with 1xPBS, fixed 
for 15 minutes at 37°C, permeabilised for 5 minutes at 4°C, then 1% BSA/1xPBS 
was added to each well for 10 minutes at 37°C. Subsequently, 1 mL of anti-BrdU 
(1:100 in DNase) was added for 2.5 hours at 37°C, washed with 0.5% Tween 
20/1xPBS, and 1 mL of secondary-Texas Red (1:50 in 1% BSA/1xPBS) was added 
and incubated for 1 hour at 37°C. The cells were washed with 0.5% Tween 
20/1xPBS, and finally mounted with DAPI. Cells were analysed using Zeiss 
Axiovert 200M fluorescent microscope. 
3.3.3.5 Calculated Fluorescent Intensity 
All fluorescent images analysed by fluorescent intensity were calculated using 
ImageJ, which has been created by the National Institute of Health, U.S 
Department of Human and Health Services. 
3.3.4 Rheology analysis of the gels 
 Gels were prepared with or without MSC spheroids and analysed after 3 days 
incubation. Analysis was carried out at 25°C within a heat controlled 
environment and with a parallel plate (20 mm diameter). Additionally, a solvent 
trap was used to minimise solvent evaporation thus, creating a saturated 
internal atmosphere. A strain sweep of the gels was initially used to ensure 
elastic modulus (G’) and viscous modulus (G’’) measurements were taken within 
the linear viscoelastic region. Frequency sweeps of the gel were carried out 
between 0.1 and 40 Hz to determine the dynamic modulus of the gel. All analysis 
was conducted using a Malvern Kinexus rheometer. 
3.3.5 Induced differentiation of MSCs via osteogenesis and 
adipogenesis 
Monolayer Cultures: Following unlabelled mNP incubation, cells were cultured 
for the first 8 days in modified alpha-MEM. Subsequently, the media was changed 
to either osteogenic induction media (DMEM, 10% FBS, 2% antibiotics, 350 mM 
ascorbate-2-phosphate and 0.1 µM Dexamethasone) or adipogenic induction 
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media (DMEM, 10% FBS, 2% antibiotics, 1 μM Dexamethasone, 1.7 nM insulin, 200 
μM indomethacin, 500 μM isobutylmethylxanthine)/adipogenic maintenance 
media (DMEM, 10% FBS, 2% antibiotics, 1.7 nM insulin) and incubated for 28 days. 
The adipogenic induction media and maintenance media was alternated every 
2/3 days. The timeline is depicted in Figure 3-2. 
Spheroid Cultures: Spheroids were cultured for 7 days in modified alpha-MEM. 
The spheroids were pooled together and centrifuged for 4 minutes at 1400 rpm, 
the supernatant was removed and the pellet was re-suspended in modified 
alpha-MEM. The cells were reseeded as monolayers and left for 72 hours. The 
media was removed and either osteogenic induction media or adipogenic 
induction/adipogenic maintenance media was added for 3 times a week for the 
next 42 days. The timeline is depicted in Figure 3-2. 
 
Figure 3-2: Timeline of experimental procedure used to induce differentiation in MSCs with 
osteogenic and adipogenic media. 
 
Oil Red O stain (assessing adipogenesis): A solution of 10 mg/mL Oil Red O in 
60% triethyl phosphate (aq) was prepared. The cells were washed with 1xPBS, 
fixed for 15 minutes at 37°C. The fixative was removed and cells rinsed with 60% 
triethyl phosphate (aq). This solution was removed and Oil Red O solution was 
added to the cells (room temperature for 10 minutes). Oil Red O was removed 
and cells rinsed with 60% triethyl phosphate (aq). Filtered Mayer Haematoxylin 
solution was added (room temperature for 2 minutes) to the cells then rinsed 
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with tepid tap water. Cells were mounted onto slides and analysed using Zeiss 
Axiovert 25 light microscope. 
Osteopontin stain (assessing osteogenesis): Following mNP incubation, the cells 
were washed with 1xPBS, fixed for 15 minutes at 37°C, permeabilised for 5 
minutes at 4°C, 1% BSA/1xPBS was added to each well for 5 minutes at 37°C. 
Subsequently, 1 mL of anti-osteopontin (1:50 dilution) with phalloidin-rhodamine 
(1:500 dilution) in 1%BSA/1xPBS was added for 1 hour at 37°C, washed with 0.5% 
Tween 20/1xPBS, and 1 mL of biotinylated secondary (1:50 in 1% BSA/1xPBS) was 
added and incubated for 1 hour at 37°C. The cells were washed with 0.5% Tween 
20/1xPBS, and finally 1 mL of streptavidin-Fluorescein (1:50 in 1% BSA/1xPBS) 
was added to each well for 30 minutes at 4°C. Following washing in 0.5% Tween 
20/1xPBS, cells were mounted with DAPI. Cells were analysed using Zeiss 
Axiovert 200M fluorescent microscope. 
3.3.6 RNA isolation 
Analysis was conducted on cells cultured as monolayer or spheroid culture 
systems for either 1 or 14 days. For the monolayer cultures, three samples were 
pooled for each replicate (n=3), whereas; for the spheroid cultures, six samples 
were pooled for each replicate (n=3). 
A Qiagen RNeasy micro kit was used during this experimental setup. After the 
appropriate incubation period, cells were lysed with TRIzol (1 mL) for 10 minutes 
at room temperature and then centrifuged at 4°C (12 000 g for 15 minutes). The 
supernatant was transferred and mixed thoroughly with 200 μL chloroform and 
incubated at room temperature (3 minutes). The mixture was centrifuged at 4°C 
(12 000 g for 15 minutes) and the aqueous phase was removed, then glycoblue (1 
μL) and isopropanol (500 μL) was added to the solution. The Eppendorf tubes 
were inverted several times, and then incubated at room temperature (10 
minutes), followed by centrifugation at 4°C (12 000 g for 20 minutes). The 
supernatant was removed leaving a blue pellet, which was vortexed with 1 mL 
ethanol (25% aq), then centrifuged 4°C (7 500 g for 5 minutes). The ethanol was 
removed to air dry the pellet, then RNase-free water (20 μL) was added and the 
samples were incubated at 55°C (10 minutes). Each sample was made up to 350 
μL with buffer RLT and vortexed then 70% ethanol (350 μL) was added and mixed 
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thoroughly, then transferred to a spin column for centrifuging at 8 000 g for 15 
seconds. Buffer RW1 (350 μL) was added to the spin column and centrifuged (8 
000 g for 15 seconds), then 80 μL DNase I solution in buffer RDD (1:8 dilution) 
was added at room temperature (15 minutes). Buffer RW1 (350 μL) was added to 
the spin column and centrifuged at 8 000 g for 15 seconds. Buffer RPE (500 μL) 
was added to the spin column, then centrifuged (8 000 g for 15 seconds) 
followed by 500 μL of 80% ethanol and centrifuged at 13 000 g for 2 minutes. The 
spin column was further centrifuged at 13 000 g for 5 minutes. The dried spin 
column was placed in a 1.5 mL Eppendorf tube and 14 μL RNase-free water was 
added then centrifuged at full speed for 1 minute. 
3.3.7 Fluidigm preparation 
The RNA was subjected to a reverse transcription using the SuperScript III 
Reverse Transcriptase. At all stages of the process, reactions were performed at 
4°C unless stated. 11 μL of each sample was added to 1 μL of oligo (dT) and 1 μL 
dNTPmix and then heated to 65°C for 5 minutes. A mixture containing 4 μL 5X 
First Strand buffer, 1 μL 0.1M DTT, 1 μL RNaseOUT Recombinant RNase inhibitor, 
0.5 μL SuperScript III RT and 0.5 μL water was prepared and added to each 
sample and left for 5 minutes. The solution was then incubated at 50°C for 30 
minutes followed by 70°C for 15 minutes to produce cDNA. All 48 primers (see 
Table 3-2) were pooled together (1 μL from each primer set pooled and 152 μL 
of DNA suspension buffer). A new solution was prepared with 1.25 μL from the 
cDNA of each sample, 2.5 μL 2x TaqMan PreAmp Master Mix, 0.5 μL pooled 
primer mix, 0.75 μL water. These samples were vortexed, centrifuged and 
subjected to 22 thermal cycles using the following programme: 
Table 3-1: Thermal cycle conditions used on each sample prior to Fluidigm analysis. 
Condition Hold 22 Cycles Hold 
Temperature 95°C 95°C 60°C 4°C 
Time 10 mins 15 secs 4 mins ∞ 
 
After the 22 thermal cycles, 1.4 μL water, 0.2 μL Exonuclease I Reaction Buffer 
and 0.4 μL Exonuclease were added to each sample and vortexed, centrifuged 
and incubated at 37°C for 30 minutes and then at 80°C for 15 minutes. After 
heating, 18 μL of TE buffer was added to each sample. The Exonuclease I treated 
sample (2.7 μL) was added to 3.0 μL 2x SsoFast EvaGreen Supermix and 0.3 μL 
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20x DNA Binding Dye sample loading reagent. Each sample was vortexed and 
centrifuged then loaded onto the chip. Additionally, 0.3 μL of each individual 
primer set was added to 3 μL 2X assay loading reagent and 2.7 μL 1x DNA 
suspension buffer was vortexed and centrifuged prior to loading on the chip. A 
48.48 Dynamic array IFC was used during this analysis. 
Table 3-2: Fluidigm primers designed for human genes. 
(*Primers used as housekeeping genes). 
Primer Sequence (5’ to 3’) 
B-Actin* 
Forward GTGGGCCGCCCTAGGCACCAG 
Reverse CACTTTGATGTCACGCACGATTTC 
Nestin 
Forward GCTCAGGTCCTGGAAGGTC 
Reverse AAGCTGAGGGAAGTCTTGGA 
ALCAM 
Forward TTCCAGTCCCTCTACTCAGAGC 
Reverse GCTAAGAAGGACTCGCAGGA 
vimentin 
Forward GGAGAAATTGCAGGAGGAGA 
Reverse TGCGTTCAAGGTCAAGACGT 
CD63 
Forward CCCTTGGAATTGCTTTTGTT 
Reverse TATTCCACTCCCCCAGATGA 
c-myc 
Forward GACTCTGAGGAGGAACAAGA 
Reverse TTGGCAGCAGGATAGTCCTT 
ENOX-2* 
Forward GAGCTGGAGGGAACCTGATTT 
Reverse CACTGGCACTACCAAACTGCA 
RUNX-2 
Forward CAGCAGCAGCAACAGCAG 
Reverse GGCGATGATCTCCACCAT 
RUNX1T1 
Forward ATCACAACAGAGAGGGCCAA 
Reverse CTGCAGGTTTCACTCGCTTT 
Osterix 
Forward TGGGCTCCCAACACTATTTC 
Reverse GGGAAGACTGAAGCCTGGA 
BMP2 
Forward AGACCTGTATCGCAGGCACT 
Reverse CCACTCGTTTCTGGTAGTTCTTCC 
BMPR2 
Forward AGCCTCTCACACCCACTCC 
Reverse GCAGAACAACCGTGAGAGG 
OPN 
Forward AGCTGGATGACCAGAGTGCT 
Reverse TGAAATTCATGGCTGTGGAA 
TWY-1* 
Forward ATTGTCATCAAGACGCAGGGC 
Reverse GTTGCGAATCCCTTCGCTGTT 
PPAR-γ 
Forward TTGCTGTCATTATTCTCAGTGGA 
Reverse GAGGACTCAGGGTGGTTCAG 
COL2A1 
Forward CTGGGACCCCTGGAAATC 
Reverse CATCAAATCCTCCAGCCATC 
ACAN 
Forward TCACGTGTAAAAAGGGCACA 
Reverse CAGGGAATTGATCTCATACCG 
B3-tubulin 
Forward GCAACTACGTGGGCGACT 
Reverse ATGGCTCGAGGCACGTACT 
CCNA1 
Forward TCAGTACCTTAGGGAAGCTGAAA 
Reverse CCAGTCCACCAGAATCGTG 
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CCNA2 
Forward CCATACCTCAAGTATTTGCCATC 
Reverse TCCAGTCTTTCGTATTAATGATTCAG 
CYCR* 
Forward ACTGCGGGAAGGTCTCTACTT 
Reverse GGGTGCCATCGTCAAACTCTA 
CCNB1 
Forward ACATGGTGCACTTTCCTCCT 
Reverse AGGTAATGTTGTAGAGTTGGTGTCC 
CCNB2 
Forward GAAGATTGGGAGAACCCTCA 
Reverse TGTGGGTTTATGGACTGCAA 
CCNC 
Forward TTTGCTGAGCTTTCTGTGGA 
Reverse AATGGTTGCCATCTCTTTTCTC 
CCND1 
Forward TGCATCTACACCGACAACTCC 
Reverse CGGATGATCTGTTTGTTCTCCG 
CCND2 
Forward TACACCGACAACTCCATCAAGC 
Reverse ATGTGCTCAATGAAGTCATGAGG 
CCND3 
Forward TACACCGACCACGCTGTCT 
Reverse GAAGGCCAGGAAATCATGTG 
UBE2D2* 
Forward CCATGGCTCTGAAGAGAATCC 
Reverse GATAGGGACTGTCATTTGGCC 
CCNE1 
Forward ACAGCTTGGATTTGCTGGAC 
Reverse TCTGCTTCTTACCGCTCTGTG 
CCNE2 
Forward GCCATTGATTCATTAGAGTTCCA 
Reverse TGAAATACTGTCCCACTCCAAAC 
CCNT1 
Forward GAACATGTCATCAAGGTAGCACA 
Reverse AATGACCAGATCTTGAACTTGTTG 
CDC2 
Forward TGAAATGTTCATGGGGGAAC 
Reverse AAAAAGCTCCTGATGCCTTG 
CDK1 
Forward AACTACAGGTCAAGTGGTAGCC 
Reverse GGAATCCTGCATAAGCACATCC 
CDK2 
Forward CCTCCTGGGCTGCAAATA 
Reverse CAGAATCTCCAGGGAATAGGG 
RNF20* 
Forward GGTGTCTCTTCAACGGAGGAA 
Reverse TAGTGAGGCATCATCAGTGGC 
CDK4 
Forward AGTGTTGGCTGTATCTTTGCAG 
Reverse ATCTCGAGGCCAGTCATCC 
CDK5 
Forward TCTTTTTCCCGGCAATGAT 
Reverse TCTGGCAGCTTGGTCATAGA 
CDK6 
Forward GAACTAGGCAAAGACCTACTTCTGA 
Reverse GGTGGGAATCCAGGTTTTCT 
CDKN1A 
Forward GTGGACCTGGAGACTCTCAG 
Reverse CCTCTTGGAGAAGATCAGCCG 
CDKN1B 
Forward GGCTAACTCTGAGGACACGC 
Reverse TGAGTAGAAGAATCGTCGGTTGC 
B2M* 
Forward TTGTCTTTCAGCAAGGACTGG 
Reverse ATGCGGCATCTTCAAACCTCC 
BIRC5 
Forward AGAACTGGCCCTTCTTGGA 
Reverse ACACTGGGCCAAGTCTGG 
PDK1 
Forward CACCAAGACCTCGTGTTGAG 
Reverse GCTTCAGGTCTCCTTGGAAGT 
ANLN 
Forward ATCTAGCCCTTTGAAAATAACATTG 
Reverse CACTCATCTCAATTTCACGTATCAC 
SGOL1 Forward AGAATAAAGCAAGCCCAGCA 
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Reverse AAAGGGTCCCCTCTTCTCAG 
SOX2 
Forward ACAACATGATGGAGACGGAG 
Reverse GATGCACAACTCGGAGATCA 
WNT3A 
Forward GCCCCACTCGGATACTTCTTAC 
Reverse CGAGCCCAGGGAGGAATACA 
GAPDH* 
Forward TCAAGGCTGAGAACGGGAA 
Reverse TGGGTGGCAGTGATGGCA 
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3.4 Results 
3.4.1 Niche Model Development: Stage 1 
Optimising the mNPs Loading Conditions of the MSCs. 
Two different mNP concentrations (0.01 mg/mL and 0.1 mg/mL), alongside 
three different incubation time periods (15 minutes, 30 minutes and 1 hour) 
were used to determine the best conditions to pre-load the MSCs in a monolayer 
culture. All samples were either in the presence or absence of an external 
magnetic field. The mNP uptake into MSCs was analysed (i) quantitatively by 
ICP-MS (Figure 3-3), and qualitatively by (ii) fluorescence microscopy (Figure 
3-4a and Figure 3-4b) and using (iii) TEM (Figure 3-5). 
The MSC samples were lysed to allow quantification of mNP uptake Figure 3-3, 
prior to analysis by ICP-MS. ANOVA analysis was conducted to determine the 
statistical differences between each parameter. The mNP uptake increased as 
the concentration of the mNPs increased, and there was a significant difference 
(p < 0.05) between the two concentrations of mNPs, at all conditions. 
Additionally, the presence of a magnetic field increased mNPs uptake 
significantly (p < 0.05), compared to the absence of a magnetic field, within all 
parameters. The highest mNPs uptake occurred after the 1 hour incubation 
period, using 0.1 mg/mL mNPs concentration and in the presence of an external 
magnetic field. However, there was no significant difference between each 
incubation period, irrespective of concentration or magnetic field. 
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Figure 3-3: Graph of mNP uptake within MSCs analysed using ICP-MS.  
Analysis was conducted using two different concentrations, three incubation time periods 
in either the presence or absence of a magnetic field. (n=3, technical replicates); Graph A 
shows the statistical significance at each concentration and same time point with or without 
a magnetic field whereas, Graph B shows the statistical significance between 
concentrations at the same time point and magnetic field environment (Error bars denote 
standard deviation; * indicates statistical significance where p < 0.05, ** indicates p < 0.01 
and *** indicates p < 0.001 as calculated using one way ANOVA)). 
A FITC fluorescent tag permitted mNP observation, via the use of fluorescence 
microscopy. Conditions were identical to the ICP-MS experiment to determine 
the mNP uptake into MSC monolayer cultures. The results, depicted in Figure 
3-4, mirror the results obtained using ICP-MS, when an increase in green 
fluorescence (mNPs) was observed at the higher mNPs concentration of 0.1 
mg/mL, compared to the lower concentration of 0.01 mg/mL. Quantitative 
analysis (Figure 3-4b) was conducted on the complete set of fluorescent images 
obtained for qualitative analysis. There was a significant difference between 
fluorescent intensity (p < 0.001) of mNP presence in the MSCs against mNP 
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concentration. Also the mNP fluorescence intensity showed a significant increase 
(p < 0.05) in the presence of a magnetic field. However, there was no statistical 
significant difference between each time period, regardless of concentration or 
magnetic field. Therefore, these results shown in Figure 3-4 correlate with the 
ICP-MS data depicted in Figure 3-3. 
Analysis was conducted on data collected from both the fluorescence images and 
ICP-MS. The results indicated the optimal pre-loading conditions of MSCs with 
mNPs were at a concentration of 0.1 mg/mL over an incubation period of 30 
minutes. 
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Figure 3-4a: Representative fluorescence images of MSCs incubated with mNPs in the presence or absence of a magnetic field. 
Two concentrations of mNPs were used, with three incubation periods; in either the presence or absence of a magnetic field. Red=actin, 
green=nanoparticles, blue=nucleus, 40x objective, scale bar = 20 μm. (n=3, three technical replicates)
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Figure 3-4b: Quantitative analysis of the complete immunofluorescent images from Figure 
3-4a demonstrating mNP uptake into MSCs. 
Two concentrations of mNPs were used, with three incubation periods; in either the 
presence or absence of a magnetic field. (Error bars denote standard deviation; * indicates 
statistical significance where p < 0.05, ** indicates p < 0.01 and *** indicates p < 0.001 as 
calculated using one way ANOVA)) 
The use of TEM provided a more detailed observation of mNP internalisation; 
allowing verification of uptake and information on intracellular location of the 
mNPs. A comparative study on the effect of the presence or absence of a 
magnetic field on the uptake of mNPs was performed at the optimum condition 
of a concentration (0.1 mg/mL) and incubated for 30 minutes. The study showed 
the mNPs were clearly visible on the outer periphery of the cells, as well as 
internally present within the MSCs (Figure 3-5). The TEM images show a magnetic 
field enhanced mNP uptake into the cell, with less NPs visible outside the cells 
(i.e. image B had a higher ratio of NPs out with the cell compared to image C) 
(see Figure 3-5). 
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Figure 3-5: Representative TEM images of MSCs incubated with mNPs. 
Cells were incubated without mNPs (A), with 0.1 mg/mL mNPs concentration for 30 minutes 
(B), and with 0.1 mg/mL mNPs concentration for 30 minutes with an external magnetic field 
(C), scale bar = 200 nm. (n=3, three technical replicates) 
 
3.4.2 Niche Model Development: Stage 2 
Assessing mNP Retention Within MSCs Following 
Trypsinisation. 
In order to generate multicellular MSC spheroids, it is necessary to make the 
MSCs responsive to a magnetic field following the internalisation of the mNPs. It 
was vital the mNPs were retained within the cells therefore, to assess mNP 
retention the MSCs were incubated under the optimised mNPs pre-loading 
conditions. These cells were subsequently trypsinised off one substrate and re-
seeded onto a different substrate, to determine (i) whether the mNPs were 
retained within the MSCs and (ii) whether the resultant MSCs were responsive to 
an external magnetic field. 
MNP retention was assessed using both light microscopy and fluorescence 
microscopy. MSCs were seeded onto glass coverslips, for 24 hours, incubated 
with mNPs for 15, 30 and 60 minutes, followed by washing, trypsinising and 
seeding onto a new coverslip. Cells were then cultured for 3 hours, prior to 
being fixed and processed for light and fluorescence microscopy. Fluorescence 
microscopy clearly demonstrated that the mNPs were retained within the MSCs, 
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and localised around the nucleus, (Figure 3-6a). Furthermore, these images 
indicated an almost total absence of mNPs in the surrounding area of the cells. 
Quantitative results depicted in Figure 3-6b showed there was no statistical 
difference between mNP up take over the three incubation periods. 
 
Figure 3-6a: Fluorescence images of MSCs with and without mNPs (for 15, 30 and 60 
minutes) following trypsinisation and re-seeding. 
Images depicting MSCs post trypsinisation and transferred from one substrate to another 
substrate. (Red = actin, green = mNPs, blue = nucleus), 40x objective, scale bar = 20 μm. 
(n=3, three technical replicates) 
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Figure 3-6b: Quantitative analysis of complete fluorescent images with and without mNPs 
(for 15, 30 and 60 minutes) following trypsinisation and re-seeding. 
(Error bars denote standard deviation) 
 
Additionally, the retention of the mNPs within the cell was confirmed using light 
microscopy (Figure 3-7), which highlighted the mNPs (brown clusters) within the 
MSCs. Furthermore, the retention of the mNPs was observed at all three 
incubation periods, where they were localised around the nucleus. Figure 3-7 
shows an image of mNP retention within the MSC after 30 minutes of incubation. 
 
Figure 3-7: Representative light microscopy image of mNPs residing within MSCs, under 
optimised pre-loading conditions, following 30 minutes incubation. 
(Brown = mNPs), 20x objective, scale bar = 50 μm. 
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3.4.3 Niche Model Development: Stage 3 
Assessing mNP-loaded MSC Response to an External 
Magnetic Field in Monolayer. 
MSCs pre-loaded with mNPs for 30 minutes, were re-seeded as monolayer 
cultures (as above) and subjected to an external magnetic field, by the 
placement of a 13 mm diameter magnet below the 6 well plate culture well, 
over an initial 24 hour culture period. Images showed the majority of cells were 
all localised within the area of the magnetic field, after the 24 hour incubation 
period (Figure 3-8). A pattern in the MSC attachment was noted, which 
corresponded with the magnetic field pattern of the disc magnet. There was a 
higher concentration of cells at the outer rim of the magnet where the magnet 
was the strongest with fewer cells in the centre of the magnetic field. 
Therefore, an assumption may be made that the mNP-loaded MSCs were able to 
respond positively to the presence of the magnetic field. 
 
Figure 3-8: Schematic diagram of 6 well plate design with the magnet beneath the well. 
Light microscopy images of MSCs incubated for 30 minutes with mNPs and cultured for 24 
hours, 5x objective, scale bar = 50 μm. 
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3.4.4 Niche Model Development: Stage 4: 
Assessing mNP-loaded MSC Viability and Phenotype in 
Monolayer Culture and 3D Spheroid Culture. 
MSCs have been traditionally cultured as in vitro monolayer systems, to assess 
niche parameters (Fernandes et al., 2013). Therefore, MSCs pre-loaded with 
mNPs were cultured as monolayers and assessed for viability and phenotype 
after 1, 3, 7 and 14 days. The cells were stained for STRO-1 and nestin, which 
are MSC surface markers, to assess the ability of the MSCs to retain their 
multipotency properties (Figure 3-9). The fluorescence images depicted in Figure 
3-9 show the cells pre-loaded with the mNPs remained viable over the 2 week 
period. Additionally, cells on day 1 demonstrated a high expression of STRO-1 
and nestin. However, cells on day 14 showed a lack of expression of either MSC 
multipotency markers. During the 2 week incubation period, the presence of 
both STRO-1 and nestin clearly decreased over time. 
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Figure 3-9: Monolayer culture of mNP-loaded MSCs cultured for up to 14 days. 
Fluorescence images were taken at day 1, 3, 7 and 14 assessing cell viability (green=living 
cells, red=dead cells, 10x objective) and phenotype (red=STRO-1/nestin, blue=nucleus, 20x 
objective). Scale bar = 50 μm. (n=3, three technical replicates) 
To generate spheroids, it is important to coerce the MSCs together to create a 
3D MSC niche model, which allow the formation of cell-cell and cell-ECM 
interactions, which are observed in vivo. As previously shown, the mNP-loaded 
MSCs responded to an external magnetic field, when cultured in monolayer (by 
localising within the magnetic field area). Therefore, the application of an 
external magnetic field to a cell suspension, should force the MSCs to migrate 
towards the field and congregate together. The cells natural adherence for 
survival and close proximity to each other caused by the magnetic field, should 
encourage cell-cell attachment. Consequently, the mNP-loaded MSCs were 
added as a cell suspension to a 6 well culture plate well with a magnet located 
directly above the well, as indicated in Figure 3-10. 
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Figure 3-10: Schematic diagram of 6 well plate design for MSC spheroid formation, with the 
magnet above the well. 
 
MSC spheroids were cultured in parallel with monolayer cultures. The spheroids 
were assessed for viability and phenotype over the same time period of 14 days. 
It was observed that following only a few hours of incubation, beneath the 
magnet, the MSCs levitated towards the field and formed a spheroid structure. 
Within the spheroid structure, the MSCs exhibited high viability over the 14 day 
culture period Figure 3-11. There was no difference in cell viability between day 
1 and day 14. Additionally, the MSCs expressed high levels of STRO-1 and nestin 
over the 2 week incubation period, at all time points. 
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Figure 3-11: Spheroid culture of MSCs with mNPs incubated for up to 14 days. 
Fluorescence image of mNP-loaded MSCs cultured for 1, 3, 7 and 14 days, to assess cell viability (green=living cells, red=dead cells) and phenotype 
(red=STRO-1/nestin, blue=nucleus). 20x objective, scale bar = 20 μm. (n=3, three technical replicates) 
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Figure 3-12 shows quantitative analysis of the immuno-fluorescence images 
(Figure 3-9 and Figure 3-11), which demonstrated there was a highly significant 
difference in the reduction of STRO-1 and nestin expression in the MSC 
monolayer cultures over time. However, there was no significant difference in 
STRO-1 or nestin expression in the MSC spheroids over time. 
 
Figure 3-12: Quantitative analysis of data collected from immuno-fluorescent images 
depicted in Figure 3-9 and Figure 3-11, which compared monolayer and spheroid culture 
conditions. 
(Error bars denote standard deviation; * indicates statistical significance where p < 0.05, ** 
indicates p < 0.01 and *** indicates p < 0.001 as calculated using one way ANOVA)) 
Research suggests the diameter size of the spheroid (above 200 μm) has a 
detrimental effect on oxygen diffusion to the spheroid centre, creating a hypoxic 
environment (Curcio et al., 2007, Gatenby et al., 2007). A study by Li et al., 
suggested cancer stem cells, which reside within a hypoxic secondary niche in 
tumours, maintain the stem cells in an undifferentiated and quiescent state (Li 
et al., 2009).Therefore, an environment of low oxygen may allow the stem cells 
to remain in a dormant condition. Figure 3-13 illustrates the size distribution of 
a selection of MSC spheroids produced for this thesis and found the mean 
diameter to be 259 µm. 
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Figure 3-13: Box plot depicting the size distribution of a sample of MSC spheroids produced 
in this thesis. (n=15) 
 
ECM is an important component of the MSC niche and maintains homeostasis. 
Therefore, it is necessary to determine whether the MSCs in the spheroids 
produce their own ECM. TEM analysis of spheroids demonstrated areas of cell-
cell contact (red arrows) with voids (black arrows) Figure 3-14. The voids 
between the cells in the spheroids indicate a lack of ECM production as 
highlighted in Figure 3-14. 
 
Figure 3-14: TEM images of cross-sectioned spheroids highlighting areas between MSCs. 
Black arrows indicate voids between MSCs in the spheroids and red arrows indicate MSC-
MSC contacts. Scale bar=1 µm. This work was carried out by Gemma McLelland (honours 
project student in 2014), University of Glasgow. 
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3.4.5 Niche Model Development: Stage 5 
Assessing the Formation of a MSC Spheroid Within a 
Collagen Gel. 
Following the success of the initial experiments, a Type I collagen gel was 
employed to generate a more complex 3D environment for the MSC spheroid. 
The gel was designed to be of a similar stiffness and composition of bone marrow 
(the location of the in vivo MSC niche). 
Collagen gels were mixed with mNP-loaded MSC suspensions and cast into 24 
well plates. Initially, the control MSCs (containing no mNPs) and mNP-loaded 
MSCs were assessed for viability and morphology in the collagen gels after 24 
hours, 72 hours and 1 week incubation periods. To assess whether the fibrous 
collagen network may inhibit cell mobility, two different magnets were applied 
to the gel below the well. Both magnets had differing field strengths (350mT and 
420 mT) and each measured 13 mm in diameter and were identical to the well 
diameter. Magnets were placed below the well, to allow the MSCs to migrate 
through the gel and congregate together to form spheroids (Figure 3-15). 
 
Figure 3-15: Schematic diagram of one of the wells in the 24 well plate design with the 
magnet below the well. 
 
The MSCs remained viable up to one week within the collagen gel, irrespective 
of the presence of mNPs or magnetic field strength (Figure 3-16 and Figure 
3-17). There was no statistical significant difference in cell viability over time in 
relation to magnetic field strength as depicted in Figure 3-18. Therefore, the 
presence of the magnetic field did not influence the cells viability over the week 
incubation period. 
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Figure 3-16: Representative viability images of control MSCs incorporated within a collagen 
gel. 
Fluorescence viability images (green=living cells, red=dead cells), 20x objective, scale bar = 
20 μm. (n=3, technical replicates) 
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Figure 3-17: Representative viability images of MSCs pre-loaded with mNPs and 
incorporated within a collagen gel. 
Fluorescence viability images (green=living cells, red=dead cells), 20x objective, scale bar = 
20 μm. (n=3 technical replicates) 
 
Figure 3-18: Schematic diagram showing the MSC viability within the gel. 
MSCs were assessed over 1 week in the presence of two different magnetic fields. (n=3, 
three technical replicates) 
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To assess cell cytoskeleton and mNP retention within the MSCs, the cells were 
again cultured up to 1 week, stained for F-actin and observed under 
fluorescence microscopy. Following a 24 hour culture period, the cells began to 
elongate within the collagen gel. After 72 hours there was minimal difference in 
cellular morphology, between cells cultured in the absence of an external 
magnetic field compared to cells exposed to the 350 mT magnet. Control MSCs 
without mNPs, irrespective of environment exhibited very little difference in 
cellular morphology, over the week incubation period (Figure 3-19). Moreover, 
the mNPs were retained within the MSCs irrespective of the different cell 
environment (no magnet, 350 mT or 420 mT magnet) over a 1 week incubation 
period (Figure 3-20). The images of the MSCs depicted elongated cytoskeletons, 
at all time points. 
 
Figure 3-19: Representative cytoskeleton images of control MSCs incorporated within a 
collagen gel. 
Fluorescence images (red=actin, green=mNPs), 20x objective, scale bar = 20 μm. (n=3, three 
technical replicates) 
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Figure 3-20: Representative cytoskeleton images of MSCs pre-loaded with mNPs and 
incorporated within a collagen gel. 
Fluorescence images (red=actin, green=mNPs), 20x objective, scale bar = 20 μm. (n=3, three 
technical replicates) 
Following verification of cell viability and mNP retention over 1 week, an 
assessment was made of the cell response to a magnetic field (Figure 3-16-Figure 
3-20). Confocal microscopy was used to assess cell location within the collagen 
gel over 24 and 72 hour incubation periods. A z-stack was taken through the gel 
to assess the location and distribution of the MSCs, with an expectation of cell 
mobility towards the bottom of the well (i.e. towards the magnet).The results 
are shown in Figure 3-21. 
The MSCs were mixed homogenously throughout the gel, prior to setting. Gel 
observations showed all the control MSCs samples remained homogeneous and 
evenly distributed throughout the collagen gel. The presence of either a weak or 
strong magnet caused the mNP-loaded MSCs to congregate to the lower part of 
the gel and there was a lack of cells present within the top part of the gel. 
Additionally, the presence of the weaker magnet caused the cells to locate in 
the lower 60% of the gel over the initial 24 hour incubation period. However, 
after 72 hours there was significant cellular movement, as all cells were found 
to reside within the bottom half of the gel. The use of the strong magnet 
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indicated the mNP-loaded MSCs were distributed within the bottom 80% of the 
gel after 24 hours. However, after 72 hours in another sample the MSCs resided 
within the bottom 50% of the gel. Therefore, these results show no statistical 
difference between the uses of magnets as the MSCs pre-loaded with mNPs were 
observed within the bottom 50% of the gel and leaving the top 50% free of cells 
after 72 hours (Figure 3-21). Therefore, both magnetic field strengths (350 mT 
and 420 mT) resulted in the same MSC distribution in the gel at 72 hours. 
 
Figure 3-21: Schematic diagram showing the MSC cell distribution within the gel. 
MSCs were assessed over 24 and 72 hours in the presence of two different magnetic fields. 
(n=3, three technical replicates) 
Unfortunately, although the MSCs did respond to the magnetic field by migration 
through the gel, the MSCs failed to congregate to form spheroids within the gel 
mixture. Therefore, in all further studies, the MSC spheroids were generated in 
media (as section 2.3.4.1), prior to transplantation into the gel mixture, before 
setting. The transplanted MSC spheroids were assessed for viability over 2 
weeks, as shown in Figure 3-22. The MSCs remained viable over the 2 week 
incubation period. 
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Figure 3-22: Schematic diagram of MSC spheroids transplanted into a collagen gel. 
Fluorescence image of spheroids incubated for 1, 3, 7 and 14 days, within collagen gels, 
assessing cell viability (green=living cells, red=dead cells). 20x objective, scale bar = 20 μm. 
(n=3, three technical replicates) 
 
3.4.6 Niche Model Development: Stage 6 
Assessing the Collagen Gel Stiffness (with and without 
spheroids). 
The bone marrow ECM retains MSCs within the niche microenvironment via a 
supportive ECM scaffold, which anchors the niche. The physical properties 
(stiffness/rigidity) of the ECM component within the bone marrow has been 
shown to affect stem cells (Lee et al., 2014). Therefore, it was important to 
verify the stiffness of the collagen gels used in the study, to ensure they had 
similar mechanical properties to the bone marrow ECM. The collagen gels, both 
with and without MSC spheroids, were assessed using rheology to determine 
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whether the stiffness of the study gels were akin to the in vivo bone marrow 
niche environment. 
Collagen gels were prepared either with or without MSC spheroids and cultured 
for 3 days. The elastic and viscous moduli of the gels were rheology tested to 
calculate the stiffness of the material (Figure 3-23). The elastic modulus of both 
the control collagen gels and the gels containing the spheroids was higher than 
the viscous modulus, when the frequency increased from 0.1 Hz to 10 Hz. 
Additionally, the elastic modulus of the collagen gels encasing the spheroids was 
slightly higher (41 Pa) compared the collagen gels without spheroids (36 Pa). 
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Figure 3-23: Stiffness of collagen gels, with and without spheroids. 
Rheology testing the elastic modulus (G’) and viscous modulus (G’’) of (A) control collagen 
gels and (B) collagen gels encompassing spheroids. (C) Comparison graph of the elastic 
modulus of control collagen gels and gels containing spheroids. (n=3, three technical 
replicates) 
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3.4.7 Niche Model Development: Stage 7 
Assessing MSC Proliferation and Cell Cycle Gene 
Expression in Monolayer and Spheroid Culture Systems. 
The MSC niche is able to uphold stem cell function by retaining the MSCs in a 
quiescent state, which is regulated by Notch, Wnt, cell-cell and cell-ECM 
signalling factors as well as a hypoxic environment (Orford and Scadden, 2008). 
MSCs in the niche may enter the cell cycle through the stimulation of these 
factors. Therefore, this study was designed to determine whether the cells 
within the niche model reflected this quiescent state. MSCs, both in monolayer 
and in spheroid culture, were analysed both using BrdU incorporation (which 
binds directly to DNA as the cell proliferates), and also via cell cycle gene 
expression. 
5-bromo-2'-deoxyuridine (BrdU) was incorporated into the media, during both 
monolayer and spheroid cell culture. BrdU binds with DNA during the DNA 
synthesis stage of the cell cycle therefore, its presence denotes a proliferative 
cell state. Cells were analysed at days 1, 3, 7 and 14. The monolayer cells, 
shown in Figure 3-24 demonstrated BrdU incorporation at days 1, 3 and 7, 
indicating the presence of proliferative cells. However, BrdU was not present at 
day 14 within the monolayer system. Conversely, the MSC spheroid cultures 
showed there was an absence of BrdU incorporation at any time point. 
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Figure 3-24: Analysis of MSC proliferation via BrdU incorporation within a monolayer and 
spheroid culture system. 
MSCs were assessed for 1, 3, 7 and 14 days, (purple = proliferating state of nucleus, blue = 
quiescent state of nucleus), 20x objective, scale bar = 50 μm. (n=3, three technical 
replicates) 
Further genomic analysis was used to assess whether the MSCs were either 
entering or engaged in the cell cycle in preparation for division within both 
monolayer and spheroid culture methods after 1 and 14 days. The cell cycle 
gene analysis is shown in Table 3-2. All data was normalised against the 
monolayer culture system at day 1 and day 14. 
The results depicted in Figure 3-25 showed the MSC spheroids, at both day 1 and 
day 14 had a reduction in cell cycle gene expression, for 75% of the selected 
genes analysed, compared to the monolayer culture system (i.e. 18 out of the 24 
genes showed a negative fold change in gene regulation). The day 1 and day 14 
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spheroids showed decreased expression in CCN A2, CCN B1, CCN E2, BIRC5, ANLN 
and SGOL1 compared to the monolayer cultures. Additionally, only the day 14 
spheroids showed an absence of gene expression for cyclin E2, cyclin kinase 2 
and ANLN. 
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Figure 3-25: Gene expression analysis of key cell cycle genes from MSCs extracted from spheroid cultures. 
Fold change analysis conducted on spheroids at DAY 1 and DAY 14 normalised to the monolayer cultures at the identical time points. (CCN=cyclin and 
CDK=cyclin dependent kinase) (n=3, technical replicates)
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3.4.8 Niche Model Development: Stage 8 
Assessing MSC Differentiation Potential in Monolayer and 
Spheroid Culture Systems. 
To assess MSC potency within both 2D and 3D MSC culture systems, the MSCs 
ability to differentiate was analysed following stimulation by osteogenic and 
adipogenic factors. Spheroid MSCs were dissociated/fragmented, then seeded as 
2D cultures, to assess differentiation potential. Therefore, MSCs were cultured 
as monolayers over 28 days whereas, the spheroids were cultured for an 
additional 14 days. 
Initially, several methods were applied to determine the optimal approach to 
dissociate/fragment the spheroids. Four techniques were used: 1) the spheroid 
was agitated using a pipette tip, 2) a narrow bore needle was slowly plunged up 
and down into the spheroid, 3) a needle was rapidly plunged up and down into 
the spheroid and 4) the spheroid was left intact. All the spheroid samples were 
then transferred onto fresh culture plates and left to incubate for 4 days (Figure 
3-26). The images showed the fragmentation process, which used the agitated 
pipette tip produced the greatest MSC outgrowth and cell coverage in the 
monolayer culture system. In addition this method left fewer MSCs remaining 
within the spheroid culture (i.e. the darker concentration of cell stain). 
Whereas, the use of the rapid agitation process with the needle produced the 
least amount of MSC outgrowth and cell coverage. The spheroids left intact and 
seeded onto coverslips showed a continual spread of cells migrating out and 
dispersing into the surrounding area. However, cells were only present around 
the spheroid and there was an uneven distribution of cells covering the 
coverslips. 
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Figure 3-26: Outgrowth of MSC monolayer from MSC spheroids. 
Spheroids were dissociated using four individual techniques, 5x objective, scale bar = 200 
μm. 
Therefore, the pipette tip method of fragmentation was adopted to grow MSCs 
in monolayer post-spheroid culture. The MSCs were subsequently induced with 
osteogenic or adipogenic media for either 28 days (monolayer) or 42 days 
(spheroids). These cultures were compared with conventional 2D MSC culture 
systems, to determine whether the stem cells were still able to differentiate 
(Figure 3-27). Osteopontin staining was evident in both monolayer and spheroid 
cultures, (Figure 3-27, image A and C) whilst lipid droplets were also evident in 
both culture systems (Figure 3-27, image B and D). This evidence verified the 
MSCs cultured under both culture systems were capable of being induced to 
express osteogenic (osteopontin) and adipogenic (lipids) markers.  
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Figure 3-27: Microscopy images of induced MSCs with osteogenic and adipogenic media. 
Monolayer cells were seeded and cultured for 28 days. Dissociated spheroids were seeded 
and cultured for 42 days. (A) Fluorescence image of MSCs cultured as monolayers induced 
with osteogenic media (red = actin, green = osteopontin, blue = nucleus). (B) Light 
microscopy image of MSCs cultured as monolayers induced with adipogenic media (red = 
lipid droplets, blue = nucleus). (C) Fluorescence image of MSCs cultured as dissociated 
spheroids induced with osteogenic media (red = actin, green = osteopontin, blue = nucleus). 
(D) Light microscopy image of MSCs cultured as dissociated spheroids induced with 
adipogenic media (red = lipid droplets, blue = nucleus). 10x objective, scale bar = 50 μm. 
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3.5 Discussion 
3.5.1 Niche Model Development: Stage 1 
Optimising the mNPs Loading Conditions of the MSCs. 
The uptake of the mNPs within the MSCs was successfully achieved at both 
concentrations and either in the presence or absence of an external magnetic 
field. Cellular uptake of mNPs has been shown to occur via a variety of 
endocytic pathways, including clathrin-dependent endocytosis, caveolae-
dependent endocytosis, macropinocytosis or clathrin- and caveolae- independent 
endocytosis (Kou et al., 2013). The exact pathway by which these mNPs enter 
the cell is still unclear. However, it is well established that the mNP size affects 
which cellular uptake pathway may be used by the cell. For example, studies 
have shown large NPs (500 nm to 5 μm) are engulfed through macropinocytosis 
and smaller NPs (60-80 nm) are internalised by caveolae-dependent endocytosis 
(Benmerah and Lamaze, 2007). Rejman et al., showed NPs ≤ 200 nm in size were 
internalised by mouse melanoma cells, via clathrin mediated endocytosis 
(Rejman et al., 2004). The mNPs used throughout this thesis had a hydrodynamic 
diameter of 200 nm, which suggests the clathrin-dependent pathway was the 
most likely method used by the MSCs to engulf the mNPs. 
However, there are other factors influencing which endocytic pathway is 
employed for NP internalisation within the cell. Surface charge on the mNP 
affects the rate of cellular uptake. The cytomembrane of the cell possesses an 
overall net negative charge, so positively (cationic) charged mNPs have a strong 
electrostatic interaction with the cell membrane, thus leading to rapid 
internalisation within the cell (Kou et al., 2013). Figure 3-3 shows the mNPs 
were being taken up by the MSCs, within 15 minutes of being subjected to mNP 
presence, irrespective of concentration or external magnetic field. The mNPs 
used in these experiments possessed a cationic surface charge. Therefore, these 
results correlate with the theory that surface charge plays an important role, in 
uptake of these mNPs within the MSCs. 
Figure 3-3 showed a correlation between mNPs concentration and the level of 
internalisation. The higher concentration (0.1 mg/mL) allowed for significantly 
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greater mNP uptake by the MSCs, at all time points and conditions compared to 
the lower concentration (0.01 mg/mL). 
The results depicted in Figure 3-3 and Figure 3-4, demonstrated a significant 
increase in mNP uptake, within the MSCs when an external static magnetic field 
was applied below the cells. The concept of applying an external magnetic field 
to enhance delivery of mNPs was initially applied to target gene delivery in cells, 
and was termed magnetofection (Plank et al., 2003). Many current pre-loading 
methods are time consuming and inefficient, with the cells being incubated with 
the mNPs for upwards of 24 hours. However, research groups have adapted the 
magnetofection method to show significant differences in mNP uptake when 
using an external magnetic field (Dejardin et al., 2011, Liu et al., 2012). Studies 
conducted by Liu et al., found mNP-labelled cancer cells uptake was increased 
by 40% using a static external magnetic field over a period of 40 minutes 
compared to labelled cells without a magnetic field (Liu et al., 2012). 
Additionally, Dejardin et al., demonstrated mNP internalisation within 
fibroblasts was greatly enhanced in the presence of a magnetic field (Dejardin et 
al., 2011). Attracting the mNPs towards the magnet located beneath the cells, 
increases the density of NPs at the cell surface (shown in Figure 3-5) allowing for 
an increased rate of endocytosis, as shown by ICP-MS (Figure 3-3). 
The ICP-MS experimental procedure did not require the use of normalising mNP 
uptake against either cell number or DNA content. Figure 3-3 reflects the 
measured amount of mNP uptake in cell lysates, after 24 hours growth (Kim et 
al., 2010, Janer et al., 2014, Child et al., 2011). However, normalising to cell 
number (e.g. via per cm2 or counting trypsinised cells) would provide a more 
accurate recording of mNP uptake in MSCs (Albanese et al., 2012, Suzuki et al., 
2014). 
3.5.2 Niche Model Development: Stage 2 
Assessing mNP Retention Within MSCs Following 
Trypsinisation. 
In order to use a magnetic field to generate MSC spheroids, the cells must be 
able to retain the mNPs and respond to an external magnetic field. The images 
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depicted in Figure 3-6 show retention of the mNPs within the MSCs, after the 
cells were trypsinised and seeded onto another substrate. 
Small particles such as mNPs, which have been internalised within cells, may be 
readily released from the cell, through a process known as exocytosis. However, 
the rate of exocytosis and excretion has been shown to be size dependent (Xu et 
al., 2012). For example, the larger the NP, the slower it is released from the 
cell. A study conducted by Chithrani and Chan, compared the exocytosis rates of 
different sized transferrin coated gold NPs (Chithrani and Chan, 2007). The 
researchers found the exocytosis rate was 2 times higher/faster for 14 nm sized 
NPs, compared to the 74 nm sized NPs. Additionally, they discovered the rate of 
exocytosis was linearly related to size of the gold NPs. Furthermore, the 
researcher assessed whether the shape of the nanoparticle affected the 
exocytosis rate and they found rod shaped nanoparticles were released faster at 
a higher rate compared to spherical shaped nanoparticles.  
Sarkar et al., studied the exocytosis rate of particles sized 1-2 μm and found 
particles were retained within MSCs for at least 7 days (Sarkar et al., 2011). 
Moreover, Guzman et al., pre-loaded neural stem cells with superparamagnetic 
iron oxide (SPIO) nanoparticles sized between 80-120 nm and took long term 
observations using MRI (Guzman et al., 2007). The researchers were able to 
detect the stem cells, labelled with the SPIO nanoparticles for up to 18 weeks 
post internalisation. Furthermore, Jo et al., labelled MSCs with iron oxide-
pullulan NPs sized ~100 nm and found these were retained within the cell for 21 
days (Jo et al., 2010). 
Collating these studies, it became apparent that both the size and shape of the 
mNPs are extremely important in the retention within the MSCs. The mNPs used 
in this study were spherical in shape and 200 nm in diameter. These mNPs were 
larger than the nanoparticles used by Guzman et al., Chithrani and Chan, and Jo 
et al. Therefore, the mNPs should remain within the MSCs and not be so readily 
exocytosed from the cells post manipulation as depicted in Figure 3-6 (Guzman 
et al., 2007, Jo et al., 2010, Chithrani and Chan, 2007). 
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3.5.3 Niche Model Development: Stage 3 
Assessing mNP-loaded MSC Response to an External 
Magnetic Field in Monolayer. 
When the magnet was placed directly under a mNP-loaded MSC suspension, all 
the cells attached to the well within the magnetic field area (see Figure 3-8). 
The magnet used had a magnetic field strength of 350 mT, with the North Pole 
facing the well and the South Pole positioned below the well (see Figure 3-28). 
The magnet distributes a non-uniform magnetic field and then induces a force on 
the mNPs. The distribution of the magnetic field studied by Dejardin et al., and 
Smith et al., applied similar magnets to cells cultured with mNPs is shown below 
in Figure 3-28 (Smith et al., 2010b, Dejardin et al., 2011). 
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Figure 3-28: Schematic diagram of magnetic field distribution from 350 mT magnet. 
Diagram of the position of the magnetic dipole moments from the 350 mT magnet 
underneath the well containing a MSC suspension labelled with mNPs. (Adapted from 
(Dejardin et al., 2011)). 
Dejardin et al., calculated the forces and field strength of the magnet on mNPs 
sized 500 nm. The researchers stated the axial force from the magnet varied 
radially across the cell culture, attracting mNPs towards the surface of the 
magnet. The distribution and position of the cells shown in Figure 3-8 correlates 
with the variation in magnetic forces exerted from the magnet observed and 
described by Dejardin et al., (Dejardin et al., 2011). These results indicate that 
the MSCs retained a sufficient number of mNPs to be easily manipulated with a 
static external magnetic field. Magnetic cell manipulation may be an excellent 
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tool to influence cell motility. Indeed, in a study conducted by Polyak et al., the 
authors were able to directly move magnetically labelled endothelial cells, to 
steel stents in vivo using an external magnetic field (Polyak et al., 2008).  
3.5.4 Niche Model Development: Stage 4: 
Assessing mNP-loaded MSC Viability and Phenotype in 
Monolayer Culture and 3D Spheroid Culture. 
The MSCs were loaded with mNPs and the cell viability was assessed over time, 
to determine whether these particles were detrimental to cells in culture. 
Previous research has suggested that the ease at which certain NPs cross the cell 
membrane barrier may increase their cytotoxic potential (Nel et al., 2006). The 
viability of the cells containing the mNPs were assessed over 14 days and 
approximately 100% of the cells remained viable as shown in Figure 3-9. 
Therefore, the amount of mNPs retained within the MSCs did not appear to 
cause any cytotoxic effects. Studies have found the internalisation of the iron 
oxide mNPs do not affect cellular responses or behaviour (Qin et al., 2013, 
Guzman et al., 2007). Qin et al., compared unlabelled and iron oxide NP 
labelled ADSCs and found the NPs did not affect cell viability, proliferation, cell 
cycle or differentiation capability (Qin et al., 2013). 
MSCs within the bone marrow niche express characteristic surface markers, 
which allows for the identification of their differentiation and self-renewal 
capacity. Therefore, these markers indicate the stem cells multipotency 
properties. Two distinct MSC surface antigen markers (STRO-1 and nestin), which 
are highly expressed in bone marrow were used to determine whether the MSCs 
were retaining their stem cell properties. Over the past 20 years, STRO-1 has 
been considered as the best-known marker to identify and isolate MSCs (Ning et 
al., 2011). A review by Lin et al., found over 100 MSC studies used STRO-1 as an 
identification and isolation marker for MSCs (Lin et al., 2011). Furthermore, 
MSCs extracted and isolated using STRO-1 possess functional properties akin to 
those in vivo (Kolf et al., 2007). 
Historically, nestin has been widely used, as an identification marker of neuronal 
cells. Recently however, MSCs supporting the HSC niche have shown high nestin 
antigen expression (Mendez-Ferrer et al., 2010, Svachova et al., 2011). 
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Furthermore, bone marrow studies reported HSC home towards nestin+ MSCs 
(Mendez-Ferrer et al., 2010). Nestin is a characteristic MSC marker of 
multipotency for cells, which are able to proliferate, migrate and differentiate 
(i.e. retain their stem cell properties) (Svachova et al., 2011). Therefore, STRO-
1 and nestin expression were assessed in the traditional 2D monolayer system 
over time, to determine whether they correlate with the properties observed 
within an in vivo niche. 
Figure 3-9 shows that within the first 3 days of monolayer culture, the MSCs 
exhibited high STRO-1 and nestin expression. However, between day 3 and day 
14, the MSCs showed a significant reduction in STRO-1 and nestin expression. 
These results indicate the MSCs are losing their “stemness” and starting to 
differentiate. Research has shown there are clear differences in gene expression 
between MSCs cultured in 2D and 3D environments, thus leading to overall 
differences in protein/antigen expression (Pedersen and Swartz, 2005). These 
differences include alterations in differentiation and self-renewal capabilities, 
which indicates that cells in 2D culture do not exhibit behaviour shown in the in 
vivo niche (Shen et al., 2013). 
Parallel studies have further highlighted issues associated with culturing MSCs 
within 2D culture environments. MSCs cultured this way exhibit unpredictable 
behaviours, including enhanced differentiation in response to “rough” handling, 
overcrowding and stress (Marx, 2013). Once isolated and cultured in 2D systems, 
MSCs initially maintain their multipotency properties. However, MSCs 
multipotency reduces over a short culture period (Baer et al., 2010, Baraniak 
and McDevitt, 2012). This loss of multipotency poses a real difficulty for their 
use within regenerative medicine, which requires large numbers of MSCs. 
A magnet located on top of the culture well, induced magnetic levitation of an 
MSC suspension towards the magnetic field, causing the MSCs to coerce together 
and form a 3D multicellular spheroid structure within several hours (Figure 
3-11). This time period correlated to the time taken to form a cohesive 
multicellular spheroid of neural stem cells using mNPs in vitro (Souza et al., 
2010). As the spheroid was generated at the air-liquid interface within the well, 
which suggested the magnetic field force was sufficient to overcome the 
gravitational forces applied on the cells.  
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The MSCs spheroids were assessed for viability, STRO-1 and nestin at the same 
time points as the monolayer MSCs studies. The viability images of the spheroids 
shown in Figure 3-11, depicted high MSC viability. These cells have been 
described as adherent cells, which require cellular adhesion for survival. 
Therefore, the cells will have formed cell-cell attachments to maintain survival 
within the 3D structure. Studies have shown spheroid cultures stabilise cells and 
prevent apoptosis, as they allow cell-to-cell interactions, which is the minimum 
requirement for cell survival (Kim et al., 2013). Additionally, spheroid cultures 
encourage strong cell-cell contacts, which in turn provides a good representation 
of the natural bone marrow niche environment (Wang et al., 2009). A study 
conducted by Hildebrandt et al., showed it was possible to maintain the cell 
viability of MSCs, within a spheroid structure, for a period of 29 days 
(Hildebrandt et al., 2011). 
MSCs within the spheroids clearly retained high STRO-1 and nestin expression 
profiles over the 2 week incubation period, indicating the MSCs were maintaining 
their multipotency, within the 3D spheroid structure. A study conducted by 
Cheng et al., assessed the stemness properties of human adipose stem cells 
(hASCs) and found significant up regulation of these markers within spheroids, 
compared to monolayer cultures (Cheng et al., 2012). Stem cell homeostasis is 
regulated and controlled by the niche, therefore it follows stem cells retention 
of high self-renewal and multipotency properties when cultured in mimicked 
environments. 
The MSC niche has been found to display low oxygen tensions (hypoxia) and 
research has suggested hypoxia maintains MSCs in an undifferentiated state 
(Harrison et al., 2002, Pasarica et al., 2009, Matsumoto et al., 2005). Therefore, 
MSCs in the hypoxic niche are able to retain their multipotent properties as 
detected by the expression of multipotency markers e.g. STRO-1 and nestin. 
Gatenby et al., found multicellular 3D spheroids with a diameter in excess of 200 
µm exhibited hypoxic regions (Gatenby et al., 2007). Studies have shown that 
oxygen is only able to diffuse 50-100 µm into a tumour spheroid, leading to 
hypoxic conditions occurring within the tumour (Curcio et al., 2007, Bryce et al., 
2009). Sun et al., detected regions of hypoxia in the centre of multicellular 
spheroids (Sun et al., 2015). The researchers observed hypoxia 100 µm from the 
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outer edge of the spheroid. Therefore, these results suggest the spheroids 
created in this thesis may exhibit hypoxia, because the average spheroid 
diameter was 259 µm (Figure 3-13), which may allow the MSCs to remain in an 
undifferentiated state. 
Furthermore, the voids adjoining the MSCs within the spheroids as shown in 
Figure 3-14 indicated an absence of ECM production from the MSCs, which may 
be due to the spheroids being in a quiescent state, as a result of hypoxia. A 
study conducted by Barkan et al., found the creation of ECM, including 
fibronectin was a result of the transition of quiescence to metastatic growth in 
mammary cancer cells (Barkan et al., 2010). Furthermore, the authors found a 
related dormant mammary cancer cell line did not produce fibronectin, 
indicating ECM production is reliant on active cell proliferation. 
3.5.5 Niche Model Development: Stage 5 
Assessing the Formation of a MSC Spheroid Within a 
Collagen Gel. 
The bone marrow niche is a complex environment, comprised of various factors, 
including numerous cellular compartments, ECM, secreted factors, physical 
parameters (stiffness and shear force) and metabolic control e.g. glycolysis 
(Lane et al., 2014). Spheroid cultures allow important cell-cell interactions 
however, they lack the complexity of the physical and ECM components of the in 
vivo niche. Therefore, to create a more realistic in vitro model, the complexity 
was increased by using collagen Type I gels. Collagen Type I has been described 
as the most abundant ECM protein within the human body and is the main 
component of bone and skin (Higuchi et al., 2012). In addition, gel stiffness may 
be tailored by simply adapting the collagen concentration, to produce the 
varying mechanical properties of any particular tissue. 
Initial experiments homogeneously mixed MSCs within the collagen gel and 
assessed for viability (see Figure 3-16 and Figure 3-17). The MSCs remained 
viable up to 1 week in the collagen, irrespective of the presence of magnetic 
fields or mNPs (Qin et al., 2013, Guzman et al., 2007). Collagen Type I scaffolds 
have been used extensively in tissue engineering and regenerative medicine 
studies, without any detrimental influence on cell viability. The MSCs remained 
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viable in this study, so it may be expected the MSCs formed cell-collagen 
(matrix) attachments (Glowacki and Mizuno, 2008, Pang and Greisler, 2010, 
Parenteau-Bareil et al., 2010). 
MSC morphology was assessed over a week using different static magnetic field 
strengths (Figure 3-19 and Figure 3-20). The stronger magnet (420 mT) did affect 
the mNP-loaded MSC morphology, which indicated the magnetic field was 
potentially affecting the cells behaviour. Meng et al., studied the morphology of 
MSCs in the presence of superconductive magnetic field (Meng et al., 2011). The 
researchers found the magnetic field caused cell shrinkage and disrupted the 
cytoskeleton (Meng et al., 2011). Therefore, the stronger 420 mT magnet was 
not used in future experiments because it caused MSC morphological changes. 
Both magnetic field strengths influenced the MSC distribution within the collagen 
gels (shown in Figure 3-21). The magnets were placed at the bottom of the well, 
whilst the gels were setting. Cell distribution was analysed using confocal 
microscopy, the results showed the cells containing mNPs responded to the 
magnets and migrated towards the magnetic field. However, the images in 
Figure 3-16-Figure 3-20 showed individual MSCs with an absence of spheroid 
formation. Whilst the mNP-loaded MSCs were clearly attracted by the axial force 
towards the surface of the magnet, the radial magnetic force did not cause the 
MSCs to coerce together. 
The failure to create a multicellular MSC structure within the gels, led to the 
generation of spheroids in media. The spheroids were then transferred to gel 
culture during the gel setting stage. These transferred spheroids/gels were 
assessed for cell viability, over a two week period showed high MSC viability 
(Figure 3-22). Furthermore, the collagen gel provided a physical medium, which 
was mechanically similar to the in vivo bone marrow environment. 
3.5.6 Niche Model Development: Stage 6 
Verifying the Collagen Gel Stiffness (with and without 
spheroids). 
The native bone marrow is a dynamic environment, within which the MSC niche 
is anchored and supported by the ECM (Gattazzo et al., 2014). The mechanical 
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characteristics of the bone marrow ECM have been shown to regulate niche 
homeostasis, proliferation and differentiation. For example, the ECM’s stiffness 
confers isometric tension within the cells’ cytoskeleton, which induces a 
dynamic response that regulates stem cell behaviour (Engler et al., 2006). The 
elastic modulus (also known as the Young’s modulus) has been used to determine 
the stiffness of ECM scaffolds and substrates. Several research studies have 
adjusted the stiffness of their substrates to mimic particular tissues, thus 
inducing MSC differentiation associated with that specific matrix elasticity (Zhao 
et al., 2014b, Li et al., 2013, Her et al., 2013, Rasi Ghaemi et al., 2013). For 
example, Engler et al., showed MSC neuronal differentiation commitment on soft 
gels (1 kPa), myogenic differentiation on stiffer gels (11 kPa) and osteogenic 
differentiation on stiff gels (34 kPa) (Engler et al., 2006). 
The bone marrow is a soft tissue, which has a reported stiffness of 
approximately 100 Pa (Metzger et al., 2014, Sobotková et al., 1988). Winer et 
al., previously analysed the rheology of bovine bone marrow and found the 
stiffness to be 220 ± 50 Pa (Winer et al., 2009). The authors cultured their MSCs 
on polyacrylamide gels (250 Pa) and found the cells mimicked in vivo niche 
behaviour by remaining quiescent. Therefore, imitating the elasticity of bone 
marrow environment allowed the researchers to mimic in vivo niche responses. 
The results depicted in Figure 3-23 showed the elastic modulus of the collagen 
gels, containing the MSC spheroids, was slightly higher than the gel without 
cells. The increased stiffness may be due to the MSCs binding to the collagen, to 
anchor the spheroid. MSCs attach to collagen via integrins, which are 
transmembrane proteins. Integrins adhere to specific amino acid sequences on 
various ECM components, such as collagen. The direct mechanical link between 
the ECM and the cell cytoskeleton, means any changes in cytoskeleton will 
directly affect the physical properties of the ECM (Walters and Gentleman, 
2015). Therefore, the addition of MSC spheroids may increase tension and alter 
the collagen gel stiffness. Additionally, the elastic modulus of the newly created 
model containing spheroids (40 Pa), shown in Figure 3-23 is comparable to the 
elastic modulus observed within the native bone marrow environment (100 Pa). 
Therefore, this addition of collagen to the MSC niche model further mimicked 
the innate MSC niche milieu in the bone marrow. 
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3.5.7 Niche Model Development: Stage 7 
Assessing MSC Proliferation and Cell Cycle Gene 
Expression in Monolayer and Spheroid Culture Systems. 
Stem cells within the bone marrow niche reside in a quiescent (resting) state, 
when the stem cells do not enter the cell cycle. There are major regulatory 
events, which occur at the initial phase of the cell cycle (G1) allowing the cell to 
progress through the S phase. During the S phase, the synthesis and replication 
of DNA is initiated readily for cell division. BrdU is a synthetic analogue of the 
nucleoside thymidine, which competes with thymidine, when the cells are in the 
S phase of the cell cycle. Therefore, BrdU becomes incorporated into the DNA of 
actively dividing cells (Taupin, 2007, Li et al., 2008). 
The images shown in Figure 3-24, show the MSCs in the monolayer culture 
system incorporated BrdU within the cell nuclei, indicating the MSCs were in or 
had gone through the S phase of the cell cycle and were actively dividing and 
proliferating. The cell proliferation correlates with the diminished expression of 
STRO-1 and nestin over time in monolayer culture supporting the fact that MSCs 
cultured in 2D systems may lead to undesired differentiation. 
Conversely, the corresponding MSC spheroid images in Figure 3-24 indicated a 
lack of BrdU incorporation within the MSC nuclei, suggesting the cells had not 
entered the S phase of the cell cycle, but remained within their quiescent state. 
A study by Cheng et al., found cell proliferation (assessed by alamar blue assay) 
was inhibited within ASC spheroids, indicating stem cells were in a quiescent 
state (Cheng et al., 2012). 
MSCs in the niche experience a low metabolic rate, which helps to reduce stem 
cell damage and this effect has been observed in spheroids (Ivanov et al., 2014). 
The low metabolic rate may slow down cell cycle progression within the MSC 
spheroids, thus delaying progression of MSCs through to the S phase of the cycle. 
Therefore, BrdU may not have been incorporated into the MSC DNA, because of 
the delayed cell cycle progression into the S phase. The BrdU in this experiment 
was only added 6 hours prior to analysis and therefore, had not sufficient time 
to become integrated into the MSC DNA. However, if the BrdU had remained in 
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situ with MSC spheroids for a longer period of time, there may have been 
incorporation into the DNA. 
Cell cycle gene analysis in Figure 3-25, showed a significant number of genes (18 
out of 24) were down regulated in spheroid culture, compared to monolayer 
culture. The cell cycle is regulated by cyclin-cyclin dependent kinase (CCN-CDK) 
complexes, which control cell cycle progression (Malumbres and Barbacid, 2005). 
Previous cell cycle observations found variations in gene expressions for CCNs 
and CDKs, and these changes indicated the location of the cell in the cell cycle 
(Bertoli et al., 2013). Cell cycle progression is driven by the increased gene 
expression of certain CCNs and CDKs at specific stages in the cycle. Studies have 
shown cells undergo three major transitions within the cell cycle (G1 to S, G2 to 
M and M to G1 phase) and these are triggered by the activity of CDKs, which bind 
with CCNs depicted in Figure 3-29 (Matsumoto and Nakayama, 2013). 
Cyclins (CCN) and cyclin dependant kinases (CDK) involved in each phase 
G0 phase G1 phase S phase Mitotic phase 
CCN C + CDK 3 
CCN D1-D3 + CDK 
4/CDK 6 
CCN E1, CCN E2 + 
CDK 2 
CCN B1, CCN B2 + CDK 1 
CCN E1, CCN E2 + CDK 
2 
CCN A1, CCN A2 + 
CDK 2/1 
CCNA1, CCN A2 + CDK 
2/1 
C-myc, CDC2, PDK1 
CDC2, ANLN, BIRC5, 
SGOL1 
CDK N1A inhibits 
progression through 
G1 phase 
 
Figure 3-29: Table and graph depicting cyclins and cyclin dependent kinase expression 
involved during the different phases of the MSC cell cycle. 
The graph shows the expression levels of CDKs in cell cycle progression. Yellow 
highlighted genes were noted to be decreased in spheroid cultures compared to monolayer 
cultures. (Adapted from Bardin and Amon (Bardin and Amon, 2001)). 
Cells are able to exit the cell cycle during the G1 phase, to enter a state of 
physiological arrest, also known as quiescence (G0). Ren and Rollins identified 
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cyclin C-CDK 3 complex regulated the transition of cells exiting the quiescent 
state and re-entering G1 phase and thus, entering the cell cycle (Ren and Rollins, 
2004). The graph in Figure 3-25 showed a reduction of cyclin C expression in the 
spheroids at days 1 and 14, compared to the monolayer system. Therefore, these 
results indicate the cells within the spheroids were being retained within a 
quiescent state and had not re-entered the cell cycle. 
The transition from G1 to S phase is initiated by the presence of growth factors. 
If the cell progresses through the G1 phase, there is a checkpoint, called the 
restriction (R) point, which the cell must pass through to continue progression to 
S phase. Once the cell passes the R point, there is no requirement for growth 
factors to complete the cell cycle. Therefore, the cell becomes committed to 
synthesising and replicating new DNA (Blagosklonny and Pardee, 2002). Prior to 
the R point, D-type cyclins (D1, D2 and D3) mediate progression through the G1 
phase. Figure 3-25 showed a significant decrease in cyclins D1 and D2 
expression, within the spheroids at day 1, compared to the equivalent time point 
in the monolayer system. 
All three D-type cyclins form active complexes with CDK 4 and CDK 6, which 
trigger phosphorylation of retinoblastoma (Rb) protein (Hinds et al., 1992). 
Additionally, at day 1 there was decreased CDK 4 and CDK 6 expression in the 
spheroids, compared to the monolayer system (see Figure 3-25). The 
phosphorylated Rb is unable to bind to E2F, which in turn activates E2F-
mediated transcription. E2F-1 transcription factor has been shown to be involved 
in activating genes that produce products. These products synthesise DNA and 
drive the cell cycle progression into the S phase (Nevins, 1998). Additionally, the 
E2F-1 transcription factor, trans-activates cyclins E and cyclins A to form 
complexes with CDK 2. Cyclin D-CDK 4/6 complexes initiate the phosphorylation 
of Rb. However, the process is completed by the cyclin E-CDK 2 complex 
(Blagosklonny and Pardee, 2002). The cyclin E-CDK 2 complex activity is high in 
the late stages of G1 and early S phases. Studies have shown cyclin E is 
accumulated between the R point and the S phase and a threshold is required for 
cell cycle progression (Dulic et al., 1992, Gong et al., 1995). Therefore, 
expression of cyclin E and CDK 2 is indicative of a cell committed to cell division. 
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Figure 3-25 showed a decrease in gene expression of both cyclins E1 and E2 at 
day 1 in the spheroids examined against monolayer cultures. 
As well as a reduction in c-myc expression in spheroids, there was increased 
expression of CDK N1A in the study samples. Studies have shown CDK N1A acts an 
inhibitor, which inhibits cell cycle progression through the G1 phase, by stopping 
phosphorylation of CDK 2 (Mandal et al., 1998). Whereas, c-myc has been shown 
to aid cell cycle progression through G1 and initiate the transition through to the 
S phase (Schmidt, 2004). The observed reduction in gene expression of the cyclin 
D-CDK 4/6 complexes in this study may have led to decreased Rb 
phosphorylation, resulting in a decrease in cyclin E expression and accumulation 
at the R point. Furthermore, the decrease in c-myc, suggests there was a delay 
in the G1 phase, restricting the progression through the cell cycle. Additionally, 
the increased expression of CDK N1A may suggest cell cycle progression was 
being inhibited through the G1 phase. Therefore, all these changes in gene 
expression may indicate the cells slow the progression through the G1 phase with 
a resulting resistance to transfer to the S phase of the cell cycle compared to 
the monolayer system. 
The day 14 spheroids showed a reduction in all three D-type cyclins, CDK 6, c-
myc and cyclin A2 expression, compared to the day 14 monolayer culture 
systems (see Figure 3-25). Moreover, there was no observed gene expression of 
either cyclin E2 or CDK 2. The decrease in all D-type cyclins expression, may had 
led to reduced Rb phosphorylation and in turn limited activation of the E2F-1 
transcription factor. This reduction in E2F-1 results in a lack of activation of 
genes involved in triggering cyclin E2 or CDK 2 production. Therefore, the 
complete absence of the cyclin E2-CDK 2 expression, may suggest the cell cycle 
had not progressed beyond the R point and arrested in the early stages of the G1 
phase. Furthermore, cyclin A activates CDK 2 and assists with cell cycle 
progression, by aiding the cell transition between the S and G2 phases. However, 
the lack of expression of CDK 2 may indicate the complex with cyclin A had not 
formed and the cell cycle had arrested at the early G1 phase. 
A study conducted by Cheung and Rando investigated gene expression in 
quiescent HSCs, muscle stem cells (MuSCs) and hair follicle stem cells (HFSCs) 
(Cheung and Rando, 2013). The study found a group of genes expressed by all 
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three cell types unravelled signatures in gene expression. The researchers 
identified a set of common genes in the quiescent cells, which were down 
regulated (ANLN, BIRC5, CCN A2, CCN B1, CCN E2 and SGOL1). The spheroid 
results depicted in Figure 3-25 showed a down regulation in all 6 of the genes 
identified by Cheung and Rando at day 1 and day 14 compared to the monolayer 
culture systems. Therefore, the results observed in Figure 3-25 correlated with 
the observations by Cheung and Rando, indicating the spheroids were in a 
quiescent and non-proliferating state at both day 1 and day 14. Furthermore, 
the gene analysis results depicted in Figure 3-25 correlate with the results 
observed in Figure 3-24. 
3.5.8 Niche Model Development: Stage 8 
Assessing MSC Differentiation Properties in Monolayer and 
Spheroid Culture Systems. 
The bone marrow niche protects the stem cells from over stimulation however, 
when required, external factors may stimulate the stem cells to migrate from 
the niche and start to differentiate into the desired cell type. Therefore, it was 
important to determine whether the MSCs retain their multipotency properties, 
in either monolayer or spheroid culture. Following longer-term culture (14 days) 
in spheroids, the MSCs were induced to differentiate down both osteogenic and 
adipogenic lineages and the MSC differential properties were assessed. The 2D 
and 3D systems depicted in Figure 3-27, showed directed differentiation, by 
either the expression of osteopontin or presence of lipid droplets in the MSCs. 
The mNP-loaded MSCs were able to differentiate down the desired lineage, 
which suggests the mNPs did not have an effect on MSC multipotency. Guzman 
et al., compared differentiation of neural stem cells with or without SPIO 
nanoparticles (Guzman et al., 2007). The researchers found no statistical 
differences between the differential capacity of both groups (Guzman et al., 
2007). However, another study suggested high doses of mNPs may influence 
chondrocytic differentiation (Kostura et al., 2004). 
Osteopontin is a protein highly expressed by immature osteoblasts, which are 
vital for bone development (Komori, 2010). Therefore, osteopontin expression, 
observed within the MSCs cultured with osteogenic differentiation media, 
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indicated the cells were differentiating through the osteogenic lineage. Oil Red 
O has been extensively used to stain lipids thus, labelling cells of adipose origin 
(Deutsch et al., 2014, Chamberlain et al., 2007, Kim et al., 2012). Therefore, 
the presence of Oil Red O (stained lipids) within the cells vacuoles, showed the 
MSCs had differentiated into adipocytes, through the adipogenic lineage. A study 
conducted by Wang et al., also induced MSCs in spheroids and monolayer 
systems into adipocytes and osteoblasts (Wang et al., 2009). The researchers 
found higher differentiation efficiency of MSCs cultured in spheroids compared 
to the monolayer system (Wang et al., 2009). 
The differentiation capacity of MSCs cultured in 2D and 3D were comparable to 
each other as highlighted in Figure 3-27. However, MSCs cultured as spheroids 
showed the cells remained quiescent (see Figure 3-24 and Figure 3-25) and 
retained their stem cell markers (see Figure 3-11) over time, until stimulated to 
differentiate as shown in Figure 3-27. MSCs cultured in the 2D monolayer system 
were also able to differentiate within in vitro cultures as shown in Figure 3-27. 
However, these MSCs also started to lose their multipotency properties very 
rapidly (Figure 3-9). Therefore, theoretically their differentiation capacity was 
reduced over time. This study did not show this expected reduction in potency. 
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3.6 Summary 
The aim in this chapter was to develop a physiologically relevant MSC bone 
marrow niche model, which was achieved by culturing MSCs in 3D spheroids, 
within a Type I collagen gel. 
Multicellular spheroids may be generated in several ways. However, this study 
adapted a method by Souza et al., which was published in Nature 
Nanotechnology in 2010. The MSCs were incubated with 200 nm fluorescently 
tagged mNPs, under the guiding force of an external magnetic field (optimised 
for both NP concentration and incubation time). The internalised mNPs did not 
have any effect on the MSCs viability, stemness, multipotency or cell cycle 
properties. Once magnetically loaded, the cells were assessed for mNP retention 
and responsiveness to a magnetic field. The cells were then magnetically 
levitated to create a multicellular MSC spheroid. 
In the monolayer culture system, the MSCs showed significant reductions in 
STRO-1 and nestin expression over time (2 weeks), which were comparable to 
other studies culturing MSCs two-dimensionally. Furthermore, the monolayer 
system exhibited MSC proliferation through the incorporation of BrdU within the 
nucleus. These results indicated the MSCs were not displaying behaviours 
observed within the native bone marrow niche and were a poor representation 
of this environment. 
Conversely, the spheroidal MSC structure exhibited high expression of STRO-1 
and nestin over the 2 week period, thus showing they retained their 
multipotency properties. Additionally, MSCs in the spheroid did not show 
incorporation of BrdU, which indicated the cells had not entered the cell cycle. 
Gene analysis showed a 75% decrease in the number of genes being expressed in 
the spheroids compared to the monolayer culture system. Furthermore, the 
MSCs cultured in the 3D spheroids were induced to differentiate into osteoblasts 
and adipocytes. These MSC behaviours mimic the innate MSC niche environment. 
The complexity of the model was increased by the use of a Type I collagen gel to 
mimic the physical properties in the bone marrow environment. Initially, the 
homogeneous mix of gel and MSCs did not lead to the amalgamation of MSCs to 
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form the necessary cell-cell contacts. Therefore, the spheroids were preliminary 
created and then transplanted into the collagen gels. Rheology analysis of the 
gels containing spheroids exhibited similar stiffness properties of a bone marrow 
environment, thus creating a more realistic ex vivo niche model. The functional 
properties of this newly developed model will be assessed in the following 
chapter. 
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4 MSC Spheroid Niche Model Response to Wound 
Healing 
4.1 General Introduction 
Bone marrow MSCs possess immune-modulatory and wound healing properties, 
which are beneficial for regenerating damaged tissue or organs (Ma et al., 2014, 
Anthony and Shiels, 2013). The wound healing process is initiated following 
injury and involves three distinct overlapping phases; inflammatory, 
proliferative and remodelling (Häkkinen et al., 2015). In the initial inflammatory 
stage, chemokines and cytokines are released from cells within the damaged 
vicinity, creating an attractant concentration gradient in the surrounding area. 
The MSCs within the bone marrow niche possess numerous chemokine and 
cytokine receptors on the cell surface. The chemokines/cytokines released post 
injury, bind to their cognate receptor on the MSCs causing a cascade of events. 
Once activated, the MSCs proliferate, migrate out from the niche and home to 
the site of injury via chemotaxis and pro-inflammatory cytokines (Rennert et al., 
2012). The MSC homing process to the damaged area comprises multiple steps, 
which include rolling, adhesion and transmigration across the vascular 
endothelium, followed by migration through tissue to the damaged area (Chen et 
al., 2011). 
Once the MSCs reach the injured site, the cells are known to play an important 
role in all three phases of wound healing. The inflammatory stage occurs within 
the first few days of injury, where factors (e.g. platelet-derived growth factor 
(PDGF), interleukin 1β (IL-1β), IL-6 and tumour necrosis factor-α (TNF-α)) are 
released from damaged cells, platelets and mast cells to recruit neutrophils and 
monocytes to the injured area (Velnar et al., 2009). Re-epithelialisation, ECM 
deposition and granulation tissue formation occur during the second proliferative 
phase. The final stage of wound healing involves the remodelling of granulation 
tissue into scar tissue (Velnar et al., 2009). 
MSCs directly suppress the native immune response by secreting anti-
inflammatory cytokines, such as IL-10 and IL-4 (Kyurkchiev et al., 2014). 
Additionally, MSCs prevent proliferation and function of the immune 
inflammatory cells including monocytes (Zhao et al., 2015). Furthermore, MSCs 
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possess and secrete antimicrobial factors, which aid the wound healing process 
(Krasnodembskaya et al., 2010). MSCs use paracrine signalling to regulate local 
cellular responses, such as local cell proliferation, migration and cell survival. 
Paracrine signalling from the MSCs have also been shown to recruit specific cell 
types to the wound. A final role for MSCs in the wound healing process is by 
directly differentiating into cells of mesenchymal lineages, to repair damaged 
tissue. 
The wound healing response is key to MSC behaviour, and confers one of the 
main benefits MSCs hold for potential regenerative medicine applications. The 
aim of this chapter was to determine whether the MSC niche model developed in 
Chapter 3 is able to express similar in vivo responses, in the presence of an 
artificially created wound. Furthermore, discover whether stimulated MSCs 
should migrate towards the site of injury and accelerate wound healing, through 
local cell proliferation, migration and differentiation. 
4.2 Objectives 
In the previous chapter, a 3D in vitro MSC niche model was created using MSC 
spheroids within collagen gel scaffolds. The MSCs in this environment mimicked 
in vivo MSC phenotype and behaviour; by expressing high levels of STRO-1 and 
nestin. The MSCs retained their multipotency properties and remained quiescent 
over time, compared to traditional 2D culture methods. It was important to 
subsequently assess the MSC niche model’s functional properties in terms of 
wound healing, to determine whether they parallel responses observed in an in 
vivo environment. 
This evaluation was achieved by subjecting the niche model to numerous wound-
healing assays, to assess whether the MSCs migrated out from the spheroid niche 
towards an artificially created wound. In addition, it was necessary to determine 
whether these migrated MSCs were actually aiding wound healing, by 
differentiating into the desired cell types. Assessment of these innate 
properties, will determine whether the MSCs within the niche model mimic the 
in vivo niche response. 
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These objectives will be achieved via: 
 Optimisation of a simple wound healing assay; the study of wound closure 
of scratched fibroblasts and osteoblasts, over time. 
 The assessment of MSC migration from a spheroid niche, in response to an 
artificial wound. 
 The genomic and proteomic investigation of migrating MSCs from the 
spheroid niche towards the wound, to determine whether the MSCs would 
trans-differentiate into the local resident cell type.  
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4.3 Materials and Methods 
4.3.1 Time-lapse assessment of wound healing assays. 
4.3.1.1  Light microscopy: time course assessment of scratched monolayers 
with or without overlaid collagen gels 
The wound healing rate of scratched monolayers in the presence or absence of 
an overlaid collagen gel was determined by culturing either h-TERTs (fibroblasts) 
or osteoblasts as confluent monolayers on CellBind plates. The monolayers were 
scratched using a P1000 pipette tip. Osteogenic differentiation media (see 
Chapter 3, section 3.3.5) was added every 2/3 days for 10 days to the osteoblast 
monolayer, prior to being scratched by the pipette tip. An artificial wound was 
created prior the addition of either fresh media or collagen gels. The monolayers 
were assessed using light microscopy to determine the closure rate of the 
scratch. 
4.3.1.2  Immunofluorescence microscopy: cell viability assessment of 
scratched monolayers 
To determine whether there was an increased presence of dead cells at the 
scratched edge, human dermal fibroblasts, h-TERTs, were seeded as a confluent 
monolayer, which was scratched with a P1000 pipette tip to create a wound. 
Fresh media was immediately placed directly onto the scratched monolayer and 
the cells were monitored over the first 24 hour period post scratch. H-TERTs 
were assessed via a live/dead stain (see section 3.3.3.1) and analysed using a 
Zeiss Axiovert 200M fluorescent microscope. 
4.3.2 Assessing MSC migration from a spheroid niche in 
response to an artificial wound. 
4.3.2.1 Immunofluorescence microscopy: cell cytoskeleton (F-actin staining) 
Either h-TERTs or primary osteoblasts were grown as a confluent monolayer on 
CellBind plates and left either unscratched or scratched using a P1000 pipette 
tip. The osteoblast monolayer culture cells were seeded and osteogenic 
differentiation media (see Chapter 3, section 3.3.5) was added every 2/3 days 
for 10 days, prior to the addition of an MSC spheroid. An artificial wound was 
created just before the addition of the spheroid/gel (i.e. the niche model). 
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Cultures were monitored every 24 hours for 3 days. The MSCs and underlying 
monolayer were fixed and stained with phalloidin-rhodamine and DAPI (see 
Section 3.3.3.2) and analysed using a Zeiss Axiovert 200M fluorescent 
microscope. 
4.3.3 MSC differentiation assessment post migration from the 
spheroid niche to wound site. 
4.3.3.1 Immunofluorescence microscopy: MSC differentiation 
(phosphorylated RUNX-2 and osteopontin staining) 
The above mentioned procedure (see Section 4.3.2.1) was followed using 
fibroblasts and osteoblast cells. The niche model was cultured for either 3 or 14 
days with both cell types, to assess migrating MSC staining for early and late 
osteogenic markers. The media covering the gels was changed twice weekly over 
the appropriate culture period. MSCs were fixed and stained with 
phosphorylated RUNX-2 (1:50 dilution), followed by biotinylated secondary (1:50 
dilution) and streptavidin-Texas Red (1:50 dilution), then mounted with DAPI on 
day 3 (see section 3.3.3.3). Whereas, on day 14 the cells were stained for 
osteopontin (1:50 dilution), followed by biotinylated secondary (1:50 dilution) 
and streptavidin-Texas Red (1:50 dilution). The cells were then mounted with 
DAPI (see section 3.3.3.3). Both day 3 and day 14 samples were analysed using a 
Zeiss Axiovert 200M fluorescent microscope. 
4.3.3.2 RNA extraction from the spheroid niche post-exposure to control and 
wounded osteoblasts 
Differentiation analysis of migrated MSCs within niche model: Analysis was 
conducted on confluent primary osteoblast monolayers, which were either left 
unscratched or scratched with a P1000 pipette tip. The cells were seeded onto 
CellBind plates and osteogenic differentiation media (see section 3.3.5) was 
added for 10 days, prior to the addition of the niche model on top. After 24 
hours or 72 hours, the collagen gels containing the spheroids were removed from 
the wells ready for RNA extraction. Six samples were pooled for each replicate 
(n=3). 
A TRIzol extraction and Qiagen RNeasy micro kit was used as described in 
Chapter 3, section 3.3.6, to extract the RNA from the MSC spheroids, within the 
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collagen gels. The RNA was subjected to Fluidigm analysis and prepared by the 
method described in Chapter 3, section 3.3.7, with a modified primer list (see 
Table 4-1). 
Table 4-1: Fluidigm primers designed for human genes. 
(*Primers used as housekeeping genes). 
Primer Sequence (5’ to 3’) 
β-Actin* 
Forward GTGGGCCGCCCTAGGCACCAG 
Reverse CACTTTGATGTCACGCACGATTTC 
 RUNX-2 
Forward CAGCAGCAGCAACAGCAG 
Reverse GGCGATGATCTCCACCAT 
ACVR1A 
Forward GCCAAGGGGACTGGTGTAAC 
Reverse GAGAATAATGAGGCCAACCTCCA 
SMAD1 
Forward GCTGCTCTCCAATGTTAACCG 
Reverse CACTAAGGCATTCGGCATACAC 
SMAD2 
Forward CCACGGTAGAAATGACAAGAAGG 
Reverse GATTACAATTGGGGCTCTGCAC 
SMAD3 
Forward GTCTGCGTGAATCCCTACCAC 
Reverse GGGATGGAATGGCTGTAGTCG 
ENOX2* 
Forward GAGCTGGAGGGAACCTGATTT 
Reverse CACTGGCACTACCAAACTGCA 
SMAD4 
Forward GGGTCAACTCTCCAATGTCCAC 
Reverse GTCACTAAGGCACCTGACCC 
SMAD5 
Forward TGGGTCAAGATAATTCCCAGCCT 
Reverse GGCTCTTCATAGGCAACAGGC 
SMAD6 
Forward CTCCCTACTCTCGGCTGTCT 
Reverse AGAATTCACCCGGAGCAGTG 
SMAD7 
Forward CCATCACCTTAGCCGACTCT 
Reverse CCAGGGGCCAGATAATTCGT 
SMAD9 
Forward CTTATCATGCCACAGAAGCCTCT 
Reverse GCTCCTCGTAACAAACTGGTCG 
BMPR1A 
Forward ACGCCGGACAATAGAATGTTGTC 
Reverse GAGCAAAACCAGCCATCGAATG 
TWY1* 
Forward ATTGTCATCAAGACGCAGGGC 
Reverse GTTGCGAATCCCTTCGCTGTT 
BMPR1B 
Forward GGTTCAGACTTCTGCTGATTCAT 
Reverse CGCAAAAGCATGTTATCAAGG 
BMP2 
Forward CTTCTAGCGTTGCTGCTTCC 
Reverse AACTCGCTCAGGACCTCGT 
BMP2 
Forward AGACCTGTATCGCAGGCACT 
Reverse CCACTCGTTTCTGGTAGTTCTTCC 
BMPR2 
Forward AGCCTCTCACACCCACTCC 
Reverse GCAGAACAACCGTGAGAGG 
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ACVR1B 
Forward GACATTGCCCCGAATCAGAGG 
Reverse GCCCGAGGGCATAAATATCAGC 
BMP4 
Forward CAGCACTGGTCTTGAGTATCCT 
Reverse AGCAGAGTTTTCACTGGTCCC 
CYCR* 
Forward ACTGCGGGAAGGTCTCTACTT 
Reverse GGGTGCCATCGTCAAACTCTA 
BMP7 
Forward CAGGCCTGTAAGAAGCACGA 
Reverse TGGTTGGTGGCGTTCATGTA 
BMP10 
Forward ACCCACCAGAGTACATGTTGG 
Reverse GCCCATTAAAACTGACCGGC 
Nestin 
Forward GCTCAGGTCCTGGAAGGTC 
Reverse AAGCTGAGGGAAGTCTTGGA 
CD63 
Forward CCCTTGGAATTGCTTTTGTT 
Reverse TATTCCACTCCCCCAGATGA 
ALCAM 
Forward TTCCAGTCCCTCTACTCAGAGC 
Reverse GCTAAGAAGGACTCGCAGGA 
Osterix 
Forward TGGGCTCCCAACACTATTTC 
Reverse GGGAAGACTGAAGCCTGGA 
UBE2D2* 
Forward CCATGGCTCTGAAGAGAATCC 
Reverse GATAGGGACTGTCATTTGGCC 
RUNX1T1 
Forward ATCACAACAGAGAGGGCCAA 
Reverse CTGCAGGTTTCACTCGCTTT 
SMURF1 
Forward ATGCAGTTCGTGGCCAGATA 
Reverse CAGGCCCGGAGTCTTCATAC 
SMURF2 
Forward GACAGGATCCTCTCGAGTGC 
Reverse AGCTTTCATAGGGTGGAATGTCT 
INHBA 
Forward AAGTCGGGGAGAACGGGTAT 
Reverse GGTCACTGCCTTCCTTGGAA 
ACVR2A 
Forward ACCATGGCTAGAGGATTGGC 
Reverse GCCAACCCAAAGTCAGCAAT 
ACVR2B 
Forward CTGCAACGAACGCTTCACTC 
Reverse CAGGACGATGAGGGAAAGGC 
RNF20* 
Forward GGTGTCTCTTCAACGGAGGAA 
Reverse TAGTGAGGCATCATCAGTGGC 
TGFB1 
Forward CGACTCGCCAGAGTGGTTATC 
Reverse GTTATCCCTGCTGTCACAGGAG 
TGFBR1 
Forward CGTTCGTGGTTCCGTGAGG 
Reverse TAATCTGACACCAACCAGAGCTG 
TRAF6 
Forward CGCACTAGAACGAGCAAGTGA 
Reverse GCCACACAGCAGTCACTTTCA 
SNAIL2 
Forward TCCTTCCTGGTCAAGAAGCA 
Reverse GGTATGACAGGCATGGAGTA 
Vimentin 
Forward GGAGAAATTGCAGGAGGAGA 
Reverse TGCGTTCAAGGTCAAGACGT 
IL-8 Forward GTGTGAAGGTGCAGTTTTGCC 
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Reverse GTGGTCCACTCTCAATCACTC 
B2M* 
Forward TTGTCTTTCAGCAAGGACTGG 
Reverse ATGCGGCATCTTCAAACCTCC 
CathepsinB 
Forward TGTGTATTCGGACTTCCTGC 
Reverse TTAAAGAAGCCATTGTCACCC 
CathepsinD 
Forward GGTGCTCAAGAACTACATGG 
Reverse ATTCTTCACGTAGGTGCTGG 
CathepsinG 
Forward AACAGATACACTCCGAGAGG 
Reverse ACGACTTTCCATAGGAGACG 
CathepsinL 
Forward GACTCTGAGGAATCCTATCC 
Reverse CTTAGGGATGTCCACAAAGC 
CathepsinS 
Forward GCGTCATCCTTCTTTCTTCC 
Reverse CCAGCTGTTTTTCACAAGCC 
GAPDH* 
Forward TCAAGGCTGAGAACGGGAA 
Reverse TGGGTGGCAGTGATGGCA 
 
Permutmatrix software (Réseau National des plates-formes Bioinformatiques 
(ReNaBi), France) was used on each cluster gene expression, to convert the 
numerical values from the collected data into a graduation scale of colours. For 
example, shades of red were used to represent the degree of up regulated 
genes, whilst shades of green indicated the degrees of down regulated genes. 
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4.4 Results 
4.4.1 Time-lapse assessment of wound healing assays. 
Confluent monolayer culture systems were scratched (to create an artificial 
wound) and time-lapse experiments were conducted, to assess the ability of the 
monolayer to repair and close the scratch/wound. Two different cell models 
were employed; (i) a connective tissue model using fibroblasts (h-TERTS) and (ii) 
a bone matrix model using primary osteoblasts. The cell models were grown in 
either the presence or absence of overlaid collagen gels (Figure 4-1). It was 
necessary to assess whether the presence of collagen gels altered the rate of 
wound closure. 
Figure 4-1 demonstrated both fibroblasts and osteoblasts directionally migrated 
from the edge of the wound inwards, across the scratch to close the wound. 
However, in the absence of a collagen gel, fibroblasts closed the wound much 
quicker, (after only 24 hours) whereas, the osteoblasts took 5 days to close the 
wound. 
However, the scratch (wound) healed slower in the presence of the collagen gel, 
in both the connective tissue and bone matrix models (Figure 4-1). The 
connective tissue model, took an extra 5 days for the scratch to close in the 
presence of collagen gels. Whereas, the bone matrix model took an extra 2 days 
for the wound to fully heal and close. 
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Figure 4-1: Light microscopy time lapse images assessing the wound healing process. 
Two different cell models were used; connective tissue (fibroblasts) and bone matrix 
(osteoblasts) models, in the presence and absence of an overlaid collagen gel. 10x 
objective, scale bar = 50 μm. 
Subsequently, a viability assessment of the scratched fibroblast monolayer 
control was carried out. MSCs are known to migrate out of the niche and are 
guided to the wound, following the release of chemokines and cytokines from 
the site of injury. Therefore, it was necessary to assess the presence of dead 
cells at the wound edges, as damaged or dying cells release danger-associated 
molecular patterns (DAMPs), as part of the pro-inflammatory response by the 
wound (Tolle and Standiford, 2013). 
Figure 4-2 demonstrated there were limited dead cells in the control, non-
scratched samples, which were not localised within a specific area but 
distributed throughout the control samples (highlighted with the white arrows). 
However, the scratched samples clearly showed a higher concentration of dead 
cells at the edge of the scratch 24 hours post injury, (highlighted by white 
arrows in Figure 4-2). Despite this finding, it was noted that the presence of 
dead cells only comprised a very small percentage, compared to the percentage 
of living cells at the wound edge. 
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Figure 4-2: Fibroblast viability assessed over 24 hours, in the presence or absence of a 
scratch. 
Live/dead stain green = living cells, red = dead cells and highlighted with white arrows. (A) 
10x objective and (B) 5x objective. Scale bar = 50 μm 
Soluble factors including cytokines, released from MSCs following injury, 
stimulate proliferation and migration of other cell types, to enhance and 
accelerate wound healing (Hocking and Gibran, 2010). Therefore, further 
research was conducted to assess whether the MSCs within the spheroid niche 
model were able to migrate out of the niche, upon injury stimulation. 
4.4.2 Assessing MSC migration from a spheroid niche, in 
response to an artificial wound. 
Chapter 3 demonstrated the absence of external stimulation allows the MSCs to 
remain quiescent and in situ within the spheroid niche (Chapter 3, Figure 3-24 
and Figure 3-25). However, the presence of stimulation, which in this case was a 
scratched monolayer, should initiate the migration of MSCs out of the niche, 
towards the wound. Further studies were conducted using both fibroblast and 
osteoblast scratched monolayer cultures, to investigate potential MSC migration 
from the niche model over time in co-culture. 
Scratched and unscratched (control) fibroblast and osteoblast monolayers were 
overlaid the with MSC spheroid niche model. Light micrographs were taken 
alongside fluorescent images (with F-actin stained monolayers (red) and mNP 
fluorescently tagged MSC spheroids (green)). Figure 4-3 showed the MSCs in the 
unscratched control samples remained within the niche during all time points in 
both fibroblast and osteoblast monolayers. These results verified that a 
confluent cell monolayer co-cultured beneath the MSC niche model failed to 
stimulate MSC migration. 
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Figure 4-3a: MSC spheroid niche co-cultured with control (unscratched) fibroblast 
monolayers assessed over 3 days. 
MSC spheroid niche cultured over an unscratched fibroblast monolayer. (A) Light 
microscopy image, (B) Fluorescence image (red = actin, green = mNPs, blue = nucleus). 10x 
objective, scale bar = 50 μm. 
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Figure 4-3b: MSC spheroid niche co-cultured with control (unscratched) osteoblast 
monolayer assessed over 3 days. 
MSC spheroid niche cultured over an unscratched osteoblast monolayer. (A) Light 
microscopy image, (B) Fluorescence image (red = actin, green = mNPs, blue = nucleus). 10x 
objective, scale bar = 50 μm. 
Conversely, when MSC niche models were co-cultured above scratched 
monolayers, the MSCs clearly migrated out of the niche after 1 day in both 
osteoblast and fibroblast models (Figure 4-4). MSC migration from the niche 
increased over time following exposure to the scratch, with more cells exiting 
the niche at day 3 compared to day 1. Moreover, at all time points, the images 
showed directional MSC migration towards the scratch, as indicated in the 
image. However, if the niche was positioned above the middle of the scratch all 
peripheral MSCs migrated out of the niche (see Figure 4-4). It was noted that 
only the niche MSCs exposed nearest to the wound became stimulated and 
migrated towards the wound site. 
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Following MSC migration, the cells were also observed to integrate within the 
wound (scratch) area therefore, these results show MSCs appear to play a role in 
wound healing (Figure 4-4). Figure 4-1 demonstrated wound closure using both 
fibroblasts and osteoblasts at days 6 and 7 respectively, when overlaid with a 
collagen gel. However, when the wound was overlaid with the MSC spheroid 
niche model (within a collagen gel), both wounds closed much earlier, by day 3. 
 
Figure 4-4a: MSC migration from the spheroid niche when co-cultured with scratched 
fibroblast monolayers, assessed over 3 days. 
MSC spheroid niche depicting migration of MSCs towards a scratch on a fibroblast 
monolayer (black and white arrows indicate migrating MSCs). (A) Light microscopy image, 
(B) Fluorescence image (red = actin, green = mNPs, blue = nucleus), edge of scratch/wound 
(dashed white line), 10x objective, scale bar = 50 μm. 
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Figure 4-4b: MSC migration from the spheroid niche when co-cultured with scratched 
osteoblast monolayers, assessed over 3 days. 
MSC spheroid niche depicting migration of MSCs towards a scratch on an osteoblast 
monolayer (black and white arrows indicate migrating MSCs). (A) Light microscopy image, 
(B) Fluorescence image (red = actin, green = mNPs, blue = nucleus), edge of scratch/wound 
(dashed white line), 10x objective, scale bar = 50 μm. 
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Figure 4-4c: Quantitative analysis showing percentage rate of wound closure over a period 
of 3 days with MSC spheroids cultured with scratched fibroblast and osteoblast 
monolayers. 
 
4.4.3 MSC differentiation assessment post migration from 
spheroid niche to wound site. 
Figure 4-4 showed the directional migration of MSCs from the niche, in the 
presence of a scratch/wound. In vivo studies have shown, following MSC arrival 
at the wound site, the cells begin to differentiate into the desired cell type and 
encourage cell proliferation within the affected area, leading to improved tissue 
repair (Maxson et al., 2012). Therefore in this study, a series of wound healing 
assays were initiated, to determine whether, following migration, the MSCs 
differentiate into the scratched (wounded) monolayer cells. 
The connective tissue (fibroblast) and bone matrix (osteoblast) scratched models 
were employed to assess potential MSC differentiation into osteoblasts. All MSC 
cultures were assessed for early and late stage bone markers, to verify 
differentiation into osteoblasts over a period of 3 to 14 days (Figure 4-5). 
The images in Figure 4-5 showed the control MSC samples without a 
scratch/wound did not cause the MSC migration, in either the osteoblast or 
fibroblast models. Furthermore, these samples showed no expression of 
phosphorylated RUNX-2 after 3 days or osteopontin on day 14. The osteoblast 
model showed osteopontin expression on day 14. However, these stained cells 
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corresponded with cells from the monolayer and not from the MSC niche cells 
(Figure 4-5b upper panel). 
Conversely, MSCs in the scratched fibroblast samples started to migrate out of 
the niche and incorporate into the scratched area by day 3, with evidence of 
more MSC migration after 14 days (Figure 4-5a). There was no observed 
phosphorylated RUNX-2 expression on day 3 or osteopontin expression after day 
14. 
Similarly, MSCs in the scratched osteoblast samples also migrated out of the 
niche by day 3 and were fully incorporated within the wound area by 14 days 
(Figure 4-5b). The migrated MSCs were shown to express phosphorylated RUNX-2 
after 3 days, following exposure to the scratch (see Figure 4-5b and Figure 4-6), 
and clear expression of osteopontin after 14 days (Figure 4-5b). 
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Figure 4-5a: Wound healing assay assessing the presence of MSC niche models. 
Fibroblast monolayer assessed at DAY 3 and DAY 14 with or without a scratch. (A) Light 
microscopy image and (B) fluorescent image, red = phosphorylated RUNX-2 
(DAY3)/osteopontin (DAY 14), green = mNPs, blue = nucleus. 10x objective, scale bar = 50 
μm. 
Chapter 4 – Wound Healing Assessment  152 
 
 
Figure 4-5b: Wound healing assay assessing the presence of MSC niche models. 
Osteoblast monolayer assessed at DAY 3 and DAY 14 with or without a scratch. (A) Light 
microscopy image and (B) fluorescent image, red = phosphorylated RUNX-2 
(DAY3)/osteopontin (DAY 14), green = mNPs, blue = nucleus. 10x objective, scale bar = 50 
μm. 
 
Figure 4-6: High magnification images of MSCs migrating towards a scratched osteoblast 
monolayer expressing phosphorylated RUNX-2 after 3 days. 
(A) Light microscopy image, (B) fluorescent image, red = phosphorylated RUNX-2, green = 
mNPs, blue = nucleus. (C) Fluorescent image highlighting phosphorylated RUNX-2. 20x 
objective. 
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Further analysis was conducted on the migrated MSCs, to identify any 
osteoblastic gene expression. This analysis would complement the results 
depicted in Figure 4-5 (i.e. RUNX-2 and osteopontin staining). The osteoblast 
monolayer was scratched (or left unscratched) and MSC spheroid gene expression 
was assessed, following exposure to a scratch either over a period of 1 day or 3 
days (see Figure 4-7 and Figure 4-8). Specific genes, involved in osteogenesis and 
stemness, were analysed via fluidigm to confirm whether the MSCs were 
differentiating in the presence of the osteoblast wound. All data was normalised 
against the corresponding unscratched wound assay, which was processed on the 
same day. 
After 3 days, there was high expression of nestin and ALCAM in both scratched 
and unscratched osteoblast models, further confirming the MSC phenotype in 
spheroid culture. There was a significant increase in RUNX-2 expression within 
the scratched model at day 3, compared to all other conditions (p < 0.001), 
supporting the RUNX-2 staining observed at day 3 in Figure 4-6. There was no 
RUNX-2 expression after 3 days in the absence of a wound.  
An increased in the expression levels of osteoblast markers- BMP-2, SMAD-2, 
SMAD-4, and SMAD-5 was recorded at both time points in the scratched assay, 
compared to the unscratched assay. 
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Figure 4-7: Heat map depicting MSC gene expression profiles extracted from the spheroid 
niche model. 
MSC spheroids were co-cultured with unscratched or scratched primary osteoblast 
monolayer cultures, for 1 day and 3 days. (A) Heat map of MSC gene expression without 
RUNX-2, (B) heat map of MSC gene expression including RUNX-2. MSC Gene expression 
was depicted relative to the unscratched assay at the same time point, (red = up regulation, 
green = down regulation). 
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Figure 4-8: Gene expression analysis of MSCs extracted from the spheroid niche model 
after co-culture with an unscratched and scratched osteoblast monolayer. 
The gel containing the MSC spheroid/niche was cultured over unscratched or scratched 
primary osteoblast monolayers, for 1 day and 3 days. MSC gene expression was conveyed 
as a fold change, relative to the unscratched assay, at the same time point. 
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4.5 Discussion 
4.5.1 Time lapse assessment of wound healing assays. 
The images in Figure 4-1 showed the scratch healed greater rate in the absence 
of a collagen gel. This rapid healing process was observed in both the connective 
and bone matrix models. In order for the scratch to close and heal, cells 
neighbouring the scratched edge, appeared to migrate and proliferate within the 
damaged area. Scratched monolayers, in the presence of a collagen gel, 
required a longer healing rate. This prolonged healing rate, in both models, may 
be due to a greater resistance to cell mobility, caused by the fibrous network of 
the collagen. Another factor prolonging the healing rate may be caused by more 
resistance to cell signalling molecule transmission through the collagen gel. 
Collagen molecules consist of three polypeptide chains, which entwine with each 
other to form a three stranded rope structure. The strands are held together by 
hydrogen and covalent bonds. These stranded structures self-assemble into 
fibrils (10 - 300 nm in diameter), which group together to form collagen fibres 
(0.5 – 3 µm wide). These fibres cross-link together to form a fibrous network 
within the gel (Parenteau-Bareil et al., 2010, Lee et al., 2001). Therefore, when 
cells migrate across the scratch to heal the wound, there may be a greater 
movement resistance compared to the control, without collagen gel. The fibrous 
collagen gel network meant the scratch sample cells took 5 times and 0.5 times 
longer respectively to heal compared to the controls, without collagen gel. 
Cellular migration through the collagen may occur via two processes. Cells may 
distort their morphology to migrate through the pores between the collagen 
fibres (Charras and Sahai, 2014). However, this migration process is limited by 
the pore size. Another way the cells may migrate through the collagen gel is by 
the release of proteolytic enzymes, matrix metalloproteinases (MMPs), which 
degrade the surrounding collagen fibres (Wolf et al., 2013, Ozeki et al., 2014, 
Zhang et al., 2014). These enzymes widen the pores by cleaving the fibres within 
the matrix thus, allowing greater motility of the cells. The cells then use 
integrin-mediated binding to the collagen and actomyosin-mediated contraction 
to propel the cell in the desired direction (Chi et al., 2014). The osteoblasts and 
fibroblasts used within these models have been shown to be able to remodel the 
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collagen gels to allow migration to the injured/scratched site (Alves et al., 
2015). Studies have shown collagen is highly dynamic as the surrounding cells 
constantly remodel it, particularly during the wound healing process (Schultz 
and Wysocki, 2009). 
Figure 4-1 also showed the connective tissue model scratch, took less time to 
heal compared to the bone matrix model, irrespective of the presence of a 
collagen gel. In vivo healing rates vary depending upon the position of the wound 
within the body; for example, connective tissue heals extremely rapidly 
compared to bone regeneration (LaStayo et al., 2003). A study conducted by 
Kawase et al., assessed cell proliferation abilities of mouse fibroblast-like cells 
compared to mouse osteoblast-like cells (Kawase et al., 2014). The researchers 
seeded both cells at the same concentration and assessed the time taken for the 
cells to reach 100% confluence. The osteoblast-like cells took twice as long to 
reach full confluence compared to the fibroblast-like cells. These results 
indicated osteoblast-like cells have a much lower proliferation rate compared 
the fibroblast-like cells. The results depicted in Figure 4-1 correlate with this 
observation, with a slower proliferation and healing rate within the bone matrix 
model. 
Following verification of wound closure, it was important to identify whether 
there were potential dead cells at the scratch edge. Damaged, stressed or 
injured cells are known to release danger signals in the form of danger 
associated molecule patterns (DAMPs), which stimulate neighbouring cell 
migration (Kato and Svensson, 2015). Damaged or injured cells, which occur 
during injury lose their structural membrane integrity and release intracellular 
contents into the surrounding area e.g. DAMPs (Rosin and Okusa, 2011). These 
molecules initiate an inflammation response and recruit dendritic cells, 
macrophages, T cells and neutrophils, by binding to pattern recognition 
receptors (PPRs) on these particular cells. Therefore, DAMPs initiate the tissue 
repair process via the recruitment of the innate immune cells, which in turn 
release cytokines and chemokines to attract other wound healing cells to the 
area (Bianchi, 2007). The live/dead images depicted in Figure 4-2 showed 
limited dead cells at the scratched edge, 1-hour post injury. Therefore, the 
migration response of the fibroblasts and osteoblasts may partly be due to 
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DAMPs being released from damaged cells to the surrounding area. Other soluble 
factors may also have been released from the live cells at the edge of the 
wound, to encourage cell migration and ultimately wound closure. 
4.5.2 Assessing MSC migration from a spheroid niche in 
response to an artificial wound  
MSCs which were co-cultured with a control (unscratched) monolayer, Figure 4-3 
showed a failure to migrate from the niche spheroids at all-time points. These 
results suggest the MSCs in the niche model remained unstimulated by the 
presence of the underlying cell monolayer. The innate bone marrow niche 
maintains MSCs in a quiescent state, and regulates the stem cell quiescence by 
numerous factors, including cell-cell contacts, intrinsic factors and the creation 
of a hypoxic environment. These MSC bone marrow niche cells remain in this 
quiescent state, until stimulated; e.g. when stem cells are required to 
regenerate damaged tissue, which has occurred as a result of injury (Wang et 
al., 2010). The results in Figure 4-3, Figure 3-24 and Figure 3-25, imply the 
spheroid MSCs were in a quiescent state, suggesting the stem cells were not 
within the proliferating cell cycle, but resting in the G0 phase outside of the cell 
cycle (Spencer et al., 2013). 
Research has shown that within the vascular neural stem cell niche, cell-cell 
contacts are extremely important in maintaining neural stem cell quiescence 
(Ottone et al., 2014). Furthermore, Ottone et al., found direct neural stem cell 
contact with endothelial cells led to stem cell quiescence, via ephrinB2 and 
Jagged1 pathway activation (Ottone et al., 2014). Within the bone marrow 
niche, a study by Yang et al., found Cdc42 expression maintained HSC 
quiescence and retained the stem cells in the correct location, by regulating the 
expression of cell adhesion molecules, including β1-integrin and N-cadherin 
(Yang et al., 2007). The niche spheroids have been shown to mimic the cell-cell 
and cell-ECM interactions observed within the in vivo niche, via the creation of a 
multicellular three dimensional structure (Fennema et al., 2013, Pampaloni et 
al., 2007). 
Another crucial niche component, in the maintenance of quiescence is a hypoxic 
environment. Studies have shown hypoxia greatly affects embryonic and adult 
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stem cell metabolic processes (Silván et al., 2009, Eliasson and Jonsson, 2010). 
Researchers have suggested that stem cells residing within a hypoxic milieu, 
decrease the rate of DNA mutations and activate signalling pathways (Notch and 
Oct4) associated with maintaining stemness (Simon and Keith, 2008). MSCs 
residing within the bone marrow niche environment, experience hypoxic 
conditions and exhibit increased Oct4 expression, which maintains stemness and 
quiescence (Mohyeldin et al., 2010). The MSC spheroid niche resides within a 
collagen gel, which is known to possess oxygen gradients creating hypoxic 
environments. These hypoxic environments are similar to those observed in the 
native niche (Mohyeldin et al., 2010, Bhang et al., 2011). Cells within the 
spheroids have exhibited quiescence and maintenance of stemness, when 
compared to parallel 2D monolayer cultures, which may in part be due to the 
hypoxic milieu (Hirschhaeuser et al., 2010, Saleh and Genever, 2011). 
Additionally, a study conducted by Ong et al., analysed oxygen gradients in 
spheroid cultures and assessed quiescence via BrdU labelling of the cells (Ong et 
al., 2010). The researchers observed hypoxic environments, as well as cell 
quiescence in the spheroids. 
Conversely, the results from Figure 4-4 demonstrated the MSC migration from 
the spheroid niche towards the wound site when co-cultured with scratched 
monolayers. Previous studies have shown MSCs migrate and home towards 
injured sites, in the presence of chemoattractant molecules released from the 
damaged area (da Silva Meirelles et al., 2009). The homing and migration 
process of the MSCs is greatly enhanced by their expression of many receptors, 
which interact with molecules released from the site of injury. Several receptors 
have been identified, which are involved in the migration and homing process, 
including chemokine receptors; CXCR4, CCR1, CCR4, CCR7, CCR9, CCR10, CXCR5 
and CXCR6 (Ryu et al., 2010, Honczarenko et al., 2006, Von Luttichau et al., 
2005). 
Chemokine receptor expression, such as CXCR4 are influenced by the Notch 
signalling pathway (Xie et al., 2013). Notch is an essential gene, which encodes a 
transmembrane signalling receptor, which in turn regulates cell fate outcomes 
e.g. cell migration. Notch signalling is a cell communication mechanism, which 
involves an interaction between a Notch receptor expressed on a membrane of 
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one cell (Cell 1) and Notch ligands attached to the membrane of a neighbouring 
cell (notch extracellular domain (NECD) on Cell 2, see Figure 4-9) (Guruharsha et 
al., 2012). Following the binding of the receptor and the ligand, the S2 cleavage 
site of the receptor on Cell 2 is exposed and proteolysis occurs by the action of 
the TNF-α converting enzyme (TACE). A second cleavage at the S3 site occurs 
through the effect of γ-secretase. This subsequent cleavage causes the Notch 
intracellular domain (NICD) to translocate into the nucleus of Cell 2. The NICD 
binds with CBF1/RBP-Jĸ/suppressor of Hairless/Lag1 (CSL) to form a complex, 
which recruits other co-activators to induce transcriptional expression of 
downstream target genes (Seke Etet et al., 2012). 
 
Figure 4-9: Simplified diagram of Notch signalling pathway. 
The binding of Notch ligand and receptor between cell 1 and cell 2 causes breakdown at S2 
and S3 of Notch receptor cleavage sites, leading to the release of the receptor’s intracellular 
domain, which trans-locates to the cell 2 nucleus, leading to the activation of downstream 
target genes. (NECD-Notch extracellular domain, NICD-Notch intracellular domain, TACE-
TNF-α converting enzyme, CSL-CBF1/RBP-Jĸ/suppressor of Hairless/Lag1). (Adapted from 
(Seke Etet et al., 2012)). 
A study by Xie et al., suggested inhibition of Notch signalling improved MSC 
migration, as a result of increased receptor CXCR4 expression (Xie et al., 2013). 
Furthermore, a study by Williams et al., showed Notch signalling activation down 
regulated CXCR4 expression in endothelial cells, which in turn led to reduced 
cell migration (Williams et al., 2008). Therefore, it may be suggested that the 
observed migration of the MSCs from the niche, shown in Figure 4-4 is due to the 
interruption in the Notch signalling with a subsequent increase in cytokine 
receptor expression, causing the migration of MSCs to the wound site. 
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The MSC in vivo homing process requires multiple steps, initiated by the rolling 
process. Low affinity interactions occur until the cell tethers via E-selectin 
receptors onto the cell using selectins, which allows the cell to transmigrate as 
depicted in Figure 4-10. This process causes integrin expression activation within 
the MSC, leading to firm cell adhesion, and thus, the cell is able to transmigrate 
to the desired location by the release of MMPs (see Figure 4-10) (Kholodenko et 
al., 2013, Khaldoyanidi, 2008, Karp and Leng Teo, 2009). Whilst the spheroid 
niche model is a very simplistic version of the in vivo environment, it is possible 
that the spheroid MSCs may adopt this in vivo migration process, in addition to 
MMP release, to migrate through the collagen gel to the monolayer site of injury. 
 
Figure 4-10: Illustration of MSC migration and homing in vivo. 
(Image adapted from (Khaldoyanidi, 2008)) 
In Figure 4-1 showed the fibroblasts, in the absence of a MSC niche, took 6 days 
to heal the wound. However, the images in Figure 4-4 showed the fibroblasts in 
the presence of a MSC niche spheroid closed the scratch within 3 days. 
Therefore, these results indicate the presence of a MSC niche, greatly increased 
the healing rate. Studies have shown MSCs enhance wound repair, via paracrine 
signalling to cells surrounding the affected area. Previous research has found 
that media collected from MSC monolayers contained chemoattractant 
molecules, recruited epidermal keratinocytes, as well as dermal fibroblasts at 
the wound site (Chen et al., 2008, Gurtner et al., 2008). Another study found 
the presence of MSCs within a wound, regulated dermal fibroblast migration, 
which in turn led to accelerated wound closure (Smith et al., 2010a). This study 
agreed with research by Hocking and Gibran, who found MSCs affected the 
regulation of fibroblast proliferation, thus accelerating wound healing (Hocking 
and Gibran, 2010). 
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In summary, the images in Figure 4-4 showed an increased MSC migration out of 
the niche over time. These results suggest attractant mechanisms were utilised 
within this niche model system. Chapter 5 describes further research, which 
studied the potential attractant molecules released from an injured monolayer 
site. 
4.5.3 MSC differentiation assessment post migration from 
spheroid niche to wound site. 
Figure 4-5 indicated the MSCs, within the scratched models were migrating out 
of the spheroid and incorporating in the scratched area. Numerous studies have 
shown MSCs enhance wound healing via paracrine signalling mechanisms, as 
discussed in Section 4.5.2. However, MSCs may also enhance this healing process 
by differentiating into resident cells, which surround the injured site.  
Researchers have established that MSCs migrate to the wound site and 
transdifferentiate into cells of the surrounding area (Sasaki et al., 2008, Wu et 
al., 2007). Sasaki et al., found MSCs were recruited to the damaged skin and 
these cells aided wound repair, by transdifferentiating into multiple skin cell 
types (Sasaki et al., 2008). However, research studies have shown conflicting 
evidence that MSCs may not differentiate into resident cutaneous cells (Javazon 
et al., 2007). Therefore, it was important to determine whether the MSCs, which 
had migrated out of the spheroid niche, were differentiating into the local cells. 
Extensive research has shown MSCs differentiate into cells of osteogenic 
lineages. Therefore, osteogenic markers (phosphorylated runt-related 
transcription factor-2 (RUNX-2) and osteopontin) were used to assess MSC 
differentiation, in both fibroblast (control) and osteoblast scratched monolayer 
models. RUNX-2 is an important transcription factor, which is known to induce 
MSC osteoblast differentiation (Tai et al., 2014). RUNX-2 has also been shown to 
be involved in the regulation of bone-related genes. Phosphorylation of RUNX-2 
is a post translational modification, which regulates RUNX-2 activity. During MSC 
osteogenic differentiation, key residues on RUNX-2 become phosphorylated, 
leading to increased RUNX-2 activity, which drives the differentiation process. 
RUNX-2 expression by MSCs, indicates the early onset of osteogenesis (Yang et 
al., 2014). Osteopontin is a marker associated with maturing osteoblasts and has 
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been used to identify MSCs, which have become further committed into 
osteogenic differentiation (Rust et al., 2007). Therefore, either phosphorylated 
RUNX-2 or osteopontin expression, within the migrating MSCs in the scratched 
models would indicate these cells were differentiating, into the resident 
osteoblastic cells. 
The control fibroblast model images depicted in Figure 4-5a, showed an absence 
of expression of phosphorylated RUNX-2 or osteopontin released from the 
migrating MSCs and/or spheroids. This result would suggest the MSCs within this 
model, were not spontaneously differentiating into cells of osteoblastic origin. 
Whereas, the presence of a scratched osteoblast monolayer led to the 
expression of both phosphorylated RUNX-2 (Figure 4-5b and Figure 4-6) and 
osteopontin (Figure 4-5b) in the migrating MSCs. Therefore, this novel 
experiment proved the MSCs migrating from the niche spheroids, into the 
scratched osteoblast area were differentiating into the resident osteoblasts. 
Fluidigm was subsequently used to compare gene expression of a selection of 
MSC and osteoblast markers, from RNA isolated from MSC spheroids co-cultured 
with scratched and unscratched osteoblast monolayers. Nestin and ALCAM are 
MSC surface markers used to characterise multipotency. High expression of 
nestin and ALCAM, after 3 days in the scratched model suggested the MSCs in the 
niche were retaining their stemness. Therefore, the MSCs were potentially able 
to self-renew and replace migrating MSCs, mimicking the bone marrow niche 
response. 
Bone morphogenetic proteins (BMPs) are essential for skeletal development and 
regeneration, particularly BMP-2, which interacts and induces RUNX-2, which in 
turn promotes osteoblast differentiation (Song et al., 2009). Furthermore, SMAD 
proteins are intracellular proteins, which regulate certain gene expression and 
are recruited by RUNX-2 to form an activator complex. These SMAD proteins 
initiate the responsive gene transcription of BMPs and are important in the initial 
processes of osteogenic differentiation. Figure 4-8 showed increased gene 
expressions of BMP-2, SMAD-2, SMAD-4 and SMAD-5 following a three day co-
culture period in the MSC scratched samples, suggesting the MSCs were 
beginning to differentiate down through the osteogenic lineage. 
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Previous studies indicate that whilst mature osteoblasts down regulate RUNX-2, 
it is up regulated in pre-osteoblasts and immature osteoblasts (Komori, 2010). 
MSCs have been shown to differentiate into immature osteoblasts, via the 
expression of RUNX-2. The day 3 scratched osteoblast samples showed high 
RUNX-2 expression, indicating the MSCs were starting to differentiate into pre-
osteoblasts or immature osteoblasts post 3 days. These results suggest the MSCs 
were migrating out of the niche, towards the scratch and starting the 
osteogenesis differentiation process.  
Additionally, BMP-2 is known to control osterix, which regulates another vital 
transcription factor for osteogenesis (Lai et al., 2011). Osterix has been shown 
to be involved in inducing pre-osteoblasts into mature osteoblasts. Therefore, 
osterix acts further along the differentiation process and downstream of RUNX-2 
(Lee et al., 2011a). The small amount of fold change of osterix expression, over 
a period of 3 days of the scratched osteoblasts, supports the theory the MSCs 
were at the initial stages of osteogenesis.  
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4.6 Summary 
This chapter aimed to further study the MSC niche model developed in Chapter 
3, by determining whether the MSCs could be stimulated, by co-culture with a 
wounded cell monolayer, to migrate towards the wound and aid would healing, 
as observed in vivo. 
Initial studies on the wound healing model (i.e. scratched monolayers) 
demonstrated that the resident monolayer cells (fibroblasts or osteoblasts), 
directionally migrated perpendicular to the scratch edge, closing the site of 
injury. Furthermore, the presence of a collagen gel prolonged the healing rate in 
both scratched fibroblast and osteoblast monolayer models. 
The co-culture of the MSC spheroid niches placed directly on top of the 
unscratched fibroblast and osteoblast monolayers, demonstrated the MSCs failed 
to migrate out of the niche into the surrounding area over three days. This result 
supported the data from Chapter 3, which demonstrated that the MSCs within 
the spheroids were in a quiescent state, and remained unstimulated by the 
presence of the monolayer. However, when the underlying monolayer was 
scratched, the MSCs directionally migrated out the spheroid, towards the 
scratched area. The addition of the MSC spheroid, accelerated the wound 
healing rate by 100%, compared to scratched models without MSC spheroids. 
Therefore, the MSCs appeared to encourage the proliferation of the local 
resident cell type to close the wound. Furthermore, following migration towards 
the wound, the MSCs became fully incorporated within the scratched area. This 
finding mimicked the in vivo niche response, where MSCs remain in a quiescent 
state when unstimulated, but in the presence of injury, they migrate out of the 
niche and accelerate the wound healing process. 
The migrated MSCs exhibited phosphorylated RUNX-2 and osteopontin 
expression, in the presence of the scratched osteoblast monolayer. Therefore, 
these results suggest the MSCs were differentiating via osteogenesis, into the 
resident cell type. Furthermore, RUNX-2 expression was observed at the gene 
level in MSCs extracted from the scratched osteoblast monolayer at day 3. Not 
only were the MSCs starting to differentiate, but there was also an increased 
nestin and STRO-1 expression, which indicated there was increased MSC 
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proliferation in the spheroid, in anticipation of the need to replace the migrated 
MSCs. 
These results suggest the MSC spheroid niche model is capable of mimicking the 
native bone marrow niche responses therefore, creating a responsive biomimetic 
model. The signals causing the MSCs to migrate out of the niche, towards site of 
injury, will be assessed in the following chapter. 
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5 Assessment of paracrine cell signalling within 
the induced MSC spheroid niche  
5.1 General Introduction 
During the wound healing process, MSCs migrate to the site of injury through a 
process of paracrine signalling. Small biologically active molecules, termed 
cytokines, assist in cell-cell communication in immune responses (Zhang and An, 
2007). Cytokines are released from cells in the injured area, which stimulate the 
movement of MSCs towards sites of trauma, inflammation and infection (Lin et 
al., 2003). Cytokines have various modes of action, which are able to affect 
neighbouring injured cells (autocrine), nearby cells (paracrine) or distant cells 
(endocrine) (Dembic, 2015). Various cells in the body produce a large variety of 
cytokines, including the interleukin, chemokine, interferon, transforming growth 
factor (TGF) and tumour necrosis factor (TNF) sub-families (Dinarello, 2007). 
Cytokines may be classified into various functional classes dependent on their 
primary properties. The table below (Table 5-1) lists a selection of cytokines and 
their mode of action in the body. 
Table 5-1: Functional classes of selected cytokines. 
(Adapted from (Dinarello, 2007)). 
Functional Class Primary Property Examples 
Chemokines Cellular emigration MCP-1, MIP-1α 
Interleukins Stimulation of T cells, synergistic 
effects, chemo-attracts neutrophils 
IL-1, IL-6, IL-8 
Interferons I and II Macrophage activation, anti-viral IFN-α, IFN-β, 
IFN-γ 
Tumour necrosis 
factor 
Induces cytolysis and cytostasis, 
enhances proliferation of T cells 
TNF-α, TNF-β 
Colony stimulating 
factors 
Haematopoietic differentiation, 
proliferation of neutrophilic, 
eosinophilic and monocytic lineages 
GM-CFS, M-CFS, 
G-CFS 
 
Cytokines are further categorised by their properties, including pro-
inflammatory and anti-inflammatory. During the initial inflammatory stage of 
the wound healing process, cells release pro-inflammatory cytokines including 
IL-6, IL-1β and TNF-α (Yagi et al., 2012). Following initial inflammatory 
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response, the chemokines subsequently induce chemotaxis. This process involves 
a directional cell migration, or homing, into the surrounding matrix. 
MSC/cytokine interaction causes an intracellular cascade of events, which 
induces MSC migration from the niche. These MSCs are further attracted to the 
injured area, due to the cytokine concentration gradient, caused by the event. 
The homing capacity of MSCs is dependent on the type of chemokine receptors 
present on the cells (Sohni and Verfaillie, 2013). Studies have identified specific 
cytokine receptors which aid MSC migration and homing, including CXCR4, CCR1, 
CCR4, CCR7, CXCR5 and CXCR6 (Sordi et al., 2005). The most studied chemokine 
and chemokine receptor associated with MSC homing and migration have been 
stromal derived factor-1 (SDF-1)/CXCL12 (chemokine) and CXCR4 (receptor). 
However, a number of studies have shown MSCs possess other cytokine 
receptors, including IL-1R, IL-6R and TNFI and aid MSC migration (Minguell et al., 
2001). 
Osteoblasts, under stressed conditions, have been shown to express and secrete 
IL-1, IL-6, IL-12, IL-18 and TNF-α, during the inflammatory response (Bost et al., 
1999, Udagawa et al., 1997). Another study found that 36 hours after injury, 
there were significantly increased levels of cytokine IL-2, suggesting this 
cytokine was involved in the initial pro-inflammatory response (Kowal-Vern et 
al., 1994). Furthermore, following skin trauma, researchers found significant 
increased levels of a few cytokines (IL-1β, IL-6, and TNF- α), which were also 
determined as pro-inflammatory mediators (Kubo et al., 2014, Grellner et al., 
2000). Therefore, in the present study, IL-1β, IL-2, IL-6, IL-12p70 and TNF-α 
were selected for analysis, from the scratched osteoblast and fibroblast 
monolayer cultures, during the first 72 hours following injury. 
5.2 Objectives 
Chapter 4 adopted the 3D MSC niche model and assessed the functional 
properties of the model, in relation to wound healing. The MSCs were found to 
directionally migrate from the spheroid niche, towards the site of monolayer 
culture injury. Subsequently, the MSCs integrated with the scratch-wound and 
advanced the healing rate. In this chapter, further investigations aim to 
establish the MSC migration cues, which trigger the cells to travel from the niche 
Chapter 5 – Identification of MSC Migration Cues 170 
 
to the site of injury. Cytokine analysis from the underlying scratched 
monolayers, would determine which biologically active molecules may be 
stimulating the MSCs, to home and migrate to the damaged area. Identification 
of specific cytokines would enable further analysis of the stimulatory effect of 
the identified cytokine(s) on MSCs within the niche model. 
These objectives will be achieved by: 
 The analysis and identification of secreted cytokines from scratched and 
unscratched monolayers, over various time periods. 
 The addition of identified cytokines to the niche model, in the absence of 
other stimuli.  
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5.3 Materials and Methods 
5.3.1 Cytokine Analysis 
5.3.1.1 Luminex assay 
Either osteoblast cells or h-TERTs were seeded onto CellBind plates. The 
osteoblast monolayer culture cells were cultured with osteogenic differentiation 
media (see Chapter 3, section 3.3.5), which was changed every 2/3 days, over a 
10 day period. The monolayer was either scratched or left unscratched followed 
by the immediate addition of fresh media. The supernatant was removed after 3 
hours, 12 hours, 24 hours and 72 hours and the Bio-Rad Bio-Plex Pro cytokine 
assay protocol was used to analyse the cytokines. 
All solutions were prepared from the Bio-Rad Pro Human Cytokine Group I, 5-
plex assay kit, except for the modified media, which was prepared in house. 
Each supernatant was centrifuged at 1000 g at 4°C for 15 minutes and the media 
was removed, in preparation for processing. The cytokine standard was 
reconstituted with modified media and 8 serial dilutions (1:4) were followed 
with the addition of modified media, to create a standard curve. A control blank 
was prepared with modified media. Each sample was further diluted (1:4) with 
modified media. Stock solutions (10x) of conjugated coupled magnetic beads 
were pooled together with assay buffer, to make a single 1x solution. The plate 
was pre-wetted with 100 μL of assay buffer, which was removed and 50 μL of the 
1x magnetic beads solution was added. 
Prior to the removal of each solution from the plate, a magnetic plate was 
applied to retain the beads within the wells. The solution was removed and the 
plate was washed twice with 100 μL of wash buffer. The standards, samples and 
blanks (50 μL) were added to the appropriate wells and left covered and shaken 
at room temperature for 30 minutes. After the appropriate incubation period, 
the solution was removed and the wells were washed thrice with wash buffer 
(100 μL). Stock solutions (10x) of detection antibodies were mixed together and 
diluted, to create a 1x solution with detection antibody diluent. The 1x solution 
was added to the wells (25 μL), left covered and shaken at room temperature for 
30 minutes. After the appropriate incubation period, the solution was removed 
and the wells were washed thrice with wash buffer (100 μL). Stock solution 
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(100x) of streptavidin-PE was diluted to create a 1x solution with assay buffer. 
The 1x solution was added to the wells (50 μL), left covered and shaken at room 
temperature for 10 minutes. After the appropriate incubation period, the 
solution was removed and the wells were washed thrice with wash buffer (100 
μL). The beads were re-suspended with assay buffer (125 μL), in preparation for 
analysis using the Bio-Rad Bio-Plex Luminex 100 plate reader. 
5.3.2 IL-6 Addition assay 
Media (1 mL) containing IL-6 (450 pg/mL) was added to MSC niche models (within 
collagen gels, prepared as previously described in section 2.3.4.2), for either 3 
hour, 12 hour, 24 hour or 48 hour incubation periods. Controls were prepared 
using fresh media, which was added to MSC niche models for up to 48 hours. 
Following each incubation period, test and control samples were fixed with 4% 
formaldehyde. These samples were stained for actin and analysed using a Zeiss 
Axiovert 200M fluorescent microscope. 
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5.4 Results 
5.4.1 Identification of cytokine secretion from scratched models. 
Figure 5-1 showed the absence of IL-1β, IL-2, IL-12p70 and TNF-α cytokines in 
the osteoblast cultures (Figure 5-1, image A). However, there was a significant 
increase of IL-6 in the presence of a scratch, compared to the unscratched 
model (Figure 5-1, image B). The control, unscratched samples, indicate a 
background level of IL-6 over the 72 hours (180 pg/mL). However, there was a 
significantly increased level of IL-6 between 3 hours and 12 hours in the 
scratched samples (an increase from 74 pg/mL to 450 pg/mL). IL-6 levels in the 
scratched osteoblasts remained constant between 12 hours and 72 hours post 
scratch. 
 
Figure 5-1: Quantitative analysis of cytokines secreted, from unscratched and scratched 
osteoblast monolayer after, 3 hours, 12 hours, 24 hours and 72 hours. 
(A) Graph depicting the concentration of secreted IL-1β, IL-2, TNF-α and IL-12p70 from 
scratched and unscratched osteoblast monolayers over 72 hours. (B) Concentration of 
secreted IL-6 from scratched and unscratched osteoblast monolayers over 72 hours. 
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Similarly, Figure 5-2 illustrated the lack of IL-1β, IL-2, IL-12p70 or TNF-α 
cytokine secretion in the fibroblast monolayer cultures (Figure 5-2, image A), 
with a significant increase of IL-6 in the presence of a scratch, compared to the 
unscratched model, up to and including the 24 hour sample period (Figure 5-2, 
image B and C). However, post 24 hours, there was a significant increase in IL-6 
concentration in both scratched and unscratched models. At 72 hours there was 
no significant difference between either models. 
 
Figure 5-2: Quantitative analysis of cytokines secreted, from unscratched and scratched 
fibroblast monolayer after, 3 hours, 12 hours, 24 hours and 72 hours. 
(A) Depicts the concentration of secreted IL-1β, IL-2, TNF-α and IL-12p70 from scratched 
and unscratched fibroblast monolayers over 72 hours. (B) Concentration of secreted IL-6 
after 3 hours, 12 hours, 24 hours and 72 hours and (C) without 72 hours time point. 
 
5.4.2 MSC niche model response to IL-6. 
Results from both Figure 5-1 and Figure 5-2 identified cytokine IL-6, as one of 
the signalling molecules secreted from the scratched osteoblast and fibroblast 
monolayer cultures. Therefore, IL-6 was deemed a potential candidate in the 
induction of MSC migration from the niche model. Therefore, IL-6 (at 450 pg/mL 
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concentration) was added to MSC niche models, in the absence of osteoblast and 
fibroblast monolayers, and assessed over a 48 hour period. Additionally, control 
gels in the absence of IL-6 were assessed over the same period of time (Figure 
5-3). 
The images depicted in Figure 5-3 showed a lack of MSC migration from the 
control samples, over the 48 hour period. Conversely, within 3 hours of the 
addition of IL-6 to the gels, there were MSC cellular protrusions from the 
spheroid into the surrounding collagen gel. At 12 hours, individual MSCs were 
noted to migrate from the spheroid niche, into the local vicinity of the gel. As 
time progressed, from 12 hours to 24 hours, there was a marked increase in the 
number of MSCs migrating out and exiting the niche. By 48 hours, migration was 
evident throughout the niche cultures. These results demonstrated a clear 
relationship between IL-6 exposure and MSC migration out of the spheroid niche 
model. 
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Figure 5-3: Niche model response to IL-6 addition over time. 
The MSC niche model was assessed with and without the addition of IL-6 to media over time 
(3 hours, 12 hours, 24 hours and 48 hours), in the absence of co-cultured monolayers. 20x 
objective, scale bar=50 µm. 
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5.5 Discussion 
5.5.1 Identification of cytokine secretion from scratched models. 
The cytokine IL-6 was the only identified secreted cytokine from the candidate 
panel in both osteoblast and fibroblast monolayers (Figure 5-1 and Figure 5-2). 
Various cells produce and secrete cytokine IL-6 to regulate numerous processes, 
including immune responses and bone homeostasis. Additionally, observations 
have shown that osteoblasts produce IL-6 (Marriott et al., 2004, Grellner et al., 
2000). IL-6 is known to regulate the differentiation of osteoblasts and 
osteoclasts. Osteoblasts secrete IL-6 to induce osteoclast differentiation and 
osteoclast-mediated bone demineralisation (Ishimi et al., 1990, Yoshitake et al., 
2008, Liu et al., 2006). IL-6 from osteoblasts stimulates osteoclast 
differentiation, by inducing the expression of the NF-κB ligand (RANKL) on 
osteoblasts, which in turn interacts with RANK expressed on osteoclast 
progenitors (Liu et al., 2006). During the bone remodelling cycle, osteoclast 
precursors fuse and become mature osteoclasts, allowing them to attach to the 
bone (Figure 5-4). These mature osteoclasts resorb bone to form Howship’s 
lacuna (Novack and Teitelbaum, 2008).  
 
Figure 5-4: Diagram demonstrating the bone remodelling process. 
IL-6 and TNF-α stimulate osteoblasts to express RANKL, which interacts with RANK 
receptors on the osteoclast progenitors causing them to fuse together to form osteoclasts. 
These osteoclasts are activated and become mature osteoclasts, which attach to the bone 
and initiate bone resorption process. (Adapted from (Meikle, 2006)). 
These cells are instrumental in the repair of damaged bone, via the bone healing 
process. A study showed osteoclasts were extremely important in the very early 
stages of bone healing, in the remodelling and resorption of bone (Schell et al., 
2006). 
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This study demonstrated that IL-6 was highly secreted, within the scratched 
osteoblast model during the initial 12 hours. These findings may therefore, 
suggest that the osteoblasts were being activated to initiate bone regeneration. 
An increased production of the cytokine from the osteoblasts, may lead to the 
potential differentiation of osteoblasts into osteoclasts. 
Following the initial increase in IL-6 secretion (during the first 12 hours), the IL-6 
levels remained at least double that of control unscratched cultures, 
subsequently, the levels of IL-6 plateaued over the next 60 hours. A study 
conducted by Kondo and Ohshima found IL-6 peaked at 12 hours, post wound 
induction of mouse skin (Kondo and Ohshima, 1996). These results correlate with 
the findings from this study in relation to the osteoblast samples. Kondo and 
Ohshima, suggest the initial significant increase in IL-6 concentration secreted 
by scratched models may be produced at this time to induce B-cell, T cell and 
macrophage differentiation, as well as stimulate keratinocyte growth to 
accelerate wound healing. Therefore, the observed increase of IL-6 in the 
media, within the scratched models, may stimulate cell growth and hasten the 
wound healing process.  
Other cells, including fibroblasts have been shown to produce and secrete IL-6, 
during the pro-inflammatory phase of wound healing post injury (Akira and 
Kishimoto, 1992). A study conducted by Lin et al., found IL-6 was critical in the 
healing of mouse skin excisions (Lin et al., 2003). Mice deficient in IL-6 displayed 
reduced wound healing rates, compared to normal wild mice. IL-6 deficiency in 
the mice affected all three phases of wound healing process thus, increasing the 
time taken to close the skin excisions (Lin et al., 2003). 
The scratched fibroblast monolayers also showed significantly increased levels of 
IL-6, compared to the unscratched sample, but only over the initial 24 hour 
period (Figure 5-2). After this time point, both unscratched and scratched 
models showed parallel increased levels of IL-6, with no significant differences 
between either model. These results may be due to the fibroblast cells 
becoming over-confluent and inducing a false positive response. The fibroblasts 
were seeded as a confluent monolayer and have a much higher proliferation 
rate, compared to osteoblasts (Fedarko et al., 1995). Therefore, when the 
fibroblasts were assessed over a period of 72 hours, the cells may have become 
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over-confluent. Over-confluent fibroblasts have previously been used as positive 
controls, for detecting matrix metalloproteinases and tissue inhibitors of 
metalloproteinases. A study by Cook et al., found fibroblasts over-expressed 
these molecules in this environment (Cook et al., 2000). Similarly, high secretion 
levels of IL-6 at 72 hours may not be a true representation of the fibroblast 
response, within the scratched and unscratched models.  
5.5.2 MSC niche model response to IL-6. 
In the initial stages of wound healing following injury, the surrounding cells 
within the damaged tissue release pro-inflammatory signals. Cytokine analysis 
highlighted IL-6 release in the scratched bone and connective tissue models. 
Cytokines are small proteins, which have various modes of action on numerous 
cell types. Cytokines diffuse into the surrounding area of injury, creating a 
concentration gradient. MSCs express numerous receptors, which interact with 
the cytokines. This interaction causes the MSCs to exit the bone marrow niche 
and migrate to the site of injury, via the cytokine concentration gradient. The 
exact homing mechanisms of MSCs to site of injury are poorly understood. 
However, studies identified numerous MSC chemokine homing receptors 
including: - CXCR4, CXCL12, CCR1, CCR7, CXCR5 and CXCR6 (Abumaree et al., 
2013). 
Additional studies have shown that damaged tissue in the initial inflammatory 
stage releases an influx of cytokines, including IL-6 (Spaeth et al., 2008). The 
increased circulation of IL-6 at the site of injury plays an active role in the 
recruitment of MSC migration to the wound (Yagi et al., 2012, Tondreau et al., 
2009). An in vitro study conducted by Shi et al., observed improved MSC 
migration and increased CXCR4 receptor expression, when the cells were pre-
treated with IL-6 (Shi et al., 2007). Moreover, Rattigan et al., demonstrated 
hypoxic breast cancer cells enhanced IL-6 production, thus increasing MSC 
recruitment to the tumour, via IL-6 interaction with its cognate IL-6 receptor 
(Rattigan et al., 2010). The authors stated the IL-6 released from the cancer 
cells acted in a paracrine fashion on nearby MSCs. The researchers were able to 
identify signalling pathways Janus kinase (JAK)/signal transducer and activator 
of transcription 3 (STAT3) and Mitogen-activated protein kinase (MAPK) 
involvement, in MSC migration/homing (Rattigan et al., 2010). 
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The JAK/STAT signalling pathway is the main signalling pathway utilised by 
numerous cytokines, including IL-6 to enter the cell and influence cell behaviour 
(e.g. cell proliferation, differentiation, migration and apoptosis) (Rawlings et 
al., 2004). MSCs are known to possess IL-6 receptors (IL-6R). Studies have shown 
that IL-6 utilises the classical signalling pathway, when IL-6 binds to its 
membrane bound IL-6 receptor (IL-6R), together with the signal-transducing 
protein, glycoprotein 130 (gp 130) (Luu et al., 2013, Heinrich et al., 1998). This 
binding causes the receptor to dimerise and activate the associated JAK tyrosine 
kinases attached to the receptor. The activated JAKs produce phosphotyrosine 
docking sites for STAT3 (a latent cytoplasmic transcription factor). The STAT3 is 
phosphorylated by the JAKs and leaves the receptor to dimerise and translocates 
to the nucleus. Once in the nucleus, the STAT3 dimer activates specific gene 
transcription (see Figure 5-5) (Aaronson and Horvath, 2002). 
 
Figure 5-5: IL-6 signalling via the gp130/JAK/STAT pathway. 
IL-6 dimerises gp 130 molecules and activates the associated JAK, which phosphorylates 
the gp 130 part inside the cell. This creates docking sites for STAT3, which become 
phosphorylated and form homo-dimers and translocate to the nucleus to activate gene 
transcription. Abbreviations used: gp 130 = glycoprotein 130, encircled Y = tyrosine, 
encircled P = phosphate. (Adapted from (Nishimoto and Kishimoto, 2006)). 
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A study by Takeda and Akira, found phosphorylated STAT3 accelerated cell cycle 
progression and promoted cellular differentiation, by regulating expression of 
Cyclin D1 and c-myc (Takeda and Akira, 2000). Additionally, researchers have 
found the JAK/STAT signalling pathway to be extremely important in the stem 
cell and stem cell niche interaction. A study by Leatherman et al., found stem 
cell adhesion (cadherins) was influenced by the JAK/STAT signalling pathway 
(Leatherman and DiNardo, 2010). The reduction of STAT92E affected DE-
cadherin binding between the stem cells causing the cells to detach and migrate 
from the niche. 
Furthermore, JAK/STAT has been shown to integrate with the BMP and growth 
hormone signalling pathway, to aid stem cell differentiation (Huang et al., 
2012). The growth hormone binds to its receptor which activates the JAK/STAT 
pathway. Further analysis has shown the growth hormone (GH) is a direct target 
of the BMP9/SMAD pathway and induces early and late osteogenic marker 
expression, causing osteogenic differentiation (Lamplot et al., 2013). 
The images depicted in Figure 5-3 clearly demonstrate that IL-6 addition to the 
MSC niche model instigated MSC migration from the spheroid niche into the 
surrounding collagen. Whereas, the absence of IL-6 allowed the MSCs to remain 
within the spheroids. These results verify IL-6 as a migratory cue for MSCs within 
the niche model. Therefore, the secreted IL-6 may have activated MSC 
recruitment, via JAK/STAT3 and MAPK signalling pathways, as highlighted by 
Rattigan et al (Rattigan et al., 2010). 
These studies suggest IL-6 secretion by the scratched monolayers, activated the 
JAK/STAT3 pathway to initiate MSC migration (see Figure 4-4 and Figure 5-3) by 
affecting the cadherin adhesion within the niche. The change in cadherin 
adhesion may initiate MSC detachment and migration from the niche, to the site 
of injury, via the IL-6 concentration gradient created by the damaged cells at 
the scratched site. Additionally, the JAK/STAT3 pathway may induce MSC 
osteogenic differentiation by also directly affecting the BMP/GH signalling 
pathway (see Figure 4-5).  
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5.6 Summary 
The study identified IL-6 as a contributory MSC migratory signal, from a panel of 
five cytokines candidates (IL-1β, IL-2, IL-6, IL-12p70, TNF-α), in both the 
fibroblast and osteoblast models. The scratched model showed a significant 
increase in IL-6 secretion into the surrounding area, compared to the 
unscratched model. This study highlights the importance of IL-6 secretion within 
both bone and connective tissue models in the initiation of the wound healing 
process. 
During the initial stage of wound healing, the site of injury induces a pro-
inflammatory response, via the release of cytokines. These small biologically 
active molecules, which include IL-6, enable the recruitment of various 
specialised cells, such as MSCs, to the injury site. This recruitment of cells 
occurs by a concentration gradient, which triggers wound regeneration and 
accelerates the rate of wound healing. In addition, IL-6 is a fundamental factor 
in the regeneration and remodelling of bone. Therefore, the significant increase 
of IL-6 in the scratched osteoblast model, may indicate IL-6 is being secreted to 
induce the bone healing process and thus, corroborates previous researchers’ 
findings. 
The isolated IL-6 cytokine was clearly shown to stimulate MSC migration out of 
the niche model into the surrounding area, without the presence of an injury. 
This finding verified the involvement of IL-6 in the initial stages of wound 
healing. 
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6 Concluding remarks: MSC in vitro niche model 
6.1 General Discussion 
Mesenchymal stem cell properties, including self-renewal, proliferation and 
differentiation, are crucial in the regeneration of damaged tissue. This area of 
study holds great future potential in the field of regenerative medicine. In vivo 
MSCs reside within a niche microenvironment in the bone marrow, which 
comprises of stem cells, differentiating progenitors, non-stem support cells and 
ECM. The interactions within this niche environment regulate maintenance, 
division and fate of the stem cell, throughout the whole lifespan of the 
organism. 
The bone marrow niche is able to integrate signals from soluble and surface-
bound factors, cell-cell contacts and mechanical properties of the surrounding 
environment, to influence stem cell fate. In the absence of such external cues, 
MSCs remain in an un-stimulated and quiescent state. However, the niche is able 
to respond rapidly to stimulating factors, resulting in stem cell proliferation and 
differentiation. Scientific consideration of MSC niche regulation has increased 
worldwide over the last decade. This interest has led to the exploration of niche 
interactions, by the recreation of the niche in an in vitro environment. 
Although the work in this thesis was unable to produce consistently sized MSC 
spheroids, the project was able to create MSC spheroids, which were all able to 
exhibit identical functionality; expressing high multipotency markers (STRO-1 
and nestin), a reduction in cell cycle progression and an improvement in the 
wound healing process. The inability to reproduce consistently sized spheroids 
may affect the reproducibility of research data in future experimentation. 
However, the use of a precise method to localise the magnetic field may benefit 
the production of uniform sized spheroids. 
The MSC niche is a complex and dynamic system, so the creation of a bio-
responsive in vitro niche model is extremely ambitious. Building an in vitro niche 
model requires 1) a fundamental understanding of the MSC niche biology and 2) 
the ability to create the desired 3D structures, which may simulate relevant 
physicochemical and biological properties. The resultant niche model should 
Chapter 6 – Discussion and Conclusion  185 
 
prove to be an improvement on current in vitro stem cell culture, thus reducing 
spontaneous cell differentiation. In addition, the model would provide an 
opportunity for detailed studies into MSC behaviour and regulation, within their 
niche environment. The overarching aim of the study would be to improve the 
retention of MSC multipotency properties, thus extending the time they may be 
used in clinical trials. Additionally, studying the signalling pathways and cell 
interactions within the MSC niche may aid artificial differentiation and the 
regeneration of diseased tissue. 
6.2 In vitro niche models compared to in vivo niche 
behaviours 
Results from in vitro niche studies do not always correlate with observations 
from the in vivo niche microenvironment. In vitro studies by Reya et al., and 
Willert et al., demonstrated Notch and Wnt signalling in the hematopoietic 
system was sufficient to promote HSC self-renewal (Reya et al., 2003, Willert et 
al., 2003). However, a study of the HSC niche in vivo, showed conditional 
deletion of the Notch receptor and ligand did not affect HSC maintenance and 
self-renewal (Mancini et al., 2005). Therefore, the in vivo results indicate more 
than one signal may be affecting this behaviour (Morrison and Spradling, 2008). 
These studies suggest the in vitro model was too simplistic in design to allow 
observation and interplay of the regulatory signals, involved in the in vivo HSC 
maintenance. 
Additionally, studies of neural stem cells by Gabay et al., and Stiles et al., 
showed a disparity between the in vitro reactions, compared to the normal in 
vivo neural stem cell niche (Stiles, 2003, Gabay et al., 2003). Canalia et al., 
concluded in vitro neural stem cell niche models should retain the intricate 
microenvironment, as well as cell-cell interactions, which are observed in the in 
vivo neural stem cell niche (Canalia et al., 2007). 
An interesting study, by Jones et al., proposed that MSCs may undergo 
phenotypic rearrangements, within in vitro modelling causing changes in MSC 
cell surface marker expression, compared to the natural in vivo bone marrow 
environment (Jones et al., 2002). Similarly, Marquez-Curtis and Janowska-
Wieczorek stated MSCs, which had been manipulated ex vivo, exhibited 
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phenotypic rearrangements (Marquez-Curtis and Janowska-Wieczorek, 2013). 
Additionally, Eggenhofer et al., postulated differences in migratory behaviour 
between cultured and non-cultured MSCs, may be due to in vitro induced 
phenotypic changes of the MSCs (Eggenhofer et al., 2014). 
The models described above do not replicate the true in vivo niche 
microenvironment, as highlighted by the outlined discrepancies. Although, there 
are known inconsistencies between in vitro models and native niche behaviours; 
the MSC spheroid niche model created in this project is an improvement, on 
previous and current niche models. The spheroid model was a better 
representation of an in vivo MSC niche, through the retention of MSC quiescence 
and multipotency properties. The model also demonstrated a wound healing 
response similar to in vivo observations. 
6.3 Applications of the MSC spheroid niche model 
In vitro models have major advantages over in vivo studies as they allow 
analysis, without the dilemmas associated with in vivo experimentation. At the 
present time, the complexity of observing intricate behaviours of the niche in 
vivo is restricted by the current limitations of medical techniques. The MSC 
spheroid model presented by this study allows the isolated investigation of MSC 
behaviour in a simplistic, yet physiologically relevant model system, which may 
be adopted for various applications. 
6.3.1 MSC regulation within the niche 
The MSC spheroid niche model provides an excellent tool to investigate the 
mechanisms controlling MSC proliferation and differentiation, within a controlled 
environment. The model was able to exhibit some cell-cell contacts, which are 
found in the in vivo bone marrow, allowing the study of MSC motility and 
response to artificial regulation and signalling. 
Future studies may include the exploration of asymmetric stem cell division. In 
the niche stem cells divide into two daughter cells; one which remains in the 
niche, and when required, one which exits the niche and differentiates. Morrison 
and Spradling reported on issues, which occurred when directly imaging stem 
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cell divisions within in vivo adult niches, because only a small percentage (2%) of 
the stem cells are actively dividing at any given time (Morrison and Spradling, 
2008). The MSCs within the bone marrow, constitutes only 0.01% of the cell 
population, which creates difficulties during the study of in vivo MSC divisions. 
Therefore, the ability to analyse MSC division in vitro, using a niche model, may 
allow a major breakthrough in scientific investigation. 
Another application of the model may permit in depth investigation of 
intercellular signals involved in regulating in the niche. Nystul and Spradling 
have studied the in vivo intercellular communication in the Drosophila follicle 
stem cell (FSC) niche (Nystul and Spradling, 2007). However, the authors were 
unable to elucidate the molecular mechanisms, involved in the prevention of 
external cells gaining entry to and displacing resident stem cells in the niche. 
The author’s stated it was important to understand these mechanisms, as 
external cells replacing niche stem cells, may cause the spread of precancerous 
mutations. Therefore, the MSC niche model may allow improved analysis of 
these mechanisms, which are involved in niche stem cell displacement, by 
labelling the MSCs within the niche with either radioactive isotopes or 
fluorescence tags to detect cell movement. On the other hand, the cells 
displacing the MSCs may also be labelled with either of the afore mentioned tags 
to assess cellular movement. The displacement mechanisms may then be 
investigated using antagonists to achieve a greater understanding of the 
processes, which protect the niche from cell infiltration. 
A further research area of interest would be the assessment and quantification 
of cell-cell and cell-ECM adhesion mechanisms, within the MSC niche. It would 
be impossible to quantify specific adhesion distances between cells in vivo 
whereas, in vitro modelling would provide a feasible alternative method of 
analysis. Adhesion within the niche is tightly regulated and integral to MSC 
differentiation and self-renewal. Understanding of these processes would allow 
direct manipulation of the MSCs, to promote either self-renewal or 
differentiation, within the niche. A recent study conducted by Burk et al., 
utilised a bone marrow niche model, which assessed N-cadherin and SDF-1α 
adhesion mechanisms in the HSC niche (Burk et al., 2015). The researchers were 
able to identify the mechanism of HSC adhesion, via N-cadherin homophilic 
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interactions and SDF-1α heterophilic interactions. Additionally, Burk et al., was 
able to measure the distances between the ligand molecules in the HSC niche 
using reflection interference contrast microscopy. These changes in ligand 
distances are detected by the HSCs, which in turn may influence HSC ability to 
either differentiate or self-renew. The niche model in this thesis, may similarly 
be used to quantify and assess adhesion mechanisms and junctions within the 
MSC niche. Therefore, controlling these distances may allow direct manipulation 
of the MSC niche to either maintain stasis of the quiescent MSCs, or initiate MSC 
migration from the niche and promote cell differentiation. 
6.3.2 Creation of a MSC bank 
Mesenchymal stromal cells are the most widely used cell type in cell therapy 
clinical trials at this time. Current trends indicate MSC use in clinical 
applications will continue to rapidly increase. However, clinical applications 
typically require the use of large numbers of MSCs, ideally in an off-the-shelf 
format (Thirumala et al., 2013). This requirement necessitates extensive MSC 
expansion ex vivo and storage, which promotes MSC multipotency (Carmelo et 
al., 2015, dos Santos et al., 2014). At present, MSCs are cryopreserved and 
banked however, this treatment leads to cell shock and loss of viability on cell 
recovery, resulting in reduced numbers of functional cells. Existing in vitro MSC 
culturing techniques are only able to maintain the stem cells for short periods of 
time, before they spontaneously differentiate. The work described in this 
project, prepares the foundation for the production of a viable and multipotent 
population of MSCs, which may be used to create a clinical bank of quiescent 
stem cells. Such an MSC bank would allow the long-term storage of 
undifferentiated MSCs, which may limit the need for invasive extractions from 
human sources. 
6.3.3 Modelling disease states 
6.3.3.1 Osteoporosis 
Interactions between adipose and bone tissue is affected by the stimulation or 
deactivation of transcription factors, signalling molecules and genes. The 
interruption of these interactions is known to be involved in various bone 
disorders including osteoporosis. Osteoporosis is a disease characterised by 
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systemic bone loss and destruction of the bone microstructure, causing fragility 
of the bone mass (Savopoulos et al., 2011). People with osteoporosis have an 
increased risk of low-traumatic fractures (Muschitz et al., 2015). Studies by 
Burkhardt et al., and Meunier et al., found osteoporotic patients showed an 
increased incidence of adipose tissue, within their bone marrow (Burkhardt et 
al., 1987, Meunier et al., 1971). Osteoporosis is linked to a shift in MSC 
differentiation from osteoblasts towards adipocyte formation in the bone 
marrow. This shift is caused by the activation of the proliferative activated 
receptor (PPAR) γ2 pathway, rather than the RUNX-2 pathway, in MSC 
differentiation (Rosen and Bouxsein, 2006). Correction of this pathway disorder, 
may help rectify this imbalance, thus redirecting MSC differentiation towards 
osteogenesis. Isolated studies utilising the MSC niche model, for example to 
block adipogenic differentiation of the MSCs and encourage osteogenesis, would 
provide useful information in the research of this topical area. 
6.3.3.2 Osteoarthritis 
Osteoarthritis occurs when the chondrocytes, within the synovial joint 
(cartilage, synovium and underlying bone) respond to injury leading to the 
degradation of cartilage within the joint. There are two phases in the 
osteoarthritis process: 1) the biosynthetic phase when the chondrocytes 
endeavour to repair damaged ECM and 2) degradative phase, when the MMPs, 
released by the chondrocytes, break down the matrix and inhibit matrix 
synthesis (Sandell and Aigner, 2001). This duel process leads to accelerated 
cartilage erosion, causing chronic pain in the joint. 
Kraus et al., suggests the identification of biomarkers using ‘omics technologies 
(genomics, proteomics, transcriptomics and metabolomics), may be used to 
detect early onset molecular abnormalities in osteoarthritis (Kraus et al., 2015). 
In normal physiology, chondrocytes maintain a balance between synthesis and 
degradation of MMPs. However, when the joint is subjected to abnormal loading, 
there is shift in this balance, leading to increased MMP levels and in turn 
increased degeneration of matrix. The MSC niche model may benefit such 
studies. MSC migration from the spheroids towards the damaged area, in this 
case scratched chondrocytes, may be monitored and assessed, to determine 
whether the cells may differentiate into chondrocytes. These migratory MSCs 
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will restore the balance of MMP synthesis and degradation, and therefore 
prevent further destruction of the matrix. Knowledge gained from the in vitro 
model experimentation may be transposed to in vivo, which both assists an early 
diagnosis (via biomarkers) and treatment to prevent osteoarthritis. 
6.3.4 Scar healing 
Following injury, the body initiates the wound healing response, to close the 
wound as rapidly as possible. The initial healing stage involves the pro-
inflammatory response, when cytokines are released from neutrophils (Maxson et 
al., 2012). This process causes fibroblasts to migrate towards the wound site and 
leads to excessive secretion of collagen, to enable closure of the wound (Huang 
et al., 2015). This collagen deposition leads to a loss of normal epithelial 
formation, resulting in the formation of fibrous scar tissue. Tissue fibrosis 
restricts natural movement, as well as contractures of the joint (Fourie, 2012). 
Furthermore, the fibrous scar tissue lacks the tensile strength or structure of 
normal skin, so the scar is vulnerable to further injury. 
The MSC niche model may be used to investigate MSC signalling mechanisms, 
which encourage proliferation of local resident epithelial cells in the prevention 
of fibroblastic granulation of the scar tissue. The signalling pathways may be 
transposed to any in vivo injury, to allow regrowth of normal epithelial tissue 
and thus, reduce the inherent movement restrictions associated with scar tissue. 
This newly created epithelial tissue will possess normal function and reduce the 
need for surgical interventions in the future. 
6.3.5 Aging of the MSC niche 
Problems associated with lack of efficient tissue repair in the aging population, 
have a major impact in the cost of medical care. Therefore, investigations into 
the maintenance of MSC ‘stemness’, through the analysis of intrinsic and 
extrinsic factors of the niche are essential to the understanding of the niche 
functions, in relation to an individual’s aging process (Silva and Conboy, 2008). A 
study on rats conducted by Carlson and Faulkner, showed the age of an 
individual rat was the sole factor in the success of muscle graft transplantation 
(Carlson and Faulkner, 1989). Young rats were able to accept both old and young 
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transplanted muscle grafts. However, old rats were unable to accept either old 
or young transplanted muscles grafts (Carlson and Faulkner, 1989). Therefore, 
the identification of age-specific factors from a range of different aged niches, 
may determine the underlying mechanisms, involved in the process of stem cell 
deterioration, over time (Silva and Conboy, 2008). 
The MSC niche model may be used to study the mechanisms and signalling 
pathways, involved in the aging process of the MSCs. This information may have 
considerable impact on regenerating damaged tissue in the aging population. 
Knowledge gained from this research may benefit post-operative elderly 
patients’ recovery, by accelerating the healing processes. 
6.3.6 Pharmacology Assessments 
The pharmaceutical industry extensively uses a process known as high 
throughput screening (HTS), to rapidly identify potential chemical targets or 
leads for the development of new drugs for the future. The HTS process has 
been characterised by its high efficiency, rapidness, simplicity, and low cost, 
which is able to screen >100 000 samples per day (Mayr and Bojanic, 2009). 
Recently, the HTS process has been applied to creating cell culture platforms for 
the use in the study of stem cell biology. There has been a vast amount of 
interest in the use of this process to reduce reagent consumption, increase 
throughput, and shorten analysis times (Maerkl, 2009). Kobel and Lutolf suggest 
there are three applications areas in the use of HTS to study stem cell niches, 
which include; i) creating platforms to screen various different niche factors and 
their combinations; ii) creating in vitro niche models to assess key aspects of 
natural niches; and iii) in depth single stem cell analysis (Kobel and Lutolf, 
2010). However, there has been limited work into the creation of HT tests, 
involving realistic in vitro stem cell niche models (Kitambi and Chandrasekar, 
2011). There have been difficulties in creating cellular- or subcellular-scale 
approaches, to simplify this spatially complex system and to study structural 
aspects of the niche. 
The MSC spheroid niche model may hold wide pharmacological implications. It 
shows promise of a human cell-based model platform, which acts as a high 
throughput, cost effective and reproducible assay, as well as mimicking the in 
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vivo niche microenvironment. Therefore, the model may be used to rapidly 
screen a multitude of drugs, for disease states including those highlighted above 
(as a ‘disease-in-a-dish’ models), as well as allowing toxicity testing thus, 
enhancing the scope for novel drug screening. 
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6.4 Conclusion 
The research encompassed in this thesis, primarily described the developmental 
stages of creating a physiologically relevant MSC in vitro niche model (Chapter 
3). This work has demonstrated the incorporation of mNPs within MSCs, enabled 
the creation of multicellular spheroids, in the presence of an external magnetic 
field. The maintenance of cell contacts, MSC behaviour and response, mimicked 
an in vivo MSC niche environment through the high expression of STRO-1 and 
nestin, as well as exhibiting multipotency. The MSCs remained in a dormant, 
quiescent state over time within the spheroid culture, compared to traditional 
2D culturing techniques. Increasing the complexity of the model using Type I 
collagen introduced cell-ECM contacts, and enhanced the in vitro model’s 
representation of a natural in vivo niche. The 3D collagen gels created an 
environment akin to in vivo bone marrow, demonstrating similar stiffness and 
ECM properties. 
Chapters 4 and 5 assessed the bio-responsive properties of the MSC spheroid 
model, to determine whether the MSCs, within the spheroids, were capable of 
detection, homing and migration towards a wound site, with consequent 
integration and differentiation. Exposure to a scratch-wounded monolayer, 
induced the MSCs to directionally migrate towards to the scratch and become 
incorporated in the wound area. Additionally, the presence of the MSC spheroid 
accelerated the wound-healing rate. However, the main finding of the study, 
was the trans-differentiation of the spheroid MSCs into the local resident cell 
type. MSCs expressing osteogenic markers, identified IL-6 as a potential MSC 
migratory signal in the wound healing process. 
This newly created in vitro MSC niche model exhibited native in vivo behaviours 
and responses in an environment, similar to natural bone marrow milieu. These 
findings indicate this model may be highly valuable in the exploration and in 
vitro study of intricate MSC niche processes. 
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6.4.1 Recommendation for Future work 
The research performed during the course of this project, has raised unexplored 
areas of interest and it may be advantageous to investigate further ways of 
improving the in vitro model. Particular areas of interest requiring further study 
are described and summarised below. 
 Investigations into additional bio-responsive behaviours of the niche 
model. 
 Assessment of MSC signalling pathways involved in MSC migration and 
niche homeostasis. 
 Improve the niche model through the incorporation of support cells i.e. 
pericytes, osteocytes and HSCs. 
 Cell cycle investigation of migrating MSCs from the niche to a wounded 
site. 
 Increase complexity of the wound healing assay by the introduction of 
neutrophils into the niche model. 
 Identify the presence of additional cytokines and chemokines released by 
wounds. 
 Assess the level of hypoxia within the MSC spheroids. 
 Improve localisation of the magnetic field to produce uniform sized 
spheroids. 
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